Endocrine Abstracts

Contents

• 19th European Congress of Endocrinology 2017
• • Prize Lectures and Biographical Notes
  • The European Journal of Endocrinology Prize Lecture
  • • Hypothalmic AMPK: a golden target against obesity?

      ea0049eje1
    • European Journal of Endocrinology Prize Winner

      ea0049eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Toward hormone-based precision medicines for metabolic diseases

      ea0049gh1
    • Geoffrey Harris Prize Winner

      ea0049gh1biog
  • European Hormone Medal Lecture
  • • Endocrine disruptors: Is it all Greek to us?

      ea0049ehm1
    • European Hormone Medal Lecture

      ea0049ehm1biog
  • Clinical Endocrinology Trust Lecture
  • • Prospects for a new assessment of polycystic ovarian syndrome

      ea0049cet1
    • Clinical Endocrinology Trust Lecture

      ea0049cet1biog
  • IPSEN1
  • • Redefining neuroendocrinology: stress, sex and cognitive and emotional regulation

      ea0049ipsen1
• Plenary Lectures
• • The fantastical world of hormones
  • • The fantastical world of hormones

      ea0049p1
  • The secret life of FGF21
  • • The secret life of FGF21

      ea0049p2
  • Update on regulation of steroidogenesis by aberrant hormone receptors
  • • Update on regulation of steroidogenesis by aberrant hormone receptors

      ea0049p3
  • The role of brain insulin resistance for the development of prediabetic phenotypes
  • • The role of brain insulin resistance for the development of prediabetic phenotypes

      ea0049p4
  • Browning of adipose tissue and metabolic regulation
  • • Browning of adipose tissue and metabolic regulation

      ea0049p5
  • Thyroid oncology in the crossroads of precision and narrative medicine
  • • Thyroid oncology in the crossroads of precision and narrative medicine

      ea0049p6
• Symposia
• • Clinical Updates in Hypoparathyroidism
  • • Congenital hypoparathyroidism

      ea0049s1.1
    • Acquired hypoparathyroidism

      ea0049s1.2
    • Clinical updates in hypoparathyroisism

      ea0049s1.3
  • Evolving diagnostics in adrenal and neuroendocrine tumours
  • • Role of genetic and biomarker tests for diagnosis of neuroendocrine tumours (NETs)

      ea0049s2.1
    • Current status in morphological imaging in adrenal and gastrointestinal neuroendocrine tumours

      ea0049s2.2
    • Current status in functional imaging

      ea0049s2.3
  • From the pituitary to the periphery
  • • Implication of the prolactin receptor in humans

      ea0049s3.1
    • GHR: are there benefits of endocrine defects?

      ea0049s3.2
    • Somatostatin receptors: news in the pituitary, lessons for the periphery

      ea0049s3.3
  • 2nd Joint Global Symposium on Obesity - The Many Dimensions of the Childhood Obesity Problem
  • • Efficacy and effectiveness of physical activity and nutrition interventions in childhood obesity treatment

      ea0049s4.1
    • The hunger genes: pathways to obesity

      ea0049s4.2
    • Can we prevent childhood obesity?

      ea0049s4.3
  • Turn your face to the sunshine
  • • Effects of maternal thyroid function on infant neurodevelopment

      ea0049s5.1
    • Vitamin D and rickets in African children

      ea0049s5.2
    • Carbohydrate metabolism in patients with Cushing disease: a glance at the incretin system

      ea0049s5.3
  • Treatment of hypothyroidism: what have we learned?
  • • What is the clinical relevance of deiodinase polymorphisms?

      ea0049s6.1
    • T4/T3 combination therapy: is there a true effect?

      ea0049s6.2
    • Rebuilding your own thyroid from stem cells; the future therapy of hypothyroidism?

      ea0049s6.3
  • Crosstalk between bone & other organ(ism)s
  • • Immune system

      ea0049s7.1
    • Osteocalcin signaling in myofibers is necessary and sufficient to increase exercise capacity

      ea0049s7.2
    • Gut microbiota and bone metabolism

      ea0049s7.3
  • Predictors of therapeutic response in functioning pituitary tumours
  • • Molecular profiling

      ea0049s8.1
    • MRI predictors of therapeutic response in GH-secreting pituitary tumours

      ea0049s8.2
    • Predictors of therapeutic response in functioning pituitary tumours

      ea0049s8.3
  • Novel type 2 diabetes treatment: Beyond glycaemic control
  • • Experimental models

      ea0049s9.1
    • Clinical studies on GLP1 - cardiovascular outcomes

      ea0049s9.2
    • SGLT2 long term protective effects

      ea0049s9.3
  • The Challenges of Male Fertility
  • • Manipulating testicular androgen production to promote lifelong male health

      ea0049s10.1
    • Fertility preservation in pre-pubertal and young males

      ea0049s10.2
    • Pubertal induction and hormone replacement in young males

      ea0049s10.3
  • New Roles for Nuclear Receptors
  • • Identification of nuclear receptors network in male fertility

      ea0049s11.1
    • Crosstalk between estrogen signalling and DNA damage repair

      ea0049s11.2
    • The role of androgens in bone

      ea0049s11.3
  • New development in Graves' Orbitopathy
  • • The orbital fibroblast: a key player and target for therapy in graves' orbitopathy

      ea0049s12.1
    • Management of Graves orbitopathy

      ea0049s12.2
    • How to predict progression in Graves orbitopathy?

      ea0049s12.3
  • Challenging pituitary diseases
  • • Hypophysitis

      ea0049s13.1
    • Empty sella

      ea0049s13.2
    • Imaging of sellar masses

      ea0049s13.3
  • Searching for the cause and approach in ectopic hormone syndromes
  • • Rare Cushing's

      ea0049s14.1
    • Searching for the cause and approach in ectopic hormone syndromes: rare acromegaly

      ea0049s14.2
    • Rare hypoglycemia

      ea0049s14.3
  • Metabolic surgery mechanisms to clinical results (Endorsed by the European Journal of Endocrinology)
  • • The upper gut anti-incretin theory

      ea0049s15.1
    • The role of bile in metabolic surgery

      ea0049s15.2
    • Long term effects of metabolic surgery

      ea0049s15.3
  • Late-breaking: the PCSK9 revolution
  • • Beyond LDL lowering: the pleiotropic roles of PCSK9

      ea0049s16.1
    • New strategies for inhibiting PCSK9

      ea0049s16.2
    • PCSK9 inihibition in clinical practice: present and future

      ea0049s16.3
  • What endocrinologists should know about the genomics of endocrine tumors
  • • Clinical consequences of the recent genomics findings in thyroid cancer

      ea0049s17.1
    • Clinical implications of SDHx mutations

      ea0049s17.2
    • Will genomics help to finally classify NET's?

      ea0049s17.3
  • Hyperandrogenism: challenges in clinical management
  • • Hyperandrogenic states: pitfalls in diagnostic approach

      ea0049s18.1
    • Metabolic perspectives for the non-classical CAH (NCAH)

      ea0049s18.2
    • Hyperandrogenism and cardiometabolic risk

      ea0049s18.3
  • How to incorporate the new guidelines for thyroid cancer in my clinical practice
  • • Thyroid microcarcinoma: to treat or not to treat?

      ea0049s19.1
    • When and how should we perform extensive surgery?

      ea0049s19.2
    • Dynamic risk stratification in low-risk vs high-risk patients

      ea0049s19.3
  • Beta cell replacement and plasticity (Endorsed by Endocrine Connections)
  • • Stem cells for [beta] cell replacement in type 1 diabetes

      ea0049s20.1
    • New Strategies for beta cell replacement

      ea0049s20.2
    • Induction of pancreatic beta-like cell neogenesis

      ea0049s20.3
  • Environmental influences on endocrine systems
  • • Lifestyle and environmental factors in metabolic diseases; endocrine disruptors: new diabetogens?

      ea0049s21.1
    • Evidence on reproductive disorders through endocrine disruption in-utero

      ea0049s21.2
    • Euthyroid: towards a euthyroid Europe

      ea0049s21.3
  • Rare bone diseases (Endorsed by the European Journal of Endocrinology)
  • • Approach for clinicians

      ea0049s22.1
    • Osteogenesis imperfecta & Ehlers-Danlos Syndrome

      ea0049s22.2
    • Fibrous dysplasia of bone/McCune-Albright syndrome

      ea0049s22.3
  • Endo Oncology: prolactin, GH and metabolic hormones in oncology pathogenesis (Endorsed by Endocrine Connections)
  • • Prolactin regulation of prostate stem cells: potential implications in prostate cancer

      ea0049s23.1
    • Is GH a cancer growth factor?

      ea0049s23.2
    • Is reducing insulin-resistance relevant to prevent cancer?

      ea0049s23.3
  • Obesity: Pharmacological solutions
  • • MSH analogs

      ea0049s24.1
    • The future drugs to come

      ea0049s24.2
    • US experience update

      ea0049s24.3
  • HPA axis regulation during a woman's life: impact on metabolic outcomes
  • • HPA axis regulation during a woman's life: impact on metabolic outcomes

      ea0049s25.1
    • HPA axis, insulin resistance and adipocytokines in the fetal-maternal unit

      ea0049s25.2
    • 11[beta]-hydroxysteroid dehydrogenase activity, androgen excess, and metabolic outcomes in woman

      ea0049s25.3
  • Tissue specific defects in thyroid hormone action
  • • Mouse models to study tissue specific hypothyroidism

      ea0049s26.1
    • Syndromes of decreased sensitivity to thyroid hormone

      ea0049s26.2
    • Restoring TH action in patients with transporter defects: the triac trial

      ea0049s26.3
  • Vitamin D beyond bone (Endorsed by Endocrine Connections)
  • • Heart & Vessels

      ea0049s27.1
    • Fertility

      ea0049s27.2
    • Muscles

      ea0049s27.3
  • Sleep, love and reproduction (Endorsed by Endocrine Connections)
  • • Candidate mechanisms underlying the association between poor sleep and obesity

      ea0049s28.1
    • Oxytocin: from biology to love

      ea0049s28.2
    • Kisspeptin and neurokinin B - novel reproductive hormones with therapeutic potential

      ea0049s28.3
  • Novel predictors of diabetes
  • • Novel predictors of type 1 diabetes

      ea0049s29.1
    • Clinical and genetic indicators for diabetes prediction

      ea0049s29.2
    • Novel predictors of diabetes - NAFLD, diabetes and CVD

      ea0049s29.3
  • Moving away from old-fashioned steroidogenesis: what are the clinical implications?
  • • Clinical relevance of alternative synthesis of androgens

      ea0049s30.1
    • Clinical relevance of steroid precursors in adrenocortical tumors

      ea0049s30.2
    • Glucocorticoid production in primary aldosteronism - from mechanisms to clinical implications

      ea0049s30.3
  • Guided session 1
  • • New international clinical practice guidelines for the care of girls and women with turner syndrome

      ea0049gs1.1
    • Growth and puberty induction

      ea0049gs1.2
    • Adult aspects of turner syndrome

      ea0049gs1.3
    • Cardiovascular health issues in turner syndrome

      ea0049gs1.4
    • Abstract unavailable

      ea0049gs1.5
    • Abstract unavailable

      ea0049gs1.6
  • Guided session 2
  • • Aggressive pituitary tumours

      ea0049gs2.1
    • Aggressive pituitary tumours

      ea0049gs2.2
    • Aggressive pituitary tumours

      ea0049gs2.3
    • Aggressive pituitary tumours

      ea0049gs2.4
    • Aggressive pituitary tumours

      ea0049gs2.5
    • Aggressive pituitary tumours

      ea0049gs2.6
• New Scientific Approaches
• • (1)
  • • Identifying molecular signatures for cancer patient stratification via metabolomics and integrative bioinformatics

      ea0049nsa1
    • Exosome profiling: potential in cancer diagnosis and stratification

      ea0049nsa2
    • Genomic approaches on epigenetics

      ea0049nsa3
    • CRISPR/cas9 cas9-generated mouse models of resistance to thyroid hormone due to THRA mutations

      ea0049nsa4
    • Methodical tools for the structural elucidation of G-protein coupled receptors

      ea0049nsa5.1
    • Small molecule agonists and antagonists as potential new therapeutics targeting the TSH receptor

      ea0049nsa5.2
    • Mitochondrial epigenetics in obesity and its co-diseases

      ea0049nsa6
• DEBATES
• • Is there a role for medical therapy for non-functioning pituitary adenomas?
  • • Is there a role for medical therapy for non- functioning pituitary adenomas? - FOR

      ea0049d1.1
    • Is there a role for medical therapy for non- functioning pituitary adenomas? - AGAINST

      ea0049d1.2
  • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? (Endorsed by the European Journal of Endocrinology)
  • • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - FOR

      ea0049d2.1
    • Incidentally discovered nonfunctioning pancreatic NETs: Surgery or not? - AGAINST

      ea0049d2.2
  • Drug holiday in osteoporosis (Endorsed by the European Journal of Endocrinology)
  • • Drug holiday in osteoporosis - FOR

      ea0049d3.1
    • Drug holiday in osteoporosis - AGAINST

      ea0049d3.2
  • Is cardiovascular risk increased in women with PCOS?
  • • Is cardiovascular risk increased in women with PCOS? - FOR

      ea0049d4.1
    • Is cardiovascular risk increased in women with PCOS? - AGAINST

      ea0049d4.2
  • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer?
  • • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - FOR

      ea0049d5.1
    • Should we still ablate all patients undergoing total thyroidectomy for thyroid cancer? - AGAINST

      ea0049d5.2
  • Is it time for initial combination in type 2 diabetes?
  • • Is it time for initial combination in type 2 diabetes? - FOR

      ea0049d6.1
    • Is it time for initial combination in type 2 diabetes? - AGAINST

      ea0049d6.2
• Meet the Expert Sessions
• • (1)
  • • How to manage diabetes in the elderly?

      ea0049mte1
    • Diagnosis and management of GH deficiency - from childhood to adulthood

      ea0049mte2
    • Hormone-secreting adrenal tumours in pregnancy

      ea0049mte3
    • Treatment of congenital hypothyroidism

      ea0049mte4
    • Modern spectrum of bone turnover markers - are they clinically useful?

      ea0049mte5
    • How best to utilise technology in diabetes?

      ea0049mte6
    • When and which treatment to use in Graves disease?

      ea0049mte7
    • How best to manage neuroendocrine tumours? - Towards a new algorithm

      ea0049mte8
    • Sarcopenia - why should we care?

      ea0049mte9
    • Contraception in women with obesity, metabolic syndrome and diabetes

      ea0049mte10
    • Drug induced osteoporosis

      ea0049mte11
    • A modern approach for treatment PCOS

      ea0049mte12
    • What can new insulins provide for management of diabetes?

      ea0049mte13
    • Thyroid carcinoma: complicated cases

      ea0049mte14
    • Gaucher disease: interdisciplinary management

      ea0049mte15
    • New treatment approaches in dyslipidemia

      ea0049mte16
    • A paediatric perspective of endocrine late complications following childhood cancer

      ea0049mtne1
    • Providing nursing care for the adult patient with endocrine late effects of cancer treatment

      ea0049mtne2
    • Unravelling the role of transient receptor potential channels in endocrine regulation and metabolism

      ea0049mtbs1
    • Regulation and dysregulation of appetite and satiety

      ea0049mtbs2
    • MicroRNAs and the regulation of glucose and lipid metabolism

      ea0049mtbs3
• Nurse Sessions
• • (1)
  • • Clinical practice overlap and seamless care - diagnosis and management of hypothyroidism in patients with diabetes mellitus

      ea0049n1.1
    • Clinical practice overlap and seamless care - links between hypogonadism, the metabolic syndrome and type 2 diabetes

      ea0049n1.2
    • Clinical practice overlap and seamless care - challenges in the management of patients with Cushing's syndrome and diabetes

      ea0049n1.3
    • Clinical practice overlap and seamless care - at risk of two endocrine emergencies: the patient with type 1 diabetes and Addison's disease

      ea0049n1.4
    • Nurses professional development and networking session - obstructive sleep apnea and comorbidities in patients with pituitary adenomas

      ea0049n2.1
    • Nurses professional development and networking session - utilising the competence framework to develop the role of endocrine nurses in adrenal insufficiency

      ea0049n2.2
    • Nurses professional development and networking session - hybrid training of nurses in/for the endocrinology; train the trainer with help of e-learning modules

      ea0049n2.3
    • Nurses professional development and networking session - developing a European position statement for endocrine nurses providing care for patients with adrenal insufficiency

      ea0049n2.4
    • Update on diet and lifestyle throughout lifespan to improve health - prevalance and treatment of vitamin D deficieny in children

      ea0049n3.1
    • Update on diet and lifestyle throughout lifespan to improve health - sexual hormones and bone, a close link throughout lifespan

      ea0049n3.2
    • Update on diet and lifestyle throughout lifespan to improve health - osteoporosis and prevention of fractures: nurses can a play key role

      ea0049n3.3
• Oral Communications
• • Adrenal-Basic & Clinical
  • • High resolution tissue mass spectrometry imaging: a new tool for identification of prognostic markers in adrenocortical carcinoma

      ea0049oc1.1
    • EZH2: a master regulator of adrenal cortex homeostasis and zonation

      ea0049oc1.2
    • Steroid metabolomics for accurate and rapid diagnosis of inborn steroidogenic disorders

      ea0049oc1.3
    • The epidemiology of pheochromocytoma: increasing incidence and changing clinical presentation. A population-based retrospective study 1977-2015

      ea0049oc1.4
    • Diagnostic accuracy of three confirmatory tests for primary aldosteronism: a prospective study and systematic review

      ea0049oc1.5
  • Diabetes Prediction and Complications
  • • microRNA expression profile in plasma from patients with type 1 diabetes: a case-control study and bioinformatics analysis

      ea0049oc2.1
    • Effectiveness of complex therapy in patients with comorbidity of type 2 diabetes and essential hypertension depending on genetic polymorphism PPAR[gamma]2

      ea0049oc2.2
    • GLP-1 based multi-agonists-induced signaling includes profound TRP channel involvement in insulin secretion

      ea0049oc2.3
    • Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial

      ea0049oc2.4
    • Urinary peptidomics for the detection of diabetic kidney disease

      ea0049oc2.5
  • Receptors & Signalling
  • • Epigenetic regulation of aldosterone synthase gene, CYP11B2 by potassium

      ea0049oc3.1
    • Elucidating the role of Liver X receptors (LXRs) in the testis using lipid systems biology

      ea0049oc3.2
    • AKR1C3-mediated adipose androgen generation drives lipotoxicity in polycystic ovary syndrome

      ea0049oc3.3
    • Treatment with thyroid hormone metabolite 3,5-T2 alters cholesterol and sex steroid metabolism in mouse liver

      ea0049oc3.4
    • Accurate staging of non-alcoholic fatty liver disease through analysis of the urinary steroid metabolome

      ea0049oc3.5
  • Thyroid Disease 1
  • • Hypothyroidism in pregnancy is associated with twin pregnancies and with adverse obstetric outcome: Analysis of 142,277 deliveries data from a single center

      ea0049oc4.1
    • Inducible thyrocyte-specific Gs alpha-deficient mice as a novel model for hypothyroidism

      ea0049oc4.2
    • A novel variant in the SERPINA7 gene causing partial TBG deficiency in a women and two male siblings: molecular and protein structural analysis

      ea0049oc4.3
    • The TSH receptor reaches the trans-Golgi network to induce PKA activation and trigger gene transcription

      ea0049oc4.4
    • Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?

      ea0049oc4.5
  • Cardiovascular Endocrinology
  • • Polarized epithelial cells release exosomes loaded with miRNAs capable of interacting with HSD11B2 and MR genes

      ea0049oc5.1
    • Association of PPAR gamma gene expression with dietary intake of fat and oil among non-diabetic subjects

      ea0049oc5.2
    • Cardio metabolic assessment of lamin A/C mutation carriers according to R482 or Non-R482 mutation

      ea0049oc5.3
    • Food history characterization of Portuguese centenarians, nutritional biomarkers and cardiovascular risk: case control study

      ea0049oc5.4
    • Sex dimorphism of renal corticosteroid signaling during development and long term consequence on blood pressure

      ea0049oc5.5
  • Diabetes therapy and complications
  • • A passe-PAR2 for [beta]-cell regeneration and protection

      ea0049oc6.1
    • Insulin-mimetic effects of short-term Rapamycin in type 1 diabetic patients prior islet transplantation

      ea0049oc6.2
    • Alterations in DNA methylation from peripheral blood cells in humans threated with metformin

      ea0049oc6.3
    • Copeptin and its association to cardiovascular dysfunction in type 2 diabetes

      ea0049oc6.4
    • Activation of the Renin-Angiotensin II-Aldosterone-System leads to increases in extracellular protein disulfide isomerase: role in insulin resistance

      ea0049oc6.5
  • Cardiovascular endocrinology (1)
  • • Estrogens enhance gonadectomy-induced adrenocortical tumor progression in mice

      ea0049oc7.1
    • Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication

      ea0049oc7.2
    • High Total 68Ga-DOTATATE-Avid Tumor Volume (TV) is associated with low progression-free survival and high disease-specific mortality rate in patients with neuroendocrine tumors

      ea0049oc7.3
    • A novel insight into the anticancer mechanism of metformin in Pancreatic Neuroendocrine Tumor cells

      ea0049oc7.4
    • Regulation of steroid receptor signalling by tumor suppressor INPP4B

      ea0049oc7.5
  • Neuroendocrinology
  • • Elucidating the molecular mechanisms underlying AIP dependent tumorigenesis

      ea0049oc8.1
    • Knocking down/out the prokineticin pathway during zebrafish development results in the GnRH neurons axons misguiding

      ea0049oc8.2
    • RNA sequencing and RT-qPCR identify different gene expression profiles in fast- vs. slow-growing non-functioning pituitary adenomas

      ea0049oc8.3
    • Cerebrovascular stroke incidence in GH-treated adults: experience from KIMS (Pfizer International Metabolic Database)

      ea0049oc8.4
    • Ephrin-B2 is required for pituitary development

      ea0049oc8.5
  • Thyroid Disease 2
  • • Thyroid function and metabolic syndrome: results from the population-based LifeLines Cohort study

      ea0049oc9.1
    • Effect of restoration of euthyroidism in patients with hypothyroidism on cold induced thermogenesis

      ea0049oc9.2
    • How much of the genetic predisposition to Hashimoto's thyroiditis can be explained by genes commonly associated with the disease?

      ea0049oc9.3
    • Thyroid dysfunction during the use of PD-1/PD-L1 blockade predicts its therapeutic response in the patients with advanced non-small cell lung cancer

      ea0049oc9.4
    • Selenium supplementation in the management of thyroid autoimmunity during pregnancy: results of the 'Serena Study' a randomized, double-blind, placebo-controlled trial

      ea0049oc9.5
  • Bone & Calcium Homeostasis
  • • Treatment of 711 patients with hypoparathyroidism: a retrospective study in 3 German endocrine centres

      ea0049oc10.1
    • Evaluation of bone quality, measured by trabecular bone score (TBS) in patients with primary hyperparathyroidism (PHH) with and without surgery

      ea0049oc10.2
    • High prevalence of radiological vertebral fractures in patients with differentiated thyroid carcinoma undergoing L-thyroxine TSH-suppressive therapy

      ea0049oc10.3
    • The effect of denosumab or bisphosphonates in women with severe postmenopausal osteoporosis after completion of teriparatide treatment

      ea0049oc10.4
    • G[alpha]11-Phe220Ser loss-of-function mutation causes familial hypocalciuric hypercalcemia type-2 (FHH2) by disrupting a hydrophobic cluster critical for G-protein signaling

      ea0049oc10.5
  • Obesity
  • • Role of Extracellular vesicles in the crosstalk between adipocytes and pancreatic beta-cells

      ea0049oc11.1
    • Three year prospective study in morbidly obese patients between longitudinal gastrectomy and gastric bypass based on a composite outcome combining weight loss efficacy and surgery related complications (PHRC SLEEVE K060213 / IDRCB2007-A00373-50)

      ea0049oc11.2
    • Interleukin-1 antagonism decreases cortisol levels in obese individuals

      ea0049oc11.3
    • Comparing effects of weight loss by liraglutide with intensive lifestyle modification on hepatic steatosis, inflammation and stiffness, and insulin resistance in obese Asians with non-alcoholic fatty liver disease (NAFLD)

      ea0049oc11.4
    • Differentiating constitutional thinness from anorexia nervosa in DSM 5 era

      ea0049oc11.5
  • Pituitary Clinical
  • • T2-Weighted signal intensity of functional pituitary adenomas: correlation with clinicopathological findings and response to treatment

      ea0049oc12.1
    • Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey

      ea0049oc12.2
    • Recombinant Growth Hormone added to physical therapy in GH-deficient adults with complete (ASIA A) Spine Injury (EudraCT 2011-005377-23)

      ea0049oc12.3
    • Subclinical cardiovascular system dysfunction in the patients with Cushing's disease

      ea0049oc12.4
    • Effects of pegvisomant and somatostatin receptor ligands on risk of vertebral fractures in patients with Acromegaly

      ea0049oc12.5
  • Reproduction & Endocrine Disruption
  • • Abstract unavailable

      ea0049oc13.1
    • Thyroid peroxidase antibodies do not predict outcome in 900 women with recurrent pregnancy loss

      ea0049oc13.2
    • Sertoli cell expressed hydroxysteroid (17beta) dehydrogenase 1 is required for male fertility

      ea0049oc13.3
    • Diabetes mellitus: a new cause of male infertility

      ea0049oc13.4
    • Urinary cadmium excretion is associated with increased synthesis of cortico- and sex steroids in a family-based Swiss population study

      ea0049oc13.5
  • Thyroid Cancer
  • • Anti-Mullerian hormone (AMH) in pre-menopausal females after ablative radioiodine (RAI) treatment for differentiated thyroid cancer (DTC): single-center study

      ea0049oc14.1
    • Suppression of heme oxygenase-1 inhibits growth and invasion of thyroid cancer

      ea0049oc14.2
    • TERT, BRAF and NRAS in the molecular profile of metastatic thyroid cancer: differences between primary and distant disease

      ea0049oc14.3
    • Inverse relation between thyroid cancer incidence and threshold for thyroid surgery: a national population-based retrospective study

      ea0049oc14.4
    • Dose aggressive variants of papillary thyroid carcinoma have worse clinical outcome than classical papillary carcinoma?

      ea0049oc14.5
• Guided Posters
• • Adrenal 1
  • • PRKACA mutations in adrenal Cushing can alter substrate specificity

      ea0049gp1
    • Contribution of retinoic acid receptor signalling to adrenal cortex morphology and functional zonation through modulation of WNT/[beta]-catenin pathway

      ea0049gp2
    • Exosomal hsa-miR-483-5p and hsa-miR-101 are potential minimally invasive biomarkers of adrenocortical carcinoma

      ea0049gp3
    • Androgen receptor signalling is essential for regression of the adrenal x-zone and regulation of the adrenal cortex in the male mouse

      ea0049gp4
    • Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation

      ea0049gp5
    • Involvement of ARMC5 in proliferation and cell cycle control of human cell cultures from adrenal nodules of primary macronodular adrenocortical hyperplasia (PMAH)

      ea0049gp6
    • Identification of a new glucocorticoid receptor mutation underscores the substantial prevalence of genetic NR3C1 alterations in adrenal hyperplasia: the French National Research Program MUTA-GR

      ea0049gp7
    • Clinical and translational relevance of circulating miR483 in adrenocortical cancer

      ea0049gp8
    • Mortality is increased in patients with Cushing's disease in long-term remission: A nation-wide study

      ea0049gp9
    • Expression of GATA transcription factors and their role in the aetiology of Testicular Adrenal Rest Tumours

      ea0049gp10
  • Adrenal 2
  • • A country comparison of glucocorticoid replacement therapy in patients with primary and secondary adrenal insufficiency: data from the EU-AIR

      ea0049gp11
    • Activation of the cAMP/PKA transduction system triggers abnormal expression of the serotonin signaling pathway in human adrenocortical cells

      ea0049gp12
    • PRKARIA (Carney complex gene) is a major regulator of the tight link between cell cycle phases and steroidogenesis in the adrenocortical tumor cells H295R

      ea0049gp13
    • Simultaneous assays of aldosterone and renin concentrations in just ten minutes could change the clinical assessment for the diagnosis of primary aldosteronism

      ea0049gp14
    • Integrated genomic and phenomic analysis reveals key molecular pathways of aldosterone producing adenoma

      ea0049gp15
    • Cardiovascular features of autonomous cortisol secretion in patients with adrenal incidentalomas

      ea0049gp16
    • Hypercortisolism is prevalent in newly diagnosed type 2 diabetes: a prospective study of 384 consecutive patients

      ea0049gp17
    • Effects of two mineralocorticoid receptor antagonists on the morphology of the adrenal cortex

      ea0049gp18
    • Plasma cortisol and aldosterone responses to insulin tolerance test and sodium depletion in women with non classic 21-hydroxylase deficiency caused by bi-allelic CYP21A2 mutations (NC-CAH)

      ea0049gp19
    • Which are the factors and causes of death in patients with adrenal insufficiency? Mortality data from EU-AIR

      ea0049gp20
  • Adrenal 3
  • • Is diabetes mellitus associated with catecholamine-secreting tumours always a secondary diabetes?

      ea0049gp21
    • Epithelial to mesenchymal transition in adrenocortical tumours: focus on FGF-FGFR pathway and c-MET

      ea0049gp22
    • Clinical features and treatment outcomes in a group of SDHx-related pheochromocytoma/paraganglioma patients

      ea0049gp23
    • Increased exosomes in endogeneous Cushing syndrome

      ea0049gp24
    • Tumor microenvironment increases migration/invasion of murine pheochromocytoma SDHB silenced spheroids

      ea0049gp25
    • Metformin reduces viability and proliferation of pheochromocytoma cells in vitro

      ea0049gp26
    • The role of in vivo metabolomics using H-MRS in SDH deficient disease

      ea0049gp27
    • A PRKACB somatic mutation in a cortisol producing adenoma: a new example of protein kinase A activation leading to adrenal Cushing syndrome

      ea0049gp28
    • Familial case of SDHB mutation presenting as a macroprolactinoma

      ea0049gp29
    • Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with cyclical ectopic adrenocorticotrophic hormone secretion

      ea0049gp30
    • Long-term treatment of acute ectopic ACTH syndrome with Etomidate

      ea0049gp31
    • Multiple pathologic fractures as the presenting manifestation of Cushing's syndrome in patients with vitamin D receptor FokI gene polymorphism

      ea0049gp32
  • Bone & Calcium Homeostasis 1
  • • [ldquo]Hyperparanet[rdquo]: a multicenter Italian study on Primary Hyperparathyroidism

      ea0049gp33
    • Fat mass distribution and resistin are independent predictors of bone mass in postmenopausal, but not premenopausal women.

      ea0049gp34
    • Aldosterone and parathyroid hormone - is there a connection?

      ea0049gp35
    • Relationship between circulating microRNAs and bone mineral density in patients with active acromegaly

      ea0049gp36
    • Effects of BCR-ABL targeted tyrosine kinase inhibitors on the whole transcriptome pattern of cultured murine osteoblasts

      ea0049gp37
    • Decreased trabecular bone score but not bone mineral density in patients with acromegaly and concurrent hypogonadism: cross-sectional study with healthy controls

      ea0049gp38
    • Association of changes in serum urate level and bone mineral density during treatment with teriparatide: a retrospective observational study

      ea0049gp39
    • Coexistence of primary hyperparathyroidism with papillary thyroid carcinoma: a case series

      ea0049gp40
    • Follow-up of patients with surgical hypoparathyroidism: unknown cause of renal function decline?

      ea0049gp41
    • Expression of hypoxia-inducible factor-1[alpha] in Calbindin-D9k Knockout mice

      ea0049gp42
  • Bone & Calcium Homeostasis 2
  • • Chromosome 2q37 microdeletions in two cases of sporadic PHP-1B with broad GNAS imprinting defects

      ea0049gp43
    • Investigation of total and free 25OHD vitamin levels in patients with chronic renal failure on different dose of cholecalciferol

      ea0049gp44
    • Methylation patterns at the novel DMR of GNAS (GNAS-AS2) in pseudohypoparathyroidism 1B (PHP1B or iPPSD3) subtypes

      ea0049gp45
    • Vitamin D correction elevates apolipoprotein levels in a sex-specific manner

      ea0049gp46
    • Recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) improves hypercalciuria in patients with hypoparathyroidism: 3-year analysis from RACE study

      ea0049gp47
    • Vitamin D levels after 4 weeks of very low calorie diet (VLCD)

      ea0049gp48
    • Upper gastrointestinal symptoms, endoscopic and pathological features, and serum gastrin and chromogranin A levels in patients with primary hyperparathyroidism

      ea0049gp49
    • Localisation of parathyroid adenomas using 11C-methionine-PET/CT when conventional imaging methods are negative

      ea0049gp50
    • Calcium to phosphorous ratio (Ca/P) as helpful index to recognize primary hyperparathyroidism, but not primary hypoparathyroidism: a big-data approach

      ea0049gp51
  • Cardiovascular & Lipid Endocrinology
  • • Liraglutide prevents right ventricle hypertrophy by avoiding ACE1 & ACE2 reduction in an experimental model of idiopathic pulmonary fibrosis

      ea0049gp52
    • Clinical, laboratory and cardiac parameters in overt primary hypothyroidism versus overt central hypothyroidism

      ea0049gp53
    • Correlation between triglyceride glucose index (TyG) and coronary artery calcification in Korean adults

      ea0049gp54
    • Both oral and vaginal combined hormonal contraceptives induce unbeneficial metabolic effects in women with PCOS: a randomized study

      ea0049gp55
    • PCSK9 in relation to coronary damage severity in patients with cardiovascular disease

      ea0049gp56
    • Clinical significance and hormonal relationships of visceral adiposity index (VAI) in independently living old subjects

      ea0049gp57
    • Circulating levels of miR24-1 cluster microRNAs are increased in primary aldosteronism

      ea0049gp58
    • Body composition and testosterone determined VO2max in 780 young men - results from the Odense Androgen Study

      ea0049gp59
    • Probiotics and nutraceuticals as a new frontier in obesity prevention and management

      ea0049gp60
    • Constructing a long-acting leptin analogue

      ea0049gp61
  • Developmental & Protein Endocrinology
  • • Effects of prenatal dexamethasone on fetal rat ovary

      ea0049gp62
    • Does the loss of RAD52 in PC contribute to resistance to antiandrogen therapy?

      ea0049gp63
    • Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover

      ea0049gp64
    • 3-year safety and efficacy Update of the VERTICAL & VISTA trials of somavaratan (VRS-317), a long-acting rhGH, in children with Growth Hormone Deficiency (GHD)

      ea0049gp65
    • Achievement of a suitable basis of comparison in phase 2 and 3 clinical trials (VERTICAL/VISTA, and VELOCITY) comparing somavaratan vs daily rhGH for pediatric GH deficiency

      ea0049gp66
    • Karyotype and mid-childhood gonadotropin concentrations in prediction of spontaneous puberty in Turner syndrome patients

      ea0049gp67
    • Assessment of reports of behaviour by patients and their parents in paediatric Cushing disease

      ea0049gp68
    • 5[beta]-reductase (AKR1D1) is a potent regulator of carbohydrate and lipid metabolism and inflammation in human liver

      ea0049gp69
    • The adverse effects of prescribed glucocorticoids are worsened by co-administration of 5[alpha]-reductase inhibitors

      ea0049gp70
  • Diabetes & complications 1
  • • Carbohydrates metabolism and H. pylori: case-control study

      ea0049gp71
    • Specific plasma amino acids alternations associated with metabolic syndrome

      ea0049gp72
    • Permanent neonatal diabetes in a 24 year old Spanish patient

      ea0049gp73
    • Rescue study of trapped AVPR2 mutants with chemicals

      ea0049gp74
    • GLP-1 acutely regulates carbohydrate and lipid metabolic routes in the liver

      ea0049gp75
    • Increased risk of diabetes and hyperglycaemia associated with treatment with statins, beta-blockers and diuretics: the PPP-Botnia study

      ea0049gp76
    • Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection

      ea0049gp77
    • Contribution of genetic predisposition and lifestyle to gestational diabetes risk

      ea0049gp78
    • The rs2292239 polymorphism in the ERBB3 gene is associated with risk for type 1 diabetes mellitus

      ea0049gp79
    • Trace elements as an oxidative stress marker in women with gestational diabetes and their neonates

      ea0049gp80
    • Abstract unavailable

      ea0049gp81
    • Reduced level of soluble TLR2 in type 2 diabetes despite increased TLR2 monocyte expression

      ea0049gp82
  • Diabetes & complications 2
  • • Vitamin D metabolites and IL1[beta] RS16944 polymorphism in type 2 diabetes patients: evidence for functional interaction

      ea0049gp83
    • Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study

      ea0049gp84
    • Abstract unavailable

      ea0049gp85
    • Increased incidence of diabetes mellitus 30 years after the radiation impact in persons exposed to ionizing radiation during the Chernobyl NPP accident

      ea0049gp86
    • Baicalin lowers glucose intolerance by controlling pancreatic hormone in high fat-induced obese diabetic rats

      ea0049gp87
    • Effect of insulin on neurotrophins' levels in the muscular wall of mice intestine and colon

      ea0049gp88
    • Clinical assessment of trabecular bone microstructure in type 2 diabetes mellitus with Trabecular Bone Score (TBS)

      ea0049gp89
    • The G allele of the BDKRB1 rs12050217 polymorphism is associated with protection for diabetic retinopathy

      ea0049gp90
    • Dipeptidyl peptidase-4 inhibitor therapy and risk of diabetic retinopathy: a population based study

      ea0049gp91
    • Non-genetic rat model of nephropathy in type 2 diabetes with attenuated streptozotocin-induced tubular alteration

      ea0049gp92
  • Diabetes therapy & complications 1
  • • microRNA expression profile in plasma from patients with diabetic kidney disease

      ea0049gp93
    • The A allele of the -866G/A polymorphism in UCP2 gene decreases high glucose-induced UCP2 expression in HUVECs

      ea0049gp94
    • The relation between PON-1 activity and 25-OH hydroxyvitamin D3 levels and other biochemical parameters in diabetic patients with respect to obesity and diabetic complications

      ea0049gp95
    • High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with diabetic nephropathy and the role of netrin-1 levels

      ea0049gp96
    • Comparison of current perception threshold measured by Neurometer in patients with type 2 diabetes mellitus to a group of normal individuals

      ea0049gp97
    • Gestacional diabetes mellitus: the new screening criteria and its outcomes

      ea0049gp98
    • Higher levels of adiponectin might contribute to lower bone mass observed in patients with type 1 diabetes, through alterations in osteocalcin energy circuit signaling of bone cells.

      ea0049gp99
    • Type 1 diabetes and hearing loss: a meta-analysis

      ea0049gp100
    • Abstract unavailable

      ea0049gp101
    • Comparison of the effects of combinations of different antihypertensive therapies on microalbuminuria and renal functions in type 2 diabetic patients

      ea0049gp102
  • Diabetes therapy & complications 2
  • • Abstract unavailable

      ea0049gp103
    • Non-stimulated c-peptide is independently associated with requirement at 1 year for insulin therapy in patients with diabetes: a retrospective cohort study of 872 patients

      ea0049gp104
    • Ceramide synthase 6 inhibition as a novel therapeutic approach for obesity and type 2 diabetes

      ea0049gp105
    • Outcomes of integrating personal continuous glucose monitors with insulin pumps in a University Diabetes Unit

      ea0049gp106
    • Specific Oct1 gene variants are associated with changes in the risk of cardiovascular death in metformin users

      ea0049gp107
    • Liraglutide improves carotid intima-media thickness in pre-elderly and elderly patients with type-2 diabetes: an 18-month prospective, real life study

      ea0049gp108
    • Treatment of diabetic ketoacidosis at type 1 diabetes mellitus presentation: 13 year experience from a tertiary centre (2004-2016)

      ea0049gp109
    • The method of reporting hypoglycemia in Randomized Control Trials (RCTs): a systematic review on RCTs conducted for SGLT-2 inhibitors

      ea0049gp110
    • Hepatic effects of GLP-1 receptor agonist Liraglutide in patients with type 2 diabetes

      ea0049gp111
    • Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes Mellitus

      ea0049gp112
  • Endocrine Nursing
  • • Impact of the socio-economic level on the management in type 2 diabetes

      ea0049gp113
    • Outcomes of a nurse-led thyroid clinic at a tertiary-care endocrine centre

      ea0049gp114
    • Education, patient empowerment and admission avoidance

      ea0049gp115
    • Recovery of the hypothalamus-pituitary-adrenal axis after transsphenoidal surgery for pituitary adenomas

      ea0049gp116
    • The Swedish Pituitary Register Nursing Group (SPRNG) Projects and Experiences

      ea0049gp117
  • Endocrine Tumours
  • • Luteinizing hormone receptor mediated GATA4 induction promotes adrenocortical tumorigenesis in gonadectomized mice

      ea0049gp118
    • Targeted molecular analysis in adrenocortical carcinomas: a way towards personalized medicine

      ea0049gp119
    • Evaluation of the occurrence of the manifestations of Carney complex in a french cohort of 70 patients during a three years standardized follow-up

      ea0049gp120
    • Immunity in adrenocortical carcinoma patients - interplay between anti-cancer immunity and steroid hormones

      ea0049gp121
    • The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study

      ea0049gp122
    • Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy

      ea0049gp123
    • VHL Genotype and risk stratification of pancreatic neuroendocrine tumors in patients with von hippel-lindau disease

      ea0049gp124
    • GPER-stimulation increases proliferation in colorectal cancer via the Hippo signalling pathway

      ea0049gp125
    • Inhibition of hRAS and CDK4/6 leads to an antiproliferative activity, blocks cell cycle and induces cell death in anaplastic thyroid cancer cell lines

      ea0049gp126
    • Benign prostatic hyperplasia is associatied with liver inflammation: it's time for prevention?

      ea0049gp127
    • Peptides derived from the sst5TMD4 extracellular domain increase malignancy of endocrine-related cancer cells

      ea0049gp128
    • Androgen receptor activation inhibits endothelial cell proliferation through an extra-nuclear signaling pathway

      ea0049gp129
    • Long non-coding RNA expression profiles in human parathyroid tumors

      ea0049gp130
  • Female Reproduction
  • • Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial

      ea0049gp131
    • Testosterone administration decreases insulin sensitivity (IS) in adult female sheep born to testosterone treated mothers

      ea0049gp132
    • Influence of BMI on AMH levels in non-PCOS women

      ea0049gp133
    • Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis (EM)-associated pain: Phase 2 safety and efficacy 24-week results

      ea0049gp134
    • Brown adipose tissue thermogenesis in women with polycystic ovary syndrome

      ea0049gp135
    • Dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin improved beta cell function and prevented a conversion rate to MTG and DM2 in metformin intolerant PCOS with high metabolic risk

      ea0049gp136
    • Genetic susceptibility for adrenal hyperandrogenism in polycystic ovary syndrome

      ea0049gp137
    • Turner's syndrome and abnormal liver chemistry: relationship with karyotype in a large dedicated clinic

      ea0049gp138
    • Sensitivity of hypothalamo-pituitary-adrenal axis in women with PCOS

      ea0049gp139
    • Nonalcoholic fatty liver disease liver fat score (NAFLD-LFS) could be used for the assessment of NAFLD in women with PCOS

      ea0049gp140
    • Effects of central sympathoinhibition with moxonidine on the elevated sympathetic nervous activity and downstream metabolic abnormalities observed in polycystic ovary syndrome

      ea0049gp141
    • Steroid receptors involvement in enamel hypomineralization resulting from exposure to low-dose DEHP and bisphenol A

      ea0049gp142
  • Male Reproduction and Endocrine Disruptors
  • • In vitro effects of Bisphenol A on two metabolic receptors signaling: MC4R and FFAR1

      ea0049gp143
    • Altered protein expression of cell cycle- and EMT-associated genes by bisphenol compounds in MCF-7 CV human breast cancer cells via estrogen receptor dependent pathway

      ea0049gp144
    • Reproductive toxicity of low dose nonylphenol in mice: a two-generation study

      ea0049gp145
    • Psychological rather than organic and/or relational components are involved in sexual dysfunction in Young/Middle aged human immunodeficiency virus (HIV)-Infected Men

      ea0049gp146
    • Effects of physical exercise or metformin on testosterone deficiency and erectile dysfunction associated to metabolic syndrome

      ea0049gp147
    • Impacts of a single ablative dose of radio iodine therapy for differentiated thyroid carcinoma on testicular function: results from the SAPIRA study

      ea0049gp148
    • Presentation, clinical features and long-term follow-up of Leydig cell tumours of the testis: 77 cases from a single center experience

      ea0049gp149
    • Semen quality in patients with adult-onset hypogonadotropic hypogonadism

      ea0049gp150
  • Neuroendocrinology & Growth Hormones
  • • Growth hormone-releasing hormone (GHRH) antagonists, MIA-602 and MIA-690, inhibit survival and proliferation of human pleural mesothelioma cells

      ea0049gp151
    • Somapacitan expected to provide IGF-I levels suitable for once-weekly dosing in children

      ea0049gp152
    • Evaluating CHARGE syndrome in CHD7-positive CHH patients: clinical implications

      ea0049gp153
    • The effect of chronic hypothalamic-pituitary-adrenal axis activation on hypothalamic glucagon-like peptide-1 action in an animal model of depression and in vitro studies

      ea0049gp154
    • A novel purified polyclonal antibody towards T-Pit is a reliable marker of corticotroph cell differentiation

      ea0049gp155
    • Liraglutide treatment prevented the increased expression of proinflammatory cytokines in the hippocampus of male pups in a perinatal stress model of food restriction

      ea0049gp156
    • Predictors of permanent, transient and three-phase postoperative diabetes insipidus

      ea0049gp157
    • The effect of chronic tianeptine administration on NLRP3 inflammasome pathway - study in an animal model of depression

      ea0049gp158
    • Pituitary androgen receptor signalling is a novel negative regulator of prolactin production

      ea0049gp159
    • Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome

      ea0049gp160
  • Obesity
  • • The association between olfaction and taste functions with serum ghrelin and leptin levels in obese women

      ea0049gp161
    • Sarcopenic obesity and associated factors in older adults with diabetes: the 2009-2010 Korean National Health and Nutrition Examination Survey

      ea0049gp162
    • Resistance training reduces skeletal muscle inflammation even after 4-week detraining in obese rats

      ea0049gp163
    • miR-26b is decreased in obesity and is associated with insulin resistance and visfatin levels

      ea0049gp164
    • The effect of FTO polymorphism rs 9939609 on obesity and metabolic disturbances in Polish people from Lower Silesia

      ea0049gp165
    • Role of Elovl6 in brown and beige adipose tissue during [beta]3-adrenergic receptor activation

      ea0049gp166
    • A link between sex hormones, obesity and gut microbiota

      ea0049gp167
    • Effects of short sleep duration on energy metabolism and energy balance in subjects with overweight and obesity

      ea0049gp168
    • Blood mercury concentration in relation to overweight or obese among Korean children and adolescents: KNHANES 2009-2013

      ea0049gp169
    • Association of the FTO gene rs9939609 polymorphism with obesity in the Republic of Tatarstan

      ea0049gp170
    • Effect of bariatric surgery on sexual function and sex hormone levels in obese patients: a meta-analysis

      ea0049gp171
    • Lipolytic effects of endogenous 3-iodothyronamine (T1AM) and synthetic analog SG-2 in vivo and in cultured adipocytes

      ea0049gp172
  • Pituitary
  • • A comparison of single-dose effects of short acting somatostatin analogs: octreotide vs pasireotide in patients with active acromegaly after surgical debulking

      ea0049gp173
    • Efficacy and safety of switching to pasireotide LAR alone or in combination with pegvisomant in acromegaly patients controlled with combination treatment of first-generation somatostatin analogues and weekly pegvisomant (PAPE study): a prospective open-label 48 week study, preliminary results 24 weeks

      ea0049gp174
    • Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients

      ea0049gp175
    • Minimally Invasive Diagnosis and Direct Transnasal Surgery: a single centre series of 100 children with Cushing's Disease with long term follow-up

      ea0049gp176
    • Octreotide subcutaneous (s.c.) depot, a novel ready-to-use formulation, provides higher exposure and maintains response in patients with acromegaly and functioning neuroendocrine tumours (NETs) previously treated with long-acting octreotide: Results from a phase 2, open-label, multicentre, randomized study

      ea0049gp177
    • Sleep patterns in patients with non-functional GHRH receptor

      ea0049gp178
    • Correction of sustained hyponatremia secondary to SIAD by the use of chronic tolvaptan therapy is associated with a reduction in Emergency Room visits, hospital admissions and days of hospitalization over a 3-year period

      ea0049gp179
    • Outcome of non-functioning pituitary adenomas that regrow after primary treatment: a study from two large specialist UK centers

      ea0049gp180
    • Targeting either GH or IGF-I levels during somatostatin analogue treatment in patients with acromegaly: A randomized, investigator-initiated multicenter study

      ea0049gp181
    • Brain white matter damage and volumes of hippocampus and hypothalamus correlates to cognitive function in craniopharyngioma

      ea0049gp182
    • Copeptin - a sensitive marker of an altered CRH-axis in pituitary disease

      ea0049gp183
    • Hormonal and metabolic effects of long-term cabergoline withdrawal in patients with hyperprolactinemia

      ea0049gp184
  • Pituitary & endocrine Tumours
  • • Localization of benign insulinomas using glucagon-like peptide-1 receptor (GLP1-R) SPECT/CT and PET/CT and MRI in a prospective clinical study

      ea0049gp185
    • 24 hour urinary 5-hydroxyindoleacetic acid (5-HIAA) doubling-time (DT) is associated with disease-specific mortality (DSM) and progression-free survival (PFS) in patients with neuroendocrine tumors (NETs)

      ea0049gp186
    • Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing's disease (CAPACITY)

      ea0049gp187
    • Vertebral fractures are prevalent among patients with acromegaly in spite of normal bone mineral density reflecting overall duration of disease regardless of biochemical control or cure

      ea0049gp188
    • Evaluation of pituitary toxicity after radiotherapy for cerebral chondrosarcomas in adult patients

      ea0049gp189
    • Safety of long-term growth hormone (GH) treatment in adults with GH deficiency (GHD): an analysis from the NordiNet® International Outcome Study

      ea0049gp190
    • GH and IGF-1 levels at 12 weeks predict long-term responses to lanreotide Autogel in treatment-naive acromegalic patients: post-hoc analyses from the PRIMARYS study

      ea0049gp191
    • Long-term treatment with pegvisomant (Somavert®): Observations from 2090 acromegaly patients followed in ACROSTUDY

      ea0049gp192
    • Amenorrhea without vasomotor symptoms in women over 40: A sign of pathological hyperprolactinemia?

      ea0049gp193
    • Serotonin, ATRX and DAXX as differential diagnostic markers of neuroendocrine tumours (NETs) in the sellar region. An immunohistochemical study in a large series of pituitary adenomas and in a non-pituitary NET

      ea0049gp194
    • Long-term follow-up of a family with a large AIP gene deletion: variable phenotypes and challenges in the management

      ea0049gp195
    • Diagnosis of acromegaly: Sex and BMI are the major determinants of growth hormone suppression during oral glucose tolerance test (OGTT)

      ea0049gp196
  • Thyroid 1
  • • Cognitive functions in primary hypothyroidism on selenium supplementation

      ea0049gp197
    • Which is the best tool to use when initiating the differential diagnosis of a thyrotoxic patient? A challenge to current guideline recommendations

      ea0049gp198
    • Cardiovascular risk factors in patients with autoimmune thyroiditis

      ea0049gp199
    • Evaluation of the effectiveness of personalized radioiodine treatment in Graves' disease

      ea0049gp200
    • Abstract unavailable

      ea0049gp201
    • Citrus flavanones naringenin and hesperetin induced mild functional alteration in thyroids of old-aged Wistar rats

      ea0049gp202
    • The oxford multidisciplinary thyroid eye disease (TED) clinic; can short waiting times and use of steroid sparing agents (SSA) reduce total steroid dose and requirement for surgery/radiotherapy?

      ea0049gp203
    • 24-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules

      ea0049gp204
    • Association of vitamin D levels with thyroid function and autoimmunity

      ea0049gp205
  • Thyroid 2
  • • Early use of steroid-sparing agents in treatment of moderate-to-severely active thyroid eye disease

      ea0049gp206
    • Prediction of response to methimazole based on clinical symptoms in new onset graves' patients, using neural networks

      ea0049gp207
    • Serum Interleukin-37 (IL-37) levels were increased and correlated with oxidative stress parameters in Hashimoto's Thyroiditis (HT) patients

      ea0049gp208
    • The increased immunohistochemical expression of IL-23 in Hashimoto's thyroiditis but not in Graves' disease patients

      ea0049gp209
    • Laser ablation of benign thyroid nodules without anesthesia: clinical tolerance, hazards and complications

      ea0049gp210
    • Orbital ectopic thyroid mistaken for mestastases

      ea0049gp211
    • Association of the Period3 clock gene polymorphism with autoimmune thyroid diseases

      ea0049gp212
    • IgG4-related fibrous variant of Hashimoto thyroiditis in a non-Asian woman

      ea0049gp213
    • Thyroid hormones deficiencies and poor outcome in chronic heart failure outpatients

      ea0049gp214
    • Hypothyroidism and heart failure outcome: a study with a long-term follow-up

      ea0049gp215
    • The correction of TSH with thyroid replacement therapy is associated with a better outcome in chronic heart failure patients

      ea0049gp216
  • Thyroid 3
  • • Thyroid function in heart failure with preserved ejection fraction (HFpEF) - evaluation of serum and myocardial thyroid hormones in an animal model of HFpEF

      ea0049gp217
    • STAT6 deficiency ameliorates Graves' disease severity by suppressing thyroid epithelial cell hyperplasia

      ea0049gp218
    • Delayed TSH recovery after dose adjustment during TSH-suppressive levothyroxine therapy in patients with differentiated thyroid cancer

      ea0049gp219
    • Analysis of a large cohort of subjects with thyroid hemiagenesis (THA) reveals random seasonality in the dates of birth

      ea0049gp220
    • Thyroid hormone T3 protects mice from fasting induced skeletal muscle atrophy by counteracting autophagy

      ea0049gp221
    • Will it be useful to measure PTH at 4 hours post thyroidectomy to decide for calcium replacement? 1st result of a prospective study

      ea0049gp222
    • Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG)

      ea0049gp223
    • Impact of chronic high fat diet consumption on the expression of organic nutrients carriers in the small intestine of mice: role of thyroid hormones in these processes

      ea0049gp224
  • Thyroid Cancer
  • • Prognostic factors for intrathyroidal papillary carcinomas - a multivariate analysis

      ea0049gp225
    • Malignancy Rate in Thyroid Nodules: Cytology versus Histology in challenging categories

      ea0049gp226
    • Fine needle aspiration biopsy in pediatric patients with thyroid nodules

      ea0049gp227
    • Differentiated thyroid cancer - comparison between patients with and without remission

      ea0049gp228
    • Trends in papillary microcarcinoma prevalence in North of Portugal

      ea0049gp229
    • Radioiodine (RAI) refractory differentiated thyroid cancer (DTC): outcome and prognostic factors for DISEASE progression

      ea0049gp230
    • Management and outcome of bone metastasis from differentiated thyroid carcinoma in the real life: the M.OS.CA.TI. study

      ea0049gp231
    • Germ-line mutations in RET-790 and RET-791 codons (exon 13) among subjects with sporadic medullary thyroid cancer

      ea0049gp232
    • Comparison of clinicopathological features in patients with familial and sporadic papillary thyroid cancer

      ea0049gp233
    • Lobectomy as a treatment option for well differentiated thyroid cancer (WDTC) between 1-4 cm: which results should we expect?

      ea0049gp234
    • Clinical Utility of response to therapy in combination with BRAF in risk assessment of thyroid cancer

      ea0049gp235
  • Thyroid Cancer & Thyroid Case Reports
  • • A rare case of medullary thyroid cancer, mesothelioma and meningioma, due to APC and RASAL1 mutations

      ea0049gp236
    • Thyrotoxic Periodic Paralysis due to Graves' disease: a mandatory differential diagnosis in Asian patients presenting with paralysis and hypokalemia

      ea0049gp237
    • A fatal case of fetal goiter: autoimmunity is the key

      ea0049gp238
    • Renal cell carcinoma metastasis to thyroid tumor: a case report

      ea0049gp239
    • Giant goiter with intrathyroid arteriovenous fistula as a cause of severe pulmonary hypertension

      ea0049gp240
    • Thyroid-related adverse events in patients treated with Nivolumab

      ea0049gp241
    • False negative fine needle aspiration thyroid cytology: an institutional experience

      ea0049gp242
    • Risk factors associated with malignancy in thyroid nodules classified as Bethesda category IV (follicular neoplasm/suspicious for follicular neoplasm)

      ea0049gp243
    • Expressions of miRNAs and BRAFV600E mutation detection in papillary thyroid carcinoma

      ea0049gp244
    • A statistical, in silico model predicts polygenic thyroid cancer risk

      ea0049gp245
• Eposter Presentations: Adrenal and Neuroendocrine Tumours
• • Adrenal cortex (to include Cushing's)
  • • Confirmatory tests for diagnosis of primary aldosteronism among Chinese hypertensives

      ea0049ep1
    • The correlation of salivary cortisol values with serum cortisol values

      ea0049ep2
    • Adrenocortical virilizing tumor in an adult woman in remission after surgical therapy performed more than 12 years ago

      ea0049ep3
    • Investigation of atrophic adrenal glands in Cushing's syndrome model rats induced by the administration of dexamethasone

      ea0049ep4
    • Long-term assessment of AddiQoL and patient diaries may identify Addison patients at high risk for adrenal crises

      ea0049ep5
    • Impact of Cortrosyn treatment on weight and adrenal structure in the wistar rat

      ea0049ep6
    • Molecular variability determines subtle adrenal biosynthetic defect in non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency

      ea0049ep7
    • Corticoids-therapy related complications in patients with primary adrenal insufficiency

      ea0049ep8
    • Severe hypertriglyceridemia in relation to toxic levels of mitotane in a patient with stage IV adrenocortical carcinoma (ACC)

      ea0049ep9
    • Addison's disease presenting as severe hypoglycaemia and cachexia

      ea0049ep10
    • Posterior reversible encephalopathy syndrome (PRES) in a patient with primary aldosteronism

      ea0049ep11
    • Evaluation of cardiovascular risk in patients with adrenal incidentaloma

      ea0049ep12
    • Hair cortisol in patients with primary aldosteronism

      ea0049ep13
    • Salivary steroid levels during diagnostic tests for adrenal insufficiency

      ea0049ep14
    • Assessment of quality of life of patients with Cushing's syndrome depending on the disease course

      ea0049ep15
    • Paraneoplastic Cushing's syndrome and nephrotic syndrome in a patient with bronchial carcinoid

      ea0049ep16
    • Frequancy of diabetes and prediabetes in patients with adrenal incidentaloma without hormonal activity

      ea0049ep17
    • To big to work! Lymphoma presenting with primary adrenal insufficiency

      ea0049ep18
    • Specificity of the posture test for subtyping of primary aldosteronism, a 10 year nationwide summary in Iceland

      ea0049ep19
    • Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells

      ea0049ep20
    • Primary Aldosteronism in Iceland, nationwide results from 2012-2016

      ea0049ep21
    • Cardiovascular risk factors do not play a role in the risk factor profile of adrenal crisis

      ea0049ep22
    • Bilateral adrenal incidentaloma: a diagnostical and therapeutical challenge

      ea0049ep23
    • Are we missing patients with primary aldosteronism (PA) if we require both elevated aldosterone: renin ratio (ARR) and elevated aldosterone levels?

      ea0049ep24
    • Severe hypoglycaemic ketoacidosis in a patient with adrenal crisis

      ea0049ep25
    • Assessment of the hypothalamic pituitary adrenal axis in patients receiving adjuvant mitotane treatment after radical resection of adrenocortical carcinoma

      ea0049ep26
    • Extra-gastrointestinal stromal tumor in the retroperitomeum which had difficulty in differential diagnosis with adrenal cancer

      ea0049ep27
    • Perceptions of medical practitioners' management of addison's disease across Africa: an on-line survey

      ea0049ep28
    • Improved metabolic outcomes for patients with subclinical Cushing's syndrome treated with surgery: Ten year experience in a tertiary centre

      ea0049ep29
    • Severe hypoaldosteronism after unilateral adrenalectomy for primary hyperaldosteronism

      ea0049ep30
    • The role of CYP11B2 polymorphism in the pathogenesis of hypertension in patients with adrenal incidentaloma

      ea0049ep31
    • Primary aldosteronism: more common than once thought: Two clinical cases

      ea0049ep32
    • Rapid reduction in left ventricular mass in primary aldosteronism after treatment; a prospective cardiac MRI study

      ea0049ep33
    • The treatment with dual release hydrocortisone in patients with adrenal insufficiency: correlation between change of the evening cortisol exposure time profile and change in metabolic profile, depression status and quality of life

      ea0049ep34
    • Treatment of adrenal insufficiency with hydrocortisone dual-release formulation: glycometabolic profile and health-related quality of life

      ea0049ep35
    • Transformation from Addison's disease to adrenocortical carcinoma presented as Cushing's syndrome with androgenisation

      ea0049ep36
    • Visinin-Like Protein-1 in the regulation of aldosterone biosynthesis

      ea0049ep37
    • Metabolic syndrome is common among patients with adrenal incidentalomas, but not associated with functional adrenal status

      ea0049ep38
    • The clinical course of patients with adrenal incidentaloma: Başkent University experience

      ea0049ep39
    • Predictive baseline morning P-cortisol levels for the response to a Synacthen test in prednisolone treated patients

      ea0049ep40
    • Silent pheochromocitoma - a rare case of adrenal incidentaloma

      ea0049ep41
    • LH and adrenal tumor size correlate with insulin resistance in menopausal patients with adrenal incidentalomas and (possible) autonomous cortisol secretion

      ea0049ep42
    • A case of recurrent Cushing's disease after total bilateral adrenalectomy

      ea0049ep43
    • Late-night salivary cortisol: cut-off definition and diagnostic value in Cushing's syndrome

      ea0049ep44
    • Adrenal involvement in MEN1 families

      ea0049ep45
    • Differential effects of aldosterone excess on potassium homeostasis and blood pressure in Asian subjects

      ea0049ep46
    • Effect of adrenal mass lateralization on diagnostic tests in patients with Cushing

      ea0049ep47
    • Late night salivary cortisol measurement may help in excluding Cushing's syndrome in patients with chronic kidney disease

      ea0049ep48
    • The short Synacthen test revisited - reevaluation of the normal reference range using LCMSMS

      ea0049ep49
    • Cushing's syndrome in pregnant woman

      ea0049ep50
    • Education sessions in patients with adrenal insufficiency

      ea0049ep51
    • Characteristics of aldosterone-producing adenomas: a tissue microarray study

      ea0049ep52
    • Adrenal cushing's syndrome surprisingly unveiling breast cancer

      ea0049ep53
    • Giant adrenal tumor in a patient admitted for fever

      ea0049ep54
    • The relative risk of developing Addison's disease among patients with type 1 diabetes mellitus: a nationwide, matched, observational cohort study

      ea0049ep55
    • The frequency of incidental liver and renal masses in patients with adrenal incidentalomas

      ea0049ep56
    • Primary adrenal insufficiency: a Portuguese multicentre study by the adrenal tumour study group

      ea0049ep57
    • Adrenal incidentaloma: a challenging dilemma!

      ea0049ep58
    • Assay of steroids with Liquid chromatography tandem mass spectrometry is superior to immunoassays in monitoring patients with 21-hydroxylase deficiency

      ea0049ep59
    • Treatment of patients with primary and secondary adrenal insufficiency with hydrocortisone modified-release (Plenadren®)

      ea0049ep60
    • Autoimmune Addison disease - data from long-term follow-up of patients from a tertiary hospital's Endocrinology Department

      ea0049ep61
    • Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency

      ea0049ep62
    • Treatment with modified-release hydrocortisone for 6 months: A clinical audit in 15 patients with adrenal insufficiency

      ea0049ep63
    • Cushing's Syndrome During Pregnancy mimicking preeclampsia - case report

      ea0049ep64
    • Potentially aggressive adrenal oncocytoma during pregnancy: about one case

      ea0049ep65
    • Primary hyperparathyroidism associated with Cushing syndrome and primary hyperaldosteronism

      ea0049ep66
    • Comparison of biochemical and hormonal parameters in patients with primary adrenal insufficiency of autoimmune and no-autoimmune cause

      ea0049ep67
    • The role of dehydroepiandrosterone sulphate (DHEAS) in the evaluation of autonomous cortisol secretion in adrenal incidentalomas

      ea0049ep68
    • Adrenocortical carcinoma in pregnancy

      ea0049ep69
    • Abnormal aldosterone/renin ratio is common in patients of African compared to European origin, is associated with hypokalaemia, and left ventricular hypertrophy, but is rarely associated with abnormal adrenal imaging characteristics

      ea0049ep70
    • Neutrophil-lymphocyte and platelet-lymphocyte ratios as biomarkers in distinguishing adrenocortical adenomas and carcinomas

      ea0049ep71
    • Adrenal involvement of Non-Hodgkin's lymphoma: a case report

      ea0049ep72
    • Challenges in differential diagnosis of adrenal incidentaloma or clinical case of multiple myeloma

      ea0049ep73
    • Iatrogenic Cushing syndrome and suprarenal secondary insufficiency due to interaction between fluticasone and ritonavir

      ea0049ep74
    • Body composition in women with Cushing's syndrome of different etiology

      ea0049ep75
    • Clinical course of patients with adrenal incidentaloma: retrospective analysis of a single center

      ea0049ep76
    • Malignant androgen-secreting adrenocortical carcinoma with adrenal insufficiency: a case report

      ea0049ep77
    • Hyperaldosteronism screening in Hypertensiologists experience - epidemiological review of over 800 cases

      ea0049ep78
    • Clinical, laboratorial and densitometric evaluation of adult women with congenital adrenal hyperplasia

      ea0049ep79
    • The effect of subclinical hypercortisolism on bone mineral density in female patients with adrenal incidentalomas

      ea0049ep80
    • Long term follow up of patients with adrenal incidentaloma and 'autonomous cortisol secretion'

      ea0049ep81
    • Adrenocortical carcinoma - casuistic analysis

      ea0049ep82
    • A near miss on blaming the heart: a rare case of Adrenocortical carcinoma with thrombus extension into right atrium and Cushing syndrome

      ea0049ep83
    • Congenital Adrenal Hyperplasia due to 11[beta]-Hydroxilase Deficiency: clinical and molecular studies of two novel families with variable phenotypes

      ea0049ep84
    • 'Record-breaking hyponatraemia' with Addison's disease

      ea0049ep85
    • 24 hour ambulatory blood pressure levels according to adrenal adenoma size

      ea0049ep86
  • Adrenal medulla
  • • Coexisting Graves's disease and pheochromocytoma

      ea0049ep87
    • Pheochromocytoma in neurofibromatosis type 1

      ea0049ep88
    • Should all patients with Neurofibromatosis type 1 undergo biochemical screening for Pheocromocytoma?

      ea0049ep89
    • Pheochromocytoma in pregnancy

      ea0049ep90
    • The role of p27 in pheochromocytoma development

      ea0049ep91
    • Role of microenvironment on metabolic control of murine pheochromocytoma SDHB silenced cells

      ea0049ep92
    • Role of microenvironment on proliferation and migration of an SDHB silenced murine Pheochromocytoma cell line

      ea0049ep93
    • Pheochromocytoma: a clinical and pathological study

      ea0049ep94
    • Biochemical testing for pheochromocytoma

      ea0049ep95
    • Paraganglioma and Fallot Tetralogy: case report

      ea0049ep96
    • Retrospective audit at a UK teaching hospital of phaeochromocytomas and paragangliomas against the 2016 guidelines

      ea0049ep97
    • Pheochromocytoma - surgical outcomes

      ea0049ep98
    • Role of urinary fractionated metanephrines and catecholaminas in the diagnosis of pheochromocytoma/paraganglioma

      ea0049ep99
    • Lung adenocarcinoma in a 34-year-old female SDHB asynptomatic mutation carrier - case report

      ea0049ep100
    • Pheochromositoma in childhood

      ea0049ep101
    • A case of silent pheochromocytoma presenting with clinical and radiological findings suggesting metastatic adrenal lesion

      ea0049ep102
    • The storm before the calm: a phaeochromocytoma

      ea0049ep103
    • Improvement of insulin secretion and oral glucose tolerance after pheochromocytoma removal: a case report

      ea0049ep104
    • Ephedrine/caffeine toxicity masquerading as phaeochromocytoma in a vigorexic male with paroxysmal hypertension and headache

      ea0049ep105
    • Loss diagnosis of pheochromocytoma in the initial evaluation

      ea0049ep106
    • Unexplained resistant hypertension in a young male with recurrent transient ischemic attacks, resembling endocrine hypertension

      ea0049ep107
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Stress cardiomyopathy in pheochromocytoma

      ea0049ep108
  • Clinical case reports - Pituitary/Adrenal
  • • Prolonged zona glomerulosa insuffiency with hyperkalemia in primary hyperaldosteronism after adrenalectomy

      ea0049ep109
    • Mature ganglioneuroma of the adrenal gland

      ea0049ep110
    • Primary adrenal insufficiency and pregnancy - a case report

      ea0049ep111
    • Paraganglioma (PG) and cyanotic congenital heart disease (CCHD): the role of tisular hypoxia

      ea0049ep112
    • Von Hippel Lindau disease in two Turkish families with different mutations

      ea0049ep113
    • Large adrenal adenoma presenting as a clinically inapparent Cushing syndrome, a trap diagnosis

      ea0049ep114
    • NK/T lymphoma adrenal presenting as adrenal insufficiency and cranial nerves neuropathies-a case report

      ea0049ep115
    • Primary hyperparathyroidism and primary hyperaldosteronism - cause or coincidence in arterial hypertension - case report

      ea0049ep116
    • Endocrine masses displayed as incidentalomas in patients with unilateral nephrectomy

      ea0049ep117
    • Case with metastatic lung cancer who developed adrenal insufficiency

      ea0049ep118
    • Adrenal haemorrhage: from Urology to Endocrinology

      ea0049ep119
    • Hemangioma a rare adrenal tumors: report of two cases

      ea0049ep120
    • A rare case: adrenal lymphangioma

      ea0049ep121
    • A rare case of a patient with MEN 4 phenotype and associated pheochromocytoma

      ea0049ep122
    • The difficulty in predicting aggressive tumour behaviour of phaeochromocytomas

      ea0049ep123
    • An unusual cause of unilateral adrenal haemorrhage

      ea0049ep124
    • Incidentaloma as a first manifestation of lymphoma

      ea0049ep125
    • Clinical case of aldosterone-producing adrenocortical carcinoma

      ea0049ep126
    • The case of adrenal incidentaloma due to unrecognized nonclassic congenital adrenal hyperplasia

      ea0049ep127
    • DOC secreting adrenal adenoma, a rare cause of hypertension

      ea0049ep128
    • Aldosterone-producing adrenocortical carcinoma and alteration of secretion pattern on recurrence: a case report

      ea0049ep129
    • Congenital adrenal hyperplasia: hazards of non-compliance with treatment!

      ea0049ep130
    • Adrenal insufficiency due to both hemorrhage and thrombosis related with primary antiphospholipid syndrome

      ea0049ep131
    • In spite of long-term symptoms, a pheochromocytoma diagnosed in pregnancy results in fetal loss despite proper approach

      ea0049ep132
    • POEMS: a rare cause of adrenal insufficiency in a young male

      ea0049ep133
    • Recurrent phaeochromocytoma - Iatrogenic

      ea0049ep134
    • An association of adrenal ganglioneuroma, Addison's disease and Mediterranean fever: a case report

      ea0049ep135
    • Adrenal carcinoma after ovariectomy. Report of a case

      ea0049ep136
    • ACTH-independent Cushing syndrome with concomitant parathyroid carcinoma

      ea0049ep137
    • Incidental adrenal cyst: a case report

      ea0049ep138
    • Gynecomastia in men: A rare case of adrenal feminizing tumors

      ea0049ep139
    • Virilization - a non-negligible manifestation of an adrenal tumor

      ea0049ep140
  • Clinical case reports - Thyroid/Others
  • • The ovarian origin of hiperandrogenism in the postmenopausal woman with the adrenal adenoma - a case report

      ea0049ep141
    • Secondary autonomic neuropathy in patient with polyglandular autoimmune syndrome III and type 1 gastric neuroendocrine tumor: a case report

      ea0049ep142
    • MEN 1 Syndrome- a case with recurrence of neuroendocrine tumor and hyperparathyroidism after 9 years of follow up

      ea0049ep143
    • Insulinoma- from diagnosis to full recovery. Case study

      ea0049ep144
    • Insulinoma masquerading as neurologic disease

      ea0049ep145
  • Endocrine tumours and neoplasia
  • • Glucose metabolism abnormalities and insulin resistance are frequent in well diferentiated digestive NETs

      ea0049ep146
    • Clinical and hormonal characteristics of adrenal incidentalomas

      ea0049ep147
    • Pituitary insufficiency, the beginning of a diagnostic journey

      ea0049ep148
    • Thyroid carcinoma in multiple endocrine neoplasia type 1

      ea0049ep149
    • Small pancreatic neuroendocrine incidentalomas: an observational prospective study

      ea0049ep150
    • Potential inhibitory effect of progesterone on breast cancer metastasis via the regulation on protein expression of apoptosis- and EMT-related genes

      ea0049ep151
    • Incidental paraganglioma, diagnosis and follow-up - case report

      ea0049ep152
    • Primary hepatic neuroendocrine tumor with multiple liver metastases treated with somatostatin analogues: case report

      ea0049ep153
    • Development of an everolimus-resistant BON1 cell line with altered cell cycle and c-Met activity

      ea0049ep154
    • False positive findings on 6-[18F]fluor-L-3,4-dihydroxyphenylalanine Positron Emission Tomography (18F-FDOPA-PET) performed for imaging of neuroendocrine tumors

      ea0049ep155
    • Imaging follow-up of non-functioning adrenal masses at Vilnius University Hospital Santariskiu Klinikos: 2010-2016

      ea0049ep156
    • Medullary thyroid carcinoma and pheochromocytoma in multiple endocrine neoplasia type 2A - a reversed order diagnosis

      ea0049ep157
    • Bilateral pheochromocytomas, asyptomatic medullary thyroid carcinoma associated with left side thyroid hemiagenesis in a patient with MEN2A: diagnostic correlations

      ea0049ep158
    • Follow-up of adrenal incidentalomas after the initial approach

      ea0049ep159
    • A case of silent pancreatic neuroendocrine tumour of carcinoid variety masquerading as an insulinoma

      ea0049ep160
    • CYP2W1*6 polymorphism as a potential predictive marker of sensitivity to mitotane treatment in adrenocortical carcinoma.

      ea0049ep161
    • Abstract unavailable

      ea0049ep162
    • Ectopic ACTH-syndrome - 31 consecutive patients from the Helsinki University Hospital

      ea0049ep163
    • Ectopic Cushing's syndrome caused by a pulmonary adrenocorticotropic hormone secreting tumour: a case report

      ea0049ep164
    • Could alcohol ablation become the standard of care for benign insulinomas?

      ea0049ep165
    • Clinical characteristics and survival of patients with paraganglioma: a single center experience

      ea0049ep166
    • Corticotroph deficiency in patients with insulinoma

      ea0049ep167
    • Hyperinsulinemic hypoglycemia in a 71-year-old patient with a suspected case of [beta]-cells hyperplasia of pancreatic body and tail- case report

      ea0049ep168
    • Respiratory symtoms lead to a diagnosis of pheochromocytoma: An unusual presentation

      ea0049ep169
    • A rare cause of secondary endocrine hypertension in a young woman with hypokaliemia and recurrent transient ischemic attacks

      ea0049ep170
    • Atypical symptoms of hypoglycemia, hiding a diagnosis of insulinoma: a case report

      ea0049ep171
    • A nomogram consisted of routine biochemical tests may increase the diagnostic accuracy of chromogranin A in detecting patients with neuroendocrine tumors

      ea0049ep172
    • Concentration of dehydroepiandrosterone sulphate in 109 males and 54 females with adrenal tumors

      ea0049ep173
    • Jejunum/ ileum Neuroendocrine Tumours: results of a multicentric retrospective study

      ea0049ep174
    • Follow-up in neuroendocrine tumors: is chromogranin A the confounder?

      ea0049ep175
    • Large intestinal metaplasia is a precancerous lesion present in patients with gastric neuroendocrine neoplasms type 1

      ea0049ep176
    • Pancreatic neuroendocrine tumors (PNETs) in patients with MEN1 syndrome

      ea0049ep177
    • Dysregulation of the components of the splicing machinery in neuroendocrine tumors and its association with malignancy and aggressiveness

      ea0049ep178
    • Serum succinate: investigation of its putative role as a new biomarker in malignant SDH-x mutated pheochromocytoma-paraganglioma patients?

      ea0049ep179
    • Survival analysis of patients with gastroenteropancreatic neuroendocrine tumors

      ea0049ep180
    • Insulinoma - clinical features and outcome of patients diagnosed at a central hospital

      ea0049ep181
    • Effects of ketoconazole on ACTH-producing and non ACTH-producing neuroendocrine tumor cells

      ea0049ep182
    • Treatment with (177Lu)-DOTATATE in patients with advanced metastatic somatostatin receptor-positive tumors

      ea0049ep183
    • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) followed in the endocrinology and nutrition service's monographic outpatient clinics of neuroendocrine tumors in hospital clinico san carlos (HCSC). Description of its characteristics and evolution

      ea0049ep184
    • Descriptive and survival study of 142 cases of gastroenteropancreatic neuroendocrine tumor (GEP-NETs) diagnosed at the Hospital Clinico San Carlos (HCSC)

      ea0049ep185
    • Nonfunctional adrenal incidentaloma affects central blood pressures and arterial stiffness parameters

      ea0049ep186
    • Landscape of sporadic adrenal tumours from surgical unit - histopathological audit of 101 cases from a single centre in Poland

      ea0049ep187
    • An elevated chromogranin A: is it always a tumor progression?-case report

      ea0049ep188
    • An unknown giant neuroendocrine tumor

      ea0049ep189
    • A challenging case of metastatic paraganglioma and metastatic melanoma and prolactinoma

      ea0049ep190
    • Biology and differential diagnosis of calcitonin secreting neuroendocrine tumors

      ea0049ep191
    • Cancerous neuroendocrine vs endocrine tumours: broad commonalities and differences

      ea0049ep192
    • Short-term contralateral recurrence of a Litynski-Conn adenoma

      ea0049ep193
    • Acinic cell adenocarcinoma of the parotid gland associated with paraneoplastic Cushing's syndrome - a rare clinical case

      ea0049ep194
    • Malignant pheochromocytoma - a challenging diagnosis with nonconsensual management

      ea0049ep195
  • Neuroendocrinology
  • • Identification of molecular targets of Sunitinib in pancreatic neuroendocrine tumours

      ea0049ep196
    • Study of different in vitro systems for the evalutation of Sunitinib effects in pancreatic neuroendocrine tumour cells

      ea0049ep197
    • Von Hippel-Lindau syndrome: in vivo portrait with 68Ga-DOTANOC PET-CT

      ea0049ep198
    • Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinico-pathological characteristics and disease outcome of 110 patients treated at single referral medical center

      ea0049ep199
    • Insulinoma: diagnostic features and treatment management

      ea0049ep200
    • A rare case: non-islet cell tumor hypoglycemia with adrenal insufficiency

      ea0049ep201
    • Late manifestation of a mixed adenoneuroendocrine carcinoma of the cecum

      ea0049ep202
    • Quality of life in patients with neuroendocrine tumors treated with 177Lu-[DOTA0,Tyr3]-octreotate: a Single Tertiary Care Portuguese Center Experience

      ea0049ep203
    • Triple tumors in a patient with insulinoma

      ea0049ep204
  • Paediatric endocrinology
  • • An analysis of R356W and Q318X mutations and 8 bp deletion in 21-hydroxylase gene CYP21A2 in causing pseudo-precocious puberty in patients with congenital adrenal hyperplasia in Pakistani children

      ea0049ep205
    • Congenital adrenal hyperplasia: impact of therapy on growth and sexual maturation - a 5-year retrospective study of a Tertiary Pediatric Endocrinology Center

      ea0049ep206
  • Pituitary - Clinical
  • • The risk of hypotension, evaluated by ambulatory blood pressure monitoring, during fasting and outside fasting in patients with adrenal insufficiency

      ea0049ep207
  • Steroid metabolism + action
  • • Steroid metabolome changes in the 1 mg dexamethasone suppression test

      ea0049ep208
  • Thyroid cancer
  • • Clinical relevance of RET proto-oncogene variants L769L and S836S (exon 11, 13, 14, and 15) in patients with sporadic medullary thyroid carcinoma

      ea0049ep209
• Eposter Presentations: Calcium and Bone
• • Bone & Osteoporosis
  • • Abstract unavailable

      ea0049ep210
    • Bisphosphonate related osteonecrosis of the jaw: risk factors: a case report

      ea0049ep211
    • Salmon calcitonin affects thyroid endocrine cells and trabecular bone in a rat model of male osteoporosis

      ea0049ep212
    • Primary hyperparathyroidism: hormonal profile and risk of complications

      ea0049ep213
    • Efficacy and safety of bisphosphonate discontinuation in postmenopausal osteoporosis: a systematic review

      ea0049ep214
    • Osteopetrosis vs Osteogenesis Imperfecta-is that so hard to distinquish? Case report

      ea0049ep215
    • Osteonecrosis of the jaw and bilateral atypical femoral fracture both occurring during treatment of osteoporosis

      ea0049ep216
    • Clinical manifestations and treatment approach in osteogenesis imperfecta

      ea0049ep217
    • Special features of body composition and bone mineral metabolism in children with primary nephrotic syndrome

      ea0049ep218
    • Bone densitometry of type 2 diabetics (about 290 patients)

      ea0049ep219
    • Effects of acromegaly on bone tissue mRNA levels relevant to bone metabolism

      ea0049ep220
    • Osteoporosis and fractures in the real world setting

      ea0049ep221
    • Is osteoporosis a curable disease?

      ea0049ep222
    • Fractures at post-partum and lactation: common presentation of different clinical entities

      ea0049ep223
    • A multidisciplinary clinic for bone metabolism diseases; descriptive analysis of our experience in quiron salud malaga hospital

      ea0049ep224
    • Spontaneous recovery of BMD after surgical cure of Cushing's syndrome due to an adrenocortical adenoma: a 9-years follow-up

      ea0049ep225
    • Cinacalcet for control of primary hyperparathyroidism: a single centre experience

      ea0049ep226
    • Bone remodeling markers predict bone loss in premenopausal women

      ea0049ep227
    • Bone mineral density in hospital male physicians over the age of 65

      ea0049ep228
    • Association between bone mineral density and muscle strength in patients with Turner syndrome, after consideration of selected hormonal and metabolic parameters

      ea0049ep229
    • Volumes of visceral adipose tissue, gynoid and android fat as predictors of reduced bone mineral density in women with menstrual disorders

      ea0049ep230
    • Effect of chronic atrophic gastritis on bone mineral density of Korean women

      ea0049ep231
    • May serotonin metabolism polymorphisms 5HTTVNTR and 5HT_2A have a clinical impact in osteoporosis development?

      ea0049ep232
    • The effect of mechanical assisted squat exercise on pulmonary function, muscle mass and function with or without sarcopenia

      ea0049ep233
    • Beta-2 adrenergic receptor (ADRB2) gene polymorphism Arg16Gly as risk factor for osteoporosis

      ea0049ep234
    • Bone histomorphometry and bone marrow adipocytes in premenopausal women with type 2 diabetes

      ea0049ep235
    • Differences in bone strength and metabolic parameters according to the presence of hyperadiponectinemia and obesity in Korean adults: The KoGES- ARIRANG study

      ea0049ep236
    • Do the surgical outcomes change if the surgeon accompanies the endocrinologist during the preoperative ultrasonography examination?

      ea0049ep237
    • Teriparatide discontinuation in a patient with post surgical hypoparathyroidism: a clinical challenge

      ea0049ep238
    • Endocrine disorders in treatment-naive male patients with HIV infection

      ea0049ep239
    • Trabecular bone score is negatively associated with bone resorbtion markers in patients with primary hyperparathyroidism

      ea0049ep240
    • Normocalcemic primary hyperparathyroidism (NPH)

      ea0049ep241
    • Secondary hyperparathyroidism and its implication on bone mineral density in patients with different stages of chronic kidney disease

      ea0049ep242
    • Impact of vitamin D on the bone quality assessed by trabecular bone score in men

      ea0049ep243
    • Neutrophil lymphocyte ratio in 6 month teriparatide therapy of osteoporosis

      ea0049ep244
    • Analysis of DXA scans of males performed in clinical center of vojvodina

      ea0049ep245
    • Biological assessment and causes of secondary osteoporosis

      ea0049ep246
  • Calcium & Vitamin D metabolism
  • • Management with Cinacalcet of non-surgical primary hyperparathyroidism in the elderly.

      ea0049ep247
    • Glucocorticoids regulate expression of lung calbindin-D9k in mouse

      ea0049ep248
    • Vitamin D intoxication caused hypercalcemia: Case report

      ea0049ep249
    • Abstract unavailable

      ea0049ep250
    • Gitelman syndrome and primary hyperparathyroidism - a rare association

      ea0049ep251
    • The volume of parathyroid adenoma is related to presurgical PTH and 25OH-D3, but not calcium levels at patients with primary hyperparathyroidism

      ea0049ep252
    • Pseudohypoparathyroidism type Ib: a case of chronic severe hypocalcaemia and seizures diagnosed in adulthood

      ea0049ep253
    • A practice review of the use of cinacalcet in primary hyperparathyroidism

      ea0049ep254
    • Is there a threshold of Vitamin D sufficiency that can prevent secondary hyperparathyroidism?

      ea0049ep255
    • Spontaneous remission of parathyroid adenoma due to parathyroid apoplexy: a case report

      ea0049ep256
    • Normocalcemic versus Hypercalcemic Primary Hyperparathyroidism: a comparative study

      ea0049ep257
    • Parathyroid carcinoma: experience of a Portuguese centre

      ea0049ep258
    • Vitamin D prescribing bias in liver transplant referrals

      ea0049ep259
    • How to differentiate primary hyperparathyroidism with D hypovitaminosis from secondary hyperparathyroidism due to D hypovitaminosis?

      ea0049ep260
    • Pseudohypoparathyroidism as an etiological cause for epilepsy: a case report

      ea0049ep261
    • Long standing primary hyperparathyroidism consequences after parathyroid surgery: fast recovery not only for bone mass

      ea0049ep262
    • Associations of nitric oxide with vitamin D and other serological factors in healthy adolescents

      ea0049ep263
    • Primary hyperparathyroidism in pregnancy

      ea0049ep264
    • Eucalcemic parathyroid hormone elevation after parathyroid surgery for sporadic primary hyperparathyroidism

      ea0049ep265
    • Primary hyperparathyroidism mimicking metastatic bone disease

      ea0049ep266
    • Acute pancreatitis as the first presentation of primary hyperparathyroidism

      ea0049ep267
    • Gender difference in clinical presentation of primary hyperparathyroidism

      ea0049ep268
    • Prevalence of hypocalcemia in adults in Minsk, Belarus

      ea0049ep269
    • Assessment of changing in the therapeutic attitude in patients with primary hyperparathyrodism in conservative management after the realization of radial densitometry

      ea0049ep270
    • A rare case: intrathymic parathyroid adenoma

      ea0049ep271
    • Audit of emergency hypercalcaemia management in the acute medical unit

      ea0049ep272
    • Higher circulating parathyroid hormone concentration fascilitates preoperative diagnostic imagings for localization in primary hyperparathyroidism

      ea0049ep273
    • Calcifediol is more effective than cholecalciferol in the treatment of severe vitamin D deficiency in a patient submitted to malabsorbitive bariatric surgery: a case report

      ea0049ep274
    • The effect of 1,25(OH)2D3 on interferon i secretion by human mononuclear cells in vitro

      ea0049ep275
    • The changing face of primary hyperparathyroidism

      ea0049ep276
    • Single center experience of intact parathyroid hormone determination in washout samples of suspicious parathyroid adenomas

      ea0049ep277
    • Primary hyperparathyroidism due to atypical adenoma: clinical, biochemical and histological features of an Italian cohort

      ea0049ep278
    • Medullary vertebral compression in primary hyperparathyroidism

      ea0049ep279
    • Management of primary hyperparathyroidism: Experience of a large UK teaching hospital

      ea0049ep280
    • Fahr Syndrome and idiopathic primary hipoparathyroidism - clinical case

      ea0049ep281
    • Clinical presentations of four patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome

      ea0049ep282
    • When is it worthwhile to perform parathyroid SPECT/CT scintigraphy in primary hyperparathyroidism?

      ea0049ep283
    • Parathormone (PTH) as a marker of vitamin D (VitD) deficiency

      ea0049ep284
    • Pathological basal ganglia calcification in isolated idiopathic hypoparathyroidism: a case report

      ea0049ep285
    • Diseases associated with hypercalcemia

      ea0049ep286
    • PTH levels in vitamin D deficiency

      ea0049ep287
    • Renal complications in patients with chronic postoperative hypoparathyroidism treated with oral calcium and active vitamin D metabolites

      ea0049ep288
    • The results of parathormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas for focused parathyroidectomy in patients with negative or suspicious sestamibi scans

      ea0049ep289
    • Weight has a weak influence on calcium-phosphorus metabolism in HIV-patients with vitamin d deficiency

      ea0049ep290
    • Chronic hypoparathyroidism disease profile from 492 patients in the PARADIGHM™ natural history global registry

      ea0049ep291
    • Prevalence of cardiometabolic risk factors among Saudi Women with vitamin D deficiency

      ea0049ep292
    • 18F-choline PET/MRI in patients with primary hyperparathyroidism and negative sestamibi SPECT/CT - report of two cases

      ea0049ep293
    • Severe hypocalcemia induced by Denosumab in a patient with Osteroporosis after malabsorptive bariatric surgery

      ea0049ep294
    • Performance characteristics of a new Waters MassTrak™ Vitamin D assay

      ea0049ep295
    • Vitamin D intoxication complicated with parathormon treatment in elderly: a case report

      ea0049ep296
    • Tc-99m sestamibi uptake by brown tumours in a patient with primary hyperparathyroidism

      ea0049ep297
    • Thyroid supression in patients with primary hyperparathyroidism may improve pre-surgical scintigraphy localisation

      ea0049ep298
    • Serum vitamin D in overweight patients with normal and impaired GFR

      ea0049ep299
    • The importance of ultrasound in the preoperative evaluation of patients with primary hyperthyroidism: a case report

      ea0049ep300
    • Abstract unavailable

      ea0049ep301
    • Ectopic production of calcitriol by non-hodgkin lymphoma as a cause of hypercalcemia: case report

      ea0049ep302
    • Primary hyperparathyroidism: elective parathyroidectomy versus conservative management; results of a retrospective cohort study

      ea0049ep303
    • Calcium metabolism and autoimmune thyroiditis

      ea0049ep304
    • Pseudohypoparathyroidism (PHP) and GNAS gene mutations - clinical spectrum from PHP type 1a to pseudopseudohypoparathyroidism

      ea0049ep305
    • Hyperparathyroidism and cardiovascular risk

      ea0049ep306
    • Risk factors associated with osteoporosis in beta-thalassaemia major patients

      ea0049ep307
    • Giants walk amongst us

      ea0049ep308
    • Hungry bone syndrome after treatment of severe primary hyperparathyroidism

      ea0049ep309
    • Clinical review of nine cases of pseudohypoparathyroidism

      ea0049ep310
    • Severe hypercalcemia revealing an atypical parathyroid adenoma

      ea0049ep311
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Hypercalcemia and cardiovascular disease

      ea0049ep312
    • Vitamin D levels in obese adults and cardiovascular risk

      ea0049ep313
  • Clinical case reports - Pituitary/Adrenal
  • • Partial gigantism: case report

      ea0049ep314
  • Clinical case reports - Thyroid/Others
  • • An unique case of celiac disease with hypocoagulation and secondary hyperparathyreodism in elderly patient - a case report

      ea0049ep315
    • Optic neuritis as presenting complaint in primary hypoparathyroidism

      ea0049ep316
    • The parathyroid carcinoma in a young adult male

      ea0049ep317
    • Clinical case of atypical parathyroid adenoma with severe hypercalcemia and multiple fragility fractures

      ea0049ep318
    • Congenital fibrous dysplasia and Klinefelter syndrome: coincidence or not?

      ea0049ep319
    • Parathyroid nodular hyperplasia: when imaging exams fail

      ea0049ep320
    • As clear as mud: an atypical case of primary hyperparathyroidism

      ea0049ep321
    • Familial hypocalciuric hypercalcemia with a new heterozygous missense mutation of CaSR gene and cinacalcet treatment

      ea0049ep322
    • Parathyroid carcinoma can be misdiagnosis with medullary thyroid cancer: how is that possible?

      ea0049ep323
    • Clinical case of pachydermoperiostosis

      ea0049ep324
    • Vascular dementia in a 57-year old woman with adenoma of parathyroid gland

      ea0049ep325
    • Equivocal preoperative imaging including 18F-fluorocholine PET-CT in primary hyperparathyroidism and nodular thyroid disease - case report

      ea0049ep326
    • Parathyroid carcinoma: a report of cases

      ea0049ep327
    • A rare case of giant parathyroid adenoma: diagnostic and therapeutic aspects

      ea0049ep328
    • Autosomal dominant hypocalcemia in a Portuguese family: novel mutation in the calcium-sensing receptor gene

      ea0049ep329
    • A case of intrathyroidal parathyroid adenoma presented with severe 25(OH)D3 deficiency, bone pain and high PTH

      ea0049ep330
    • The rare cause of primary hyperparathyroidism: Parathyroid Carcinoma

      ea0049ep331
    • A parathyroid adenoma presented with diffuse bone lesions and anemia

      ea0049ep332
    • Common bone lesions may be a sign of parathyroid carcinoma in the primary hyperparathyroidism

      ea0049ep333
    • Broken bones and blindness- a rare cause of osteoporosis

      ea0049ep334
    • An usual cause of post operative hypocalcemia

      ea0049ep335
    • Brown tumor in a normocalcemic patient

      ea0049ep336
    • Symptomatic bisphosphonate-induced hypocalcaemia after severe idiopathic hypercalcaemia

      ea0049ep337
    • Transient hyperglycemia during the course of primary hypoparathyroidism: Case study

      ea0049ep338
    • Hyperparathyroidism jaw tumour syndrome (HPT-JT)

      ea0049ep339
    • Fahr syndrome revealing a pseudohypoparathyroidism

      ea0049ep340
    • Parathyroid cyst: the forgotten diagnosis of a neck mass

      ea0049ep341
    • [ldquo]Pseudo or not[rdquo]: differential diagnosis of hyperparathyroidism with severe electrolyte imbalance in transgender patient: a challenging case report

      ea0049ep342
  • Developmental endocrinology
  • • Adolescent onset distal renal tubular acidosis presenting with significant growth retardation without rickets

      ea0049ep343
  • Endocrine tumours and neoplasia
  • • Differential roles of carboxylated and uncarboxylated Osteocalcin in stage I breast cancer as a diagnostic biomarker

      ea0049ep344
    • Gross CDC73 deletions in young patients with primary hyperparathyroidism in Russia

      ea0049ep345
    • Multiple endocrine neoplasia type 1 phenocopies: role of the genes associated with familial primary hyperparathyroidism

      ea0049ep346
    • Recurrent ectopic parathyroid carcinoma

      ea0049ep347
    • Exome analysis of a large family with familial isolated primary hyperparathyroidism (FIHP) and multiple cancers

      ea0049ep348
    • Parathyroid cancer - clinical presentation, prognostic factors and long-term evolution

      ea0049ep349
    • A suspicious case of multiple endocrine neoplasia

      ea0049ep350
  • Endocrine tumours and neoplasia (1)
  • • Bone mineral density in obese children

      ea0049ep351
  • Paediatric endocrinology
  • • Progressive osseous heteroplasia in a child with pseudohypoparathyroidism type I

      ea0049ep352
  • Steroid metabolism + action
  • • Genetic variations in the HSD11B1 gene in patients treated with glucocorticoids show associations with bone mineral density

      ea0049ep353
• Eposter Presentations: Diabetes, Obesity and Metabolism
• • Calcium & Vitamin D metabolism
  • • Abstract unavailable

      ea0049ep354
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Metabolic syndrome in digestive neoplasms

      ea0049ep355
    • Dyslipidemia-associated skin lesions as a short key for etiology unraveling and management of life-threatening acute pancreatitis in young male

      ea0049ep356
    • Metformin and changes in blood pressure and heart rate in lean patients with polycystic ovary syndrome (PCOS)- preliminary study

      ea0049ep357
    • Screening for type 2 diabetes mellitus as a method of secondary prevention of cardiovascular lesions

      ea0049ep358
    • Soybean phytoestrogens reduce 27-hydroxycholesterol concentration in the liver of middle-aged female rats

      ea0049ep359
    • Awareness and prevalence of metabolic syndrome among high-risk individuals attending internal medicine clinics across Jordan

      ea0049ep360
    • Nine months of practice in California - self-referrals in endocrinology

      ea0049ep361
    • Identifiying underdiagnosed or undertreated patients with familial hypercholesterolemia from the central laboratory registries

      ea0049ep362
    • The effect of admission hyperglycemia on clinical outcome of ischaemic stroke patients

      ea0049ep363
    • Deleting genomic region of Hsd17b1 in mice results into a hypomorphic Naglu allele, and consequently to a phenotype mimicking a lysosomal storage disease

      ea0049ep364
    • Salivary lactate levels during anaerobic threshold (AT) training

      ea0049ep365
    • The effect of tocilizumab - an interleukin-6 receptor antagonist - on lipid levels in rheumatoid arthritis

      ea0049ep366
    • Homocystein-significant marker of metabolic syndrome and atherosclerosis risk

      ea0049ep367
    • Graft vs host disease and insulin resistance after bone marrow transplantation

      ea0049ep368
    • Coronary artery calcium score in prediabetes - preliminary results

      ea0049ep369
    • Cardiometabolic risk and female sexuality: focus on clitoral vascular resistance

      ea0049ep370
    • Metformin and changes in serum lipid profile in lean patients with polycystic ovary syndrome (PCOS)

      ea0049ep371
    • Prevalence of major cardiovascular risk factors among people living with HIV in a low risk country for cardiovascular disease

      ea0049ep372
    • The role of leptin signalling in the development of cardiovascular diseases in obesity

      ea0049ep373
    • Influence factors on lipid profile among patients with rheumatoid arthritis

      ea0049ep374
    • Abstract unavailable

      ea0049ep375
    • Oxidative stress and metabolic profiles assessment after melatonin and irbesartan co-administration in a novel pharmaceutical formulation

      ea0049ep376
    • The dual FXR/TGR5 agonist INT-767 counteracts nonalcoholic steatohepatitis and visceral adipose tissue dysfunction in a rabbit model of high fat diet-induced metabolic syndrome

      ea0049ep377
    • Prevalence of metabolic syndrome and its relation to physical activity and nutrition in Azerbaijan

      ea0049ep378
    • Isolated low HDL-Cholesterol in patients with type 2 diabetes about 168 cases

      ea0049ep379
    • Can hypoglycemic episodes in type 1 diabetics trigger cardiac arrhythmias?

      ea0049ep380
    • Family hypercholesterolemia: about 4 cases

      ea0049ep381
    • Description of an educational intervention lifestyle program in reducing cardiovascular risk factors

      ea0049ep382
    • Role of lactate dehydrogenase-A (LDH-A) in atherosclerosis

      ea0049ep383
  • Clinical case reports - Pituitary/Adrenal
  • • Prediction of type 1 diabetes in autoimmune polyglandular syndrome type 2

      ea0049ep384
  • Clinical case reports - Thyroid/Others
  • • Insulin autoimmune syndrome (Hirata Disease) triggered by a tyrosine kinase inhibitor drug in a Latin American patient

      ea0049ep385
    • Fulminant diabetic ketoacidosis complicating nivolumab immunotherapy

      ea0049ep386
    • Dyslipidemia and antiretroviral therapy: a case report

      ea0049ep387
    • Diabetic patient with suppurative thyroiditis caused by Salmonella enterica complicated with acute kidney injury

      ea0049ep388
    • Improved xanthomas after leptin replacement short therapy in congenital lipodystrophy patient

      ea0049ep389
    • Resistant hypertension in an obese type 2 diabetic male with obstructive sleep apnea: resolution with CPAP, weight loss and Dulaglutide

      ea0049ep390
    • Morgagni-Stewart-Morel Syndrome in a 61-years patient: case report

      ea0049ep391
    • Continuous glucose monitoring in glycogen storage disease type Ia - a major improvement for patients

      ea0049ep392
    • Diabetes mellitus: one train may hide another

      ea0049ep393
    • Endocrine manifestations of Woodhouse-Sakati Syndrome - a Portuguese case

      ea0049ep394
    • Hypoglycaemia due to hydroxychloroquine in a patient who underwent Roux-en-Y gastric bypass surgery

      ea0049ep395
    • A case report of insulin autoimmune syndrome in a Caucasian

      ea0049ep396
    • Acquired generalized lipodystrophy associated with latent autoimmune diabetes mellitus in adults: a new metabolic phenotype

      ea0049ep397
    • Humalog Mix50® massive overdose for suicidal purpose: a case report

      ea0049ep398
    • Extensive venous thrombosis of the upper extremity in a newly diagnosed type 2 diabetic female

      ea0049ep399
    • Early association of three autoimmune disorders in a young male with polyglandular autoimmune syndrome type IIIA

      ea0049ep400
  • Developmental endocrinology
  • • Nutritional status in ambulatory patients by Medicine Laboratory

      ea0049ep401
    • Satiety, hunger and gastrointestinal hormones after a test meal in patients after gastric bypass surgery: an association with amino acids

      ea0049ep402
  • Diabetes (to include epidemiology, pathophysiology)
  • • The fatty acid profile in diabetic children

      ea0049ep403
    • Sitagliptin use may reduce oral cancer risk in patients with type 2 diabetes

      ea0049ep404
    • Does a first-degree family history of diabetes impact placental vascular circulation and placental inflammatory response?

      ea0049ep405
    • Episodes of poorly controlled diabetes in 1486 patients admitted in Orthopedic Surgery and Traumatology

      ea0049ep406
    • Episodes of poorly controlled diabetes in 173 patients admitted in Vascular Surgery

      ea0049ep407
    • Postprandial triglyceride responses and insulin resistance among night shift health care workers

      ea0049ep408
    • Improving safety in diabetes management and reducing insulin errors in hospital - practically achievable or a utopian fantasy?

      ea0049ep409
    • Heterozygote c.313delC (p.H105TfsX11) mutation of Glucokinase gene in patient with Waardenburg syndrome type 1

      ea0049ep410
    • GLIS3 rs7020673 and rs10758593 polymorphisms interact in the susceptibility for type 1 diabetes mellitus

      ea0049ep411
    • Vitamin D level in naive Type2 Diabetes Mellitus in Fayoum University Hospital

      ea0049ep412
    • Association of wolfram syndrome with chronic renal failure in a boy

      ea0049ep413
    • Hypoglycaemia in hospital is associated with longer hospital stay and decline of renal function

      ea0049ep414
    • Could we prevent insulin induced lipohypertrophy in diabetic patients?

      ea0049ep415
    • Relation between serum leptin concentration and insulin resistance syndrome in patients with type 2 diabetes mellitus

      ea0049ep416
    • Epidemiological and clinical study of diabetes in immigrants from Bangladesh in Athens versus Greek patients

      ea0049ep417
    • Vitamin D levels in newly diagnosed type I diabetes mellitus and relationship with organ specific autoimmune disorders

      ea0049ep418
    • Is secreted frizzled-releated protein 4 (SFRP-4) a possible biomarker for [beta] cell dysfunction?

      ea0049ep419
    • The clinical efficacy of the nucleo CMP forte usage in the combined treatment of diabetic peripheral neuropathy

      ea0049ep420
    • Effect of glucose ingestion on serum fractalkine levels in healthy subjects and diabetic patients

      ea0049ep421
    • Epidemiological features of type 1 diabetes in children and adolescents in the Republic of Armenia

      ea0049ep422
    • High incidence of glucose metabolism disorders in patients undergoing coronary angiography without history of diabetes

      ea0049ep423
    • The relation between type II diabetes and chronic depression in primary care practice in Jordan

      ea0049ep424
    • Anti-islet cell antibodies in a sample of Egyptian females with gestational diabetes and its relation to development of type 1 diabetes mellitus

      ea0049ep425
    • A retrospective analysis of the impact of new diagnostic criteria for gestational diabetes mellitus on the endocrinology service at a tertiary hospital

      ea0049ep426
    • Insulin autoimmune syndrome-a case report

      ea0049ep427
    • Incidence estimate of type 1 Diabetes in Youth in Dhaka

      ea0049ep428
    • Is thiol/disulfide homeostasis related to parity and gravidity in gestational diabetes?

      ea0049ep429
    • Endocrine factors associated with postprandial hypoglycaemia in patients with cystic fibrosis: a pilot study

      ea0049ep430
    • Vascular dementia and type 2 diabetes: incidence and outcomes in elderly patients in a ten year study

      ea0049ep431
    • Study of the glycemic control in the hospitalized patient

      ea0049ep432
    • Hypoglycaemia: Prevalence and factors associated in the old-hospitalized patient

      ea0049ep433
    • The importance of islet antigen-2 and glutamic acid decarboxylase antibodies in proper diagnosis of diabetes mellitus at the age ≥30 and <70 years

      ea0049ep434
    • The increase in unsaturated fatty acids is related with an anti-inflammatory profile in the hypothalamus of non-diabetic IRS2-deficient mice

      ea0049ep435
    • Epidemiological indicators and prevalence of risk factors of diabetes type 2 among the inhabitants of Almaty city and Almaty region of Kazakhstan

      ea0049ep436
    • Association of FGF21 soluble levels with metabolic profile in Gestational Diabetes patients

      ea0049ep437
    • Site-specific cancer risk in people with type 2 diabetes: Nationwide population-based cohort study in Korea

      ea0049ep438
    • Erosio interdigitalis blastomycetica- discrete and early sign for diabetes mellitus

      ea0049ep439
    • Postpartum Tip 2 DM follow-up after gestational diabetes mellitus

      ea0049ep440
    • Diabetic nephropathy in type 1 diabetes mellitus

      ea0049ep441
    • Diabetes and smoking: epidemiological study in two ethnic groups

      ea0049ep442
    • Prevalence of hyperglycemia in patients hospitalized in the health area of cuenca (Spain)

      ea0049ep443
    • Testosterone levels in men with diabetes mellitus. What relation?

      ea0049ep444
    • Vitamin D and testosterone in diabetes mellitus: cross-sectional study results

      ea0049ep445
    • The relationship between serum uric acid and insulin resistance and sensitivity parameters in Turkish type 2 diabetes mellitus patients

      ea0049ep446
    • Relationship with T helper 1 cytokines and type 2 diabetes

      ea0049ep447
    • Adipocytokines, incretins, insulin resistance and body composition coherence in women with previously diagnosed gestational diabetes mellitus

      ea0049ep448
    • The coherence of carbohydrate metabolism and metabolic parameters (adipocytokines, incretins, insulin resistance) in women with previously diagnosed gestational diabetes mellitus

      ea0049ep449
    • Instable diabetes revealing pheochromocytoma

      ea0049ep450
    • Unacylated ghrelin does not seem to influence glucose homeostasis in obese women

      ea0049ep451
    • Influence of a part of Korean red ginseng on blood glucose control and complication markers of type 2 diabetic NSY rats

      ea0049ep452
    • The prevalence of diabetic neuropathy, painful diabetic neuropathy and the at risk diabetic foot in Qatar

      ea0049ep453
    • Changes in gene expression MADCAM1, S1PR1, CXCR4 and CCR7 in offspring of rats with experimental gestational diabetes

      ea0049ep454
    • Study of expression of genes mTOR, Foxp3, IL1[beta] and IL17A in parapancreatic adipose tissue of rats with streptozotocin-induced diabetes and after metformin administrations

      ea0049ep455
    • Response to stroke in diabetic versus non-diabetic patients. Should Diabetes education systematically include advise on stroke symptoms and the correct response to them?

      ea0049ep456
    • The T allele of the rs1746661G/T polymorphism in FNDC5 (irisin) gene is associated with increased systolic blood pressure

      ea0049ep457
    • The relations of apelin with the carbohydrate metabolism in hypertensive patients with type 2 diabetes or without it

      ea0049ep458
    • Maturity-onset diabetes of the young type 5 (mody 5): a case report

      ea0049ep459
    • New-onset diabetes after transplantation (NODAT): an evaluation of risk factors in renal transplantation

      ea0049ep460
    • Malnutrition and sarcopenia in diabetic institutionalized older people: are there differences with non diabetic people?

      ea0049ep461
    • New onset diabetes after transplantation (NODAT): frequency and characterization of patients in renal transplantation

      ea0049ep462
    • Incidence of diabetic ketosis and ketoacidosis in Caucasian adults with type 2 diabetes mellitus: a population-based study

      ea0049ep463
    • HOMA-IR and HOMA-islet indices in the evaluation of different carbohydrate metabolism disorders during glucocorticoid therapy

      ea0049ep464
    • Carbohydrate metabolism disorders associated with different glucocorticoid therapy schemes

      ea0049ep465
    • Type B insulin resistance syndrome in a patient with connective tissue disease

      ea0049ep466
    • Parvovirus B19 infection may have a role in the etiopathogennesis of type 1 DM

      ea0049ep467
    • Hyperinter study: evaluation of glycemic values in acute inpatients from medical and surgical units. population without diabetes

      ea0049ep468
    • Evaluation of oral glucose tolerance test as a screening test detecting glucose metabolism impairment in patients chronically treated with glucocorticoids without previous history of diabetes

      ea0049ep469
    • Impact of exercise training on insulin sensitivity estimated by HOMA model in elite athletes: association with body composition

      ea0049ep470
    • Abstract unavailable

      ea0049ep471
    • Dysregulation of the splicing machinery could represent an early, predictive event in the development of type 2 diabetes

      ea0049ep472
    • Abstract unavailable

      ea0049ep473
    • Debut diabetes characteristics

      ea0049ep474
    • Effect of vitamin D supplementation on Glucose Tolerance, HOMA indices and on the risk of GDM in pregnant women with vitamin D deficiency - a prospective interventional study

      ea0049ep475
    • Rapid tests use in the evaluation of neurocognitive effects of Ramadan fasting in type 2 diabetic patients: Results of a pilot study

      ea0049ep476
    • Lack of postpartum reclassification test in gestational diabetes - factors conditioning loss of follow-up

      ea0049ep477
    • Gonarthrosis, Diabetes Mellitus (Type 1 or 2), Leptin, Nesfatin-1

      ea0049ep478
    • A right time for pregnant women with type 1 diabetes mellitus

      ea0049ep479
    • The assessment of possible eating disorders among patients with type 2 diabetes mellitus using EAT-26 questionnaire

      ea0049ep480
    • Mediterranean diet and glycaemic control in a Mediterranean population with type 1 diabetes: a pilot study

      ea0049ep481
    • Analysis of zinc status in type 2 diabetic patients and its correlation with glycemic control

      ea0049ep482
    • Bone mineral density in male patients with type 2 diabetes mellitus, with and without hypogonadism

      ea0049ep483
    • Pregnancy outcome in relation to a disorder of glucose tolerance during pregnancy

      ea0049ep484
    • Single standard labour tactic at 39-40 weeks in pregnancy with gestational diabetes - is it the best policy?

      ea0049ep485
    • Insulin autoimmune syndrome: the relationship between insulin, c-peptide and glucose in active and recovering disease states

      ea0049ep486
    • Lipoprotein particle size in women with type 1 diabetes mellitus and its relationship to carotid intima-media thickness

      ea0049ep487
    • The upper limb infection in diabetic patients (about 32 cases)

      ea0049ep488
    • The peculiarities of structural and functional state of the myocardium and blood vessels in patients with type 2 diabetes mellitus and arterial hypertension depending on the dynamics of adipokines

      ea0049ep489
    • Casuistic from Endocrinology Medical Consultation at Clinica Girassol 2015

      ea0049ep490
    • Depression and quality of life in patients with type 2 diabetes mellitus

      ea0049ep491
    • Diabetes Mellitus type 1: characterization of patients at the endocrinology ambulatory follow up during the year 2015

      ea0049ep492
    • Bronze diabetes - a rare secondary cause of diabetes

      ea0049ep493
    • The epidemiology of type 2 diabetes mellitus and its complications in South Korea

      ea0049ep494
    • Prevalence of obesity and diabetes among in a developing country (Albania)

      ea0049ep495
    • Maturity onset diabetes of the young - clinical characteristics of a portuguese cohort

      ea0049ep496
    • The relationship between Serum Vaspin and atherogenic risk factors in T2DM

      ea0049ep497
  • Diabetes complications
  • • Prevalence of diabetic neuropathy and nephropathy in different ethnic minorities

      ea0049ep498
    • Correlation of homocysteine with macro and microvascular complication in patients with diabetes mellitus type 2

      ea0049ep499
    • Overweight and obesity in pregnant with diabetes mellitus type 1

      ea0049ep500
    • Does empowerment from an 'ABC approach' and 'Telemedicine' improve outcomes in a nurse-led diabetes kidney clinic?

      ea0049ep501
    • Causes of diabetic ketoacidosis: type 1 diabetes versus type 2 diabetes

      ea0049ep502
    • Abstract unavailable

      ea0049ep503
    • Is proteinuria always associated with diabetes mellitus?! Do we always make right diagnosis?!

      ea0049ep504
    • A Review of the literature: What are the impacts of hypoglycaemia in insulin-dependent diabetic adults?

      ea0049ep505
    • A protective effect of lobeglitazone on renal fibrosis in unilateral ureteral obstruction mice model

      ea0049ep506
    • Using the plastic closure techniques of wound defecting treatment of patients with diabetic foot syndrome

      ea0049ep507
    • Insulin therapy with an impact on inflammation can change the risk for cardiovascvular diseases in type 2 diabetes

      ea0049ep508
    • Prayer marks in immigrants from Bangladesh with diabetes mellitus who live in Greece

      ea0049ep509
    • Therapy of hormonal disorders in women with acne

      ea0049ep510
    • N-Terminal pro-B-type natriuretic peptide level in type 2 diabetic patients

      ea0049ep511
    • Metabolic risk factors in adolescent girls with type 1 diabetes

      ea0049ep512
    • Transcultural prevalence of depression in type 2 diabetic patients in Egypt and Yemen

      ea0049ep513
    • Telmisartan attenuates hyperglycemia-aggravated VCAM-1 expression and monocytes adhesion in TNF[alpha]-stimulated endothelial cells by increasing GSK3[beta]-Ser⁹ phosphorylation

      ea0049ep514
    • Continuous glucose monitoring system in the value of diabetes mellitus type 1 control

      ea0049ep515
    • Chronic kidney disease in elderly patients with type 2 diabetes: 6 years of follow-up study

      ea0049ep516
    • Association of metabolic risk factors with hyperfiltration and urine albumin creation ratio in represent Korean population (Korea National Health and Nutrition Examination Survey 2011-2014) without chronic kidney disease

      ea0049ep517
    • Clinical correlates of TNF alpha levels in anemic patients with early diabetic nephropathy

      ea0049ep518
    • Non-alcoholic steatohepatitis and diabetes mellitus: a case report

      ea0049ep519
    • A novel lipid tetrad index as predictor of premature coronary artery disease in diabetic patients

      ea0049ep520
    • Assessing the impact of 'nephrogenic' risk factors on the development of cardiac pathology in patients with long duration diabetes type 1

      ea0049ep521
    • Abstract unavailable

      ea0049ep522
    • The prevalence of common risk factors for depression development in diabetes mellitus of the type 1

      ea0049ep523
    • Comorbilities and morbimortality of patients with hospital hyperglycemia in the health area of Cuenca (Spain)

      ea0049ep524
    • Diabetes and mental health disorders: not a good combination

      ea0049ep525
    • Management of diabetic peripheral neuropathy (DPN) using low frequency pulsed electro magnetic field (LF-PEMF)

      ea0049ep526
    • Correlation of NGAL and thyroid function in patients with type 1 diabetes

      ea0049ep527
    • Impaired awareness of hypoglycemia in adults with type 1 diabetes is not associated with peripheral neuropathy

      ea0049ep528
    • A rare presentation of diabetic ketoacidosis: Rhino-orbito-cerebral mucormycosis

      ea0049ep529
    • Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

      ea0049ep530
    • Significance of hemorheological approach for screening diabetic nephropathy in the type II diabetes mellitus

      ea0049ep531
    • New features of pathogenetic treatment of diabetic neuropathy (DN) at on early stage

      ea0049ep532
    • The effect of different antihypertensive treatment protocoles on glycemic control and lipid profile in type 2 diabetic patients with microalbuminuria and stage 1 hypertension

      ea0049ep533
    • Transcultural prevalence of depression in type 2 diabetic patients in Egypt and Yemen

      ea0049ep513 (1)
    • Telmisartan attenuates hyperglycemia-aggravated VCAM-1 expression and monocytes adhesion in TNF[alpha]-stimulated endothelial cells by increasing GSK3[beta]-Ser⁹ phosphorylation

      ea0049ep514 (1)
    • Continuous glucose monitoring system in the value of diabetes mellitus type 1 control

      ea0049ep515 (1)
    • Chronic kidney disease in elderly patients with type 2 diabetes: 6 years of follow-up study

      ea0049ep516 (1)
    • Association of metabolic risk factors with hyperfiltration and urine albumin creation ratio in represent Korean population (Korea National Health and Nutrition Examination Survey 2011-2014) without chronic kidney disease

      ea0049ep517 (1)
    • Clinical correlates of TNF alpha levels in anemic patients with early diabetic nephropathy

      ea0049ep518 (1)
    • Non-alcoholic steatohepatitis and diabetes mellitus: a case report

      ea0049ep519 (1)
    • A novel lipid tetrad index as predictor of premature coronary artery disease in diabetic patients

      ea0049ep520 (1)
    • Assessing the impact of 'nephrogenic' risk factors on the development of cardiac pathology in patients with long duration diabetes type 1

      ea0049ep521 (1)
    • Abstract unavailable

      ea0049ep522 (1)
    • The prevalence of common risk factors for depression development in diabetes mellitus of the type 1

      ea0049ep523 (1)
    • Comorbilities and morbimortality of patients with hospital hyperglycemia in the health area of Cuenca (Spain)

      ea0049ep524 (1)
    • Diabetes and mental health disorders: not a good combination

      ea0049ep525 (1)
    • Management of diabetic peripheral neuropathy (DPN) using low frequency pulsed electro magnetic field (LF-PEMF)

      ea0049ep526 (1)
    • Correlation of NGAL and thyroid function in patients with type 1 diabetes

      ea0049ep527 (1)
    • Impaired awareness of hypoglycemia in adults with type 1 diabetes is not associated with peripheral neuropathy

      ea0049ep528 (1)
    • A rare presentation of diabetic ketoacidosis: Rhino-orbito-cerebral mucormycosis

      ea0049ep529 (1)
    • Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

      ea0049ep530 (1)
    • Significance of hemorheological approach for screening diabetic nephropathy in the type II diabetes mellitus

      ea0049ep531 (1)
    • New features of pathogenetic treatment of diabetic neuropathy (DN) at on early stage

      ea0049ep532 (1)
    • The effect of different antihypertensive treatment protocoles on glycemic control and lipid profile in type 2 diabetic patients with microalbuminuria and stage 1 hypertension

      ea0049ep533 (1)
    • Impact of skin bundle implementation on hospital aquired pressure foot ulcers and lenght of stay in inpatients with diabetes

      ea0049ep534
    • Continuous glucose monitoring system in patients with gestational diabetes mellitus: a prospective study

      ea0049ep535
    • The analysis of interrelation of filtrational ability of kidneys and indicators of the androgenic state at patients with diabetes mellitus type 1

      ea0049ep536
    • PDE5i preserves renal function in models of Diabetic Nephropathy: from bench to bedside

      ea0049ep537
    • Relationship between microvascular complications of Diabetes Mellitus and trace element levels

      ea0049ep538
    • The frequency of different risk factors for diabetic ketoacidosis in real clinical practice in Russia

      ea0049ep539
    • Somnological parameters for patients with type 1 diabetes and nocturnal hypoglycemia

      ea0049ep540
    • The value of blood glucose levels for the parameters of nocturnal sleep for patients with type 1 diabetes

      ea0049ep541
    • Emotional state association with microvascular complications, disease duration and glycaemic control in type 1 diabetic patients

      ea0049ep542
    • The trigger off severe vomiting and hypertension during pregnancy in type 1 diabetic patient: case report

      ea0049ep543
    • Predictor factors of hypertension induced in pregnancy in patients with gestacional diabetes mellitus

      ea0049ep544
    • Patient first admitted as diabetic ketoacidosis and diagnosed as MODY 3

      ea0049ep545
    • Screening for macrovascular complications in diabetic patients in Korca, Albania

      ea0049ep546
    • Osteoprotegerin as a cardiovascular risk marker in diabetic patients

      ea0049ep547
    • Diabetic ketoacidosis in an intensive care unit - review

      ea0049ep548
    • Prognostic factors and all-cause mortality in patients with type 2 diabetes presenting with diabetic ketoacidosis: a population based, case-control study

      ea0049ep549
    • Can the most frequent DRB1* gene's alleles be associated with cardiovascular autonomic neuropathy among patients with type 1 diabetes mellitus? A case - control pilot study

      ea0049ep550
    • Genome-wide DNA methylation analysis for type 2 diabetes mellitus and cardiovascular disease: from a 23-year follow-up in the Da Qing diabetes prevention study

      ea0049ep551
    • Prevalence of eye complications and its correlation with kidney function: clinical practice data of diabetes patients

      ea0049ep552
    • Atherosclerotic cardiovascular risk assessment score in diabetes patients: a retrospective analysis of clinical data

      ea0049ep553
    • The association between pancreatic steatosis and diabetic retinopathy in patients with non-obese type 2 diabetes mellitus

      ea0049ep554
    • Dyslipidaemia and diabetes: a real world clinical evidence in Indian scenario

      ea0049ep555
    • Markers of nonalcoholic fatty liver disease in patients with diabetes

      ea0049ep556
    • Meal composition affects risk markers for kidney disease differently in type 2 diabetes and healthy subjects

      ea0049ep557
    • Audit of a nurse-led and pharmacist assisted diabetes renal out-patient clinic - does it help improve medicines management and clinical outcomes?

      ea0049ep558
    • Inhibin B levels and bone health in male adult patients with Type 1 Diabetes Mellitus

      ea0049ep559
    • Cardiovascular disease and risk factors in patients with type 1 diabetes mellitus

      ea0049ep560
    • Platelet aggregation and physiological anticoagulants in acute insulin-induced hypoglycemia in patients with type 1 diabetes (DM1)

      ea0049ep561
    • Biomarkers status and their relation with the presence of type 2 diabetes with and without angiopathy

      ea0049ep562
    • Severe hypoglycaemias in patients with unnoticed hypoglycaemias: a two-year follow up

      ea0049ep563
    • Small for gestational age and gestational diabetes - Should we be more permissive?

      ea0049ep564
    • A case of pulmonary tuberculosis presented with recurrent diabetic ketoacidosis

      ea0049ep565
    • Which one is much more cause in osteoarthritis? Diabetes mellitus Type 1 or 2?

      ea0049ep566
    • Prevalence of distal symmetric polyneuropathy in diabetic patients in general medicine wards

      ea0049ep567
    • Tubular and glomerular biomarkers of kidney injury on glucagon-like peptide-1 (GLP-1) therapy in type 1 diabetic patients

      ea0049ep568
    • Diabetic choroidopathy and renal function

      ea0049ep569
    • Risk factors of diabetic foot complications

      ea0049ep570
    • Diabetes mellitus as an important comorbidity in patient with sepsis

      ea0049ep571
    • The prevalence of chronic kidney disease and albuminuria in patients with Type 1 and Type 2 diabetes attending a single centre

      ea0049ep572
    • Two case reports of diabetic ketoacidosis: as lethal as avoidable

      ea0049ep573
    • Characteristics of patients with cystic fibrosis and hydrocarbon alteration in an adult unit

      ea0049ep574
    • Management of diabetic ketoacidosis in haemodialysis patient

      ea0049ep575
    • Severe diabetic gastroparesis - two cases of challenging treatment

      ea0049ep576
    • Predictors of in-hospital mortality in diabetic patients - analysis of 958305 hospitalizations

      ea0049ep577
    • Gestacional diabetes mellitus: 4 years study case at a tertiary level maternity hospital

      ea0049ep578
  • Diabetes therapy
  • • A modelling approach for cost-savings in the elderly ontarian population with type 2 diabetes due to reduction in mild hypoglycemia events for SGLT-2 inhibitor versus sulfonylurea (SU) initiation after metformin

      ea0049ep579
    • Do adding B vitamins and folate to metformin has beneficial effect on renal function and lipids in type 2 diabetic patients

      ea0049ep580
    • The role of sodium-glucose co-transporter 2 inhibitors as add-on therapy in type 2 diabetes

      ea0049ep581
    • Abstract unavailable

      ea0049ep582
    • Hypoglycemia, weight changes and health related quality of life (HRQoL) instruments for diabetes care

      ea0049ep583
    • Use of an innovative Technology Enabled Care service (TECS) 'Florence' to empower patients and enhance adherence to BP treatments in diabetes

      ea0049ep584
    • The decreased adiponectin level after the treatment with glibenclamide is associated with deterioration of left ventricular function

      ea0049ep585
    • Effects of inositol on glucose homeostasis: systematic review and meta-analysis of randomized controlled trials

      ea0049ep586
    • A rare pediatric presentation of type 1 diabetes mellitus with duchenne muscular dystrophy - what to expect in the future?

      ea0049ep587
    • Significant effect of a group education program on glycemic control and incidence of hypoglycemia in patients with diabetes mellitus type 1: A case-controlled study

      ea0049ep588
    • Dapagliflozin induced vulvovaginitis in an atopic patient with type 2 diabetes mellitus

      ea0049ep589
    • Efficacy of body weight reduction on SGLT-2 inhibitor in people with type 2 diabetes mellitus

      ea0049ep590
    • Modification of lifestyle and influence on leptin and insulin resistance to prevent type 2 diabetes mellitus

      ea0049ep591
    • Australian women with diabetes survey of contraceptive use and beliefs about safety of contraceptive options

      ea0049ep592
    • Management and control of hospital hyperglycemia in the health area of cuenca (Spain)

      ea0049ep593
    • Impact of the insulin pump therapy on quality of life children and adolescents with diabetes mellitus type 1

      ea0049ep594
    • Efficacy of insulin detemir treatment in type 2 diabetes mellitus is associated with a allele od the catechol o-methyltransferase polymorphism

      ea0049ep595
    • A dramatic improvement in metabolic parameters and cutaneous manifestations of insulin-resistance in a type 2 diabetic patient with Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome) treated with pioglitazone

      ea0049ep596
    • Comparison of neonatal outcome in women with gestational diabetes on different pharmacoglogical agents dilevered at term

      ea0049ep597
    • The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

      ea0049ep598
    • Pancreas transplantation: experience in a central hospital

      ea0049ep599
    • Correlates of health-related quality of life in Bulgarian patients with type 2 diabetes mellitus

      ea0049ep600
    • Effects of sitagliptin monotherapy on insulin resistance and immune functions in type 2 diabetic patients

      ea0049ep601
    • Real practice experience: Degludec vs Glargina U300

      ea0049ep602
    • Glycemic control and weight evolution in DM2 patients with canaglifozina

      ea0049ep603
    • Intralesional epidermal growth factor treatment on diabetic foot ulcers

      ea0049ep604
    • Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes

      ea0049ep605
    • Rabson mendenhall syndrome-a dilemma to treat in a resource poor country

      ea0049ep606
    • Does tolerance develop toward GLP-1 receptor agonists' glucose-lowering effect?

      ea0049ep607
    • Comparative evaluation the effects of bariatric surgery and exenatide treatment on the clinical and laboratory parameters in obese type 2 diabetic patients

      ea0049ep608
    • Increase in time in target when using a basal-bolus algorithm for insulin dosing with insulin glargine U300 during hospital stay

      ea0049ep609
    • Intensity of dapagliflozin induced glycosuria correlates with previous glycemic control but not with body weight or duration of type 2 diabetes

      ea0049ep610
    • How can dapagliflozin affect blood pressure response in a real-life cohort of people with type 2 diabetes and hypertension?

      ea0049ep611
    • Trends in prescription of Sodium-glucose co-transporter-2 inhibitors (SGLT2i) over the last three years in a specialized setting

      ea0049ep612
    • The insulin delivery system and its impact on quality of life and on psychopathological symptomatology

      ea0049ep613
    • New long-acting insulins in type 1 diabetes: implications for real clinical practice

      ea0049ep614
    • Effect of oral nitrate administration on glucose metabolism and inflammation in obese type 2 diabetic rats

      ea0049ep615
    • Impact of a universal educational animation movie in an hour workshop on the knowledge of patients with gestational diabetes

      ea0049ep616
    • Insulin requirements in pregnant women with DM 1 with different duration of the disease

      ea0049ep617
    • Liraglutide restores the hyperglycemia-induced endothelial oxidative stress in vitro

      ea0049ep618
    • Incretin-based therapies and pancreatic/biliary tract cancer

      ea0049ep619
    • Palpable purpura in an uncontrolled diabetic patient: an uncommon possible side effect of linagliptin

      ea0049ep620
    • Dulaglutide added on Empagliflozin improves blood pressure, body weight, glycemic control and albuminuria in obese diabetic patients

      ea0049ep621
    • Modern treatment approaches of patients with type 2 diabetes and non-alcoholic fatty liver disease

      ea0049ep622
    • The role of diabetic educational programs in glycemic control in patients attending to our day hospital

      ea0049ep623
    • Real-time detection of hazardous changes in blood glucose at the first trimester of pregnancy in women with type 1 diabetes: a pilot study

      ea0049ep624
    • Sense of coherence and glycaemic control among a sample of newly diagnosed type II diabetics in rural Crete

      ea0049ep625
    • Gestacional diabetes mellitus with and without insulin therapy: a case study

      ea0049ep626
    • Evaluation and descriptive analysis of our type 1 diabetes population and their insulin therapy

      ea0049ep627
    • Effects of dapagliflozin in treatment of gastroparesis considering the state of carbohydrate metabolism in patients with type 2 diabetes mellitus

      ea0049ep628
    • Self-monitoring of blood glucose: how are glycemic readers used in practice?

      ea0049ep629
    • Determinants of patient's adherence and its relation to therapeutic success after hospital admission for decompensated diabetes

      ea0049ep630
  • Endocrine Disruptors
  • • Study of metabolic and some hormonal aspects among pubertal type 1 diabetic girls

      ea0049ep631
    • Bone-to-muscle endocrine axis modulating adaptation to exercise in athletes of mountain cycling in a Portuguese Marathon

      ea0049ep632
  • Endocrine tumours and neoplasia
  • • Dumping syndrome post total gastrectomy

      ea0049ep633
    • A case report of insulinoma in a patient with chronic headache

      ea0049ep634
  • Female Reproduction
  • • Real-time continuous glucose monitoring during pregnancy in women with type 1 diabetes: glycemic control and key obstertric outcomes

      ea0049ep635
    • Differential pattern of insulin signaling in adipose tissue and skeletal muscle in adult female sheep exposed prenatally to testosterone

      ea0049ep636
    • The evaluation of sexual function of women with type 1 diabetes mellitus

      ea0049ep637
  • Growth hormone IGF axis - basic
  • • GH is related to hepatic mitochondrial activity in humans

      ea0049ep638
    • Modulation of the 22 kD/20 kD growth hormone (GH) ratio by exercise, fasting and glucose load in premenopausal women

      ea0049ep639
    • Insulin resistance and acromegaly: about 15 cases

      ea0049ep640
  • Neuroendocrinology
  • • Comparison of GHRH + arginine vs glucagon test for the evaluation of growth hormone secretion status in a cohort of adults with Prader-Willi syndrome (PWS)

      ea0049ep641
  • Nuclear receptors and Signal transduction
  • • Dietary intake of linoleic, linolenic, oleic, and arachidonic acid PPAR-gamma gene expression in visceral and subcutaneous adipose tissue among healthy subjects

      ea0049ep642
  • Obesity
  • • Association between meal intake behavior and body composition/psychological well-being in Japanese adults

      ea0049ep643
    • A comparison of the metabolic parameters of obese and non-obese nafld patients with insulin resistance

      ea0049ep644
    • Associations between dietary food patterns and metabolic syndrome risk in Albanian adolescents

      ea0049ep645
    • Type 1 diabetes and metabolic syndrome

      ea0049ep646
    • Intima media thickness of carotid arteries and cognitive function in Georgian nondiabetic obese and overweight hypertensive subjects

      ea0049ep647
    • CGI-58 gene expression profile in individuals with different body mass index

      ea0049ep648
    • Fractalkinea as an inflammatory marker in obese subjects

      ea0049ep649
    • The case of 36 years old obese male patient with high degree of proteinuria and a loosing weight as the major strategy of treatment

      ea0049ep650
    • Mobile and wireless technology to combat obesity. Using on-line program of good nutrition and wright diet: prevention and part of the treatment of diabetes mellitus

      ea0049ep651
    • Oligonol supplementation decreases abdominal obesity and the prevalence of metabolic syndrome in a sample of overweight and obese Saudi females without dietary restriction or lifestyle modification

      ea0049ep652
    • Metabolic and bone effects of high fat diet on adult zebrafish

      ea0049ep653
    • Growth hormone signaling and action in obese versus lean human subjects: evidence of increased hepatic GH sensitivity in obesity

      ea0049ep654
    • Insulin signaling is involved in the regulation of UCP-1 expression in brown adipose tissue after chronic central leptin infusion

      ea0049ep655
    • Can night eating syndrome increase basal metabolic rate?

      ea0049ep656
    • Association between cardiometabolic risk indicators and FGF 19 in healthy Saudi individuals of different BMI grades

      ea0049ep657
    • The role of pioglitazone and vitamin E for the treatment of NASH with or without metabolic syndrome

      ea0049ep658
    • MicroRNAs, associated with coronary heart disease in patients with obesity and diabetes mellitus type 2

      ea0049ep659
    • The surgical approach to obesity in numbers

      ea0049ep660
    • Decreased HDL cholesterol efflux capacity in morbidly obese individuals as a surrogate marker for increased cardiovascular risk

      ea0049ep661
    • The association of anthropometric measurements and PPAR-[gamma] gene expression among healthy adult subjects

      ea0049ep662
    • Results of computer-assisted intravital microscopy in overweight and obesity

      ea0049ep663
    • Assessment of adipose tissue distribution in youg women with polycystic ovary syndrome

      ea0049ep664
    • Decreased muscle strength is associated with vitamin D and albumin levels after bariatric surgery

      ea0049ep665
    • Comparison between mathematical indexes and histopathological findings in the diagnosis of nonalcoholic fatty liver disease in mexican population

      ea0049ep666
    • Obesity and infertility among Tunisian women of reproductive age: about 40 cases

      ea0049ep667
    • Mindfulness-oriented weight management course in a tier 3/tier 4 obesity service

      ea0049ep668
    • Menopause is a major determinant of endocannabinoid 2-arachidonoylglycerol plasma level and of its relevance as biomarker of dyslipidemia and insulin resistance in lean women

      ea0049ep669
    • Genetical predictors of neuroendocrine disturbances in children with severe obesity

      ea0049ep670
    • Endocannabinoid 2-arachidonoylglycerol plasma level is a BMI-independent biomarker of cardiometabolic risk in adult males with higher relevance in lean and aged conditions

      ea0049ep671
    • Unfavourable blood pressure and lipid levels in obese individuals from the general population

      ea0049ep672
    • Relation of insulin resistance to neurocognitive function and electroencephalography in obese chıldren

      ea0049ep673
    • Abstract unavailable

      ea0049ep674
    • Lipid profiles and vitamin D receptor polymorphisms in overweight/obese dialysis patients

      ea0049ep675
    • Bone mineral density and bone turnover markers after bariatric surgery

      ea0049ep676
    • Effects of mediterranean diet in obese patients with metabolic syndrome and depression

      ea0049ep677
    • Visceral obesity in youth followed by decreased testosterone leading to erectile dysfunction and risk of early atherosclerosis

      ea0049ep678
    • The prevalence of obesity and related factors: An urban survey study

      ea0049ep679
    • Effect of Vitamin D supplementation on body composition in overweight men: A randomized controlled trial

      ea0049ep680
    • Intensified telematic treatment for obesity using the web platform PREDIRCAM2, descriptive basal characteristics and preliminary results

      ea0049ep681
    • Suboptimal prediction of advanced fibrotic liver disease by standard non-invasive scoring systems in obese patients undergoing bariatric surgery

      ea0049ep682
    • Discussion with cases: Could we achieve the goal with non-surgical treatments in morbid obese patients?

      ea0049ep683
    • Body compositions in obesity may corralete the minimal change of tyhroid functions within normal range

      ea0049ep684
    • Association of Transforming growth factor [beta] and Fibroblast growth factor 21 with cardiovascular diseases in obese patients

      ea0049ep685
    • The dynamics of anthropometric data in fertile age women by various types of the treatment

      ea0049ep686
    • Effects of IL-1[beta] on the hypothalamic-pituitary-gonadal axis in men with obesity and metabolic syndrome - A randomized, double-blind, placebo-controlled trial

      ea0049ep687
    • Demographic and baseline characteristics of an obese population admitted for bariatric surgery in a secondary care centre

      ea0049ep688
    • Clinical and metabolic markers of X-syndrome

      ea0049ep689
    • Impact of weight changes on the incidence of diabetes mellitus: a Korean nationwide cohort study

      ea0049ep690
    • Metabolic profile reversal after bariatric surgery

      ea0049ep691
    • Hydroxysteroid (17beta) dehydrogenase 13 knockout mice present with inflammation associated liver steatosis

      ea0049ep692
    • Visceral vs subcutaneous white adipose depots response to insulin treatments in rats

      ea0049ep693
    • Association between obesity and glomerular hyperfiltration: impact on metabolic risk factors

      ea0049ep694
    • Characteristics of cellular immunity in men with obesity and hypogonadism

      ea0049ep695
    • GLP-1 therapy and the immune system - can we predict responders from non-responders?

      ea0049ep696
    • An assessment of the relationship between abdominal obesity and the severity of upper extremity lymphedema

      ea0049ep697
    • Associations between the dysregulation of splicing machinery components and the development of hepatic steatosis in obese women

      ea0049ep698
    • Irisin and cardiovascular risk

      ea0049ep699
    • Circulating adipomyokines, inflammatory marker, insulin resistance, and physical fitness among severely obese Korean children and adolescents

      ea0049ep700
    • Genetic variants of the adiponectin gene and its association with adiponectin level in metabolic syndrome women

      ea0049ep701
    • Obesity, cardiomyopathy and anabolic hormones

      ea0049ep702
    • Are there any associations between vitamin D levels and insulin resistance in obese patients?

      ea0049ep703
    • Elevated serum adiponectin in Alzheimer's disease as neuroprotective strategy

      ea0049ep704
    • Late dumping syndrome in pregnant women after ROUX-EN-Y gastric bypass (RYGB) surgery

      ea0049ep705
    • Folate: a new player in metabolic syndrome?

      ea0049ep706
    • Evolution of body composition 3 years after sleeve gastrectomy

      ea0049ep707
    • Comparative study between laparoscopic gastric bypass and laparoscopic sleeve gastrectomy

      ea0049ep708
    • Prevalence of mono-ethyl-hexyl phthalate and mono-ethyl phthalate in Serbian population and their influence on leptin and thyroid function in obesity

      ea0049ep709
    • Using diaserein on the patients with glucose intolerance

      ea0049ep710
    • Bone mineral density in obese patients

      ea0049ep711
    • Role of cognitive-behavioral therapy in the treatment of obesity

      ea0049ep712
    • Dynapenic obesity and myosteatosis in women with and without the metabolic syndrome

      ea0049ep713
    • Concern about body image, impulsiveness and personality traits in the morbidly obese before bariatric surgery and in patients who have undergone surgery

      ea0049ep714
    • Lifestyle of morbidly obese patients awaiting bariatric surgery and in the cohort of patients who have undergone surgery

      ea0049ep715
    • Thyroid hormone treatment reduces inflammatory cytokines in mesenteric adipose tissue improving insulin sensitivity of obese rats

      ea0049ep716
    • Predictive factors of outcome in bariatric surgery

      ea0049ep717
    • Prevalence of obesity in Algeria

      ea0049ep718
    • Testosterone deficiency in obese males: is insulin resistance the one to blame?

      ea0049ep719
    • Anthropometric and metabolic effects of a milk-based intensive lifestyle intervention in severely obese adults

      ea0049ep720
    • Association of cortisol, DHEA-S and cortisol/DHEAS ratio with insulin resistance in overweight and obese women

      ea0049ep721
    • Obesity and fruit and vegetables consumptions in children

      ea0049ep722
    • Neuromedin B receptor: role in adipogenesis and a possible target for obesity treatment

      ea0049ep723
  • Paediatric endocrinology
  • • Intracranial lesions in children and adolescents with morbid obesity; results of long-term follow-up

      ea0049ep724
    • Congenital hyperinsulinism in two siblings due to the same ABCC8 mutation: the clinical importance of an early diagnosis and treatment

      ea0049ep725
    • Association between oxidative stress and bone turnover markers in the obese children

      ea0049ep726
  • Steroid metabolism + action
  • • In vivo porcine and in vitro HepG2 models with 11[beta]-HSD1 overproduction

      ea0049ep727
    • Hepatic and adipose tissue insulin resistance as a consequence of intermittent hypoxia are exacerbated by glucocorticoid receptor antagonism in man

      ea0049ep728
    • Dexras1 regulates MSC-derived adipogenesis and osteogenesis

      ea0049ep729
    • Gender specific metabolic phenotype in the 5[beta]-reductase knockout mouse

      ea0049ep730
• Eposter Presentations: Environment, Society and Governance
• • Cardiovascular Endocrinology and Lipid Metabolism
  • • Measuring of quality of life and health characteristics among 40-79 old population in Hungary

      ea0049ep731
  • Clinical case reports - Thyroid/Others
  • • Does standardising the dynamic endocrine testing process improve patient communication and safety?

      ea0049ep732
  • Developmental endocrinology
  • • Endocrinology training programs in member countries of the International Society of Endocrinology (ISE): a pilot survey evaluation comparing regions and cultures

      ea0049ep733
    • The basic characteristics of delivery of endocrinologic care in Slovakia from outpatients care perspective

      ea0049ep734
  • Diabetes (to include epidemiology, pathophysiology)
  • • Gestational diabetes risk in three Israeli population subgroups

      ea0049ep735
  • Diabetes complications
  • • Improvement of specialised help to patient with diabetic foot syndrome in Uzbekistan

      ea0049ep736
    • Assessment of the prevalence of type 1 diabetes microvascular complications in young adults in the repablic of Belarus with regard to the duration of the disease

      ea0049ep737
  • Endocrine Disruptors
  • • Endocrine disrupting chemicals exacerbate type 1 diabetes mellitus model

      ea0049ep738
    • Stimulating effect of 17[beta]-estradiol and TCDD and on the protein expression of cytochrome P450 1A1 gene in cellular and xenografted models of breast cancer

      ea0049ep739
    • Abstract unavailable

      ea0049ep740
    • 24 hrs chronomics of BP/HR in terms of double amplitude, acrophase, hyperbaric index and its relation with circadian rhythm of 6-sulfatoxy melatonin in night shift nursing professionals: A Case-control study

      ea0049ep741
    • The effects of halogenated-hydrocarbon uron herbicides, as endocrine disruptor compounds on the oxytocin (OT) hormone regulation in vitro

      ea0049ep742
    • The protective role of Zingiber officinale extract against methyl thiophanate induced toxicity in male rats

      ea0049ep743
    • Systematic screening for environmental and behavioral determinants identifies factors detrimental to skeletal health

      ea0049ep744
    • Quantitative image based analysis of endocrine disruptor effects on mitochondria morphology-function in prostate cancer cells

      ea0049ep745
  • Endocrine tumours and neoplasia
  • • NENs, NETs, NECs: Accessing expert care

      ea0049ep746
  • Female Reproduction
  • • The accuracy of lifestyle management information on websites for the management of PCOS

      ea0049ep747
  • Pituitary - Clinical
  • • Learning from adult growth hormone deficient patients' advisory panel

      ea0049ep748
  • Thyroid (non-cancer)
  • • Iodine supplementation in children and pregnant women from rural areas of Belarus in 2015-2016

      ea0049ep749
• Eposter Presentations: Interdisciplinary Endocrinology
• • Adrenal cortex (to include Cushing's)
  • • Comparison of 17-OH-Progesterone results by a radioimmunoassay and a chemiluminescent assay

      ea0049ep750
  • Calcium & Vitamin D metabolism
  • • The effect of parathyroidectomy on graft function in kidney transplant recipients with persistent hypercalcemia

      ea0049ep751
    • The effect of corticosteroids on development of femoral head osteonecrosis in patients after kidney transplantation

      ea0049ep752
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Resveratrol increases hepatic SHBG expression through human constitutive androstane receptor: a new Contribution to the French Paradox

      ea0049ep753
    • Therapeutic potentials of small molecular weight allosteric agonist of relaxin receptor

      ea0049ep754
    • PCSK9 inhibitors effects on lipid profile in familial hypercholesterolemia in a specific Lipid Unit: experience in first year commercialization

      ea0049ep755
    • Non-lipidic effects of PCSK9 inhibitors in real life

      ea0049ep756
    • Renal function preservation with Manidipine vs Amlodipine in type 2 diabetic hypertensive patients with persistent microalbuminuria

      ea0049ep757
    • Effects of calcineurin inhibitors on abdominal obesity in kidney transplant recipients

      ea0049ep758
    • Anthropometric measurements, nutrition and exercise habits in kidney transplant recipients

      ea0049ep759
    • Hyperglycemia as a factor changing the level of the patient's rehabilitation after ischemic stroke

      ea0049ep760
    • An investigation into role of circulating concentrations of vitamin D and calcium in the development of hypertension and related cardiovascular diseases

      ea0049ep761
  • Clinical case reports - Thyroid/Others
  • • Multiple autoimmune syndrome: about six observations

      ea0049ep762
    • Endocrine complications in a female patient with [beta]-thalassemia major following bone marrow transplantation

      ea0049ep763
    • Association of Basedow disease with pernicious anemia: a case report

      ea0049ep764
    • Chronic hyponatremia caused by Thiazide diuretic: A case report

      ea0049ep765
    • Raynaud phenomenon in a young PCOS patient

      ea0049ep766
    • Polyglandular autoimmune syndrome type III-case report

      ea0049ep767
    • Resistance of SIAD to tolvaptan despite initial control in progressive small cell lung cancer

      ea0049ep768
    • Overestimation of HbA1c by an unusual hemoglobin variant

      ea0049ep769
    • Myasthenia gravis associated with Graves' disease and adrenal insufficiency

      ea0049ep770
    • Incidental asplenia in a patient with presumed type 2 autoimmune polyglandular syndrome (APS-2): misclassification or overlap?

      ea0049ep771
    • Immune checkpoint inhibitors related thyroiditis - a report of two cases

      ea0049ep772
    • Nivolumab-associated pituitary, adrenal and thyroid autoimmune disorders

      ea0049ep773
    • Meigs' syndrome in a 63 year-old woman - case report

      ea0049ep774
  • Developmental endocrinology
  • • GH influences plasma fasting adropin concentration in patients with turner syndrome

      ea0049ep775
  • Diabetes (to include epidemiology, pathophysiology)
  • • Diagnosis of cystic fibrosis related diabetes

      ea0049ep776
    • Erk- and Akt-mediated osteocalcin signaling in human pancreatic [beta]-cells does not directly involve GPRC6A activation

      ea0049ep777
  • Diabetes complications
  • • The comparison of cardiovascular events in kidney transplant recipients with and without type 2 diabetes mellitus

      ea0049ep778
  • Endocrine Disruptors
  • • The adrenal gland after diosgenin application in a rat model of the menopause

      ea0049ep779
    • Association of autoimmune endocrinopathies and celiac disease

      ea0049ep780
    • Characterization of murine Leydig cell lines as tools to study androgen synthesis disruption by xenobiotics

      ea0049ep781
    • Identification of chemicals disrupting adrenal steroid production by steroid profiling in H295R cells

      ea0049ep782
    • Endocrine dysfunctions associated with Hodgkin Lymphoma treatment

      ea0049ep783
  • Endocrine tumours and neoplasia
  • • Multidisciplinary committee on endocrine tumors: an analysis of 6-year experience

      ea0049ep784
    • ER status heterogeneity in breast cancer: role in response to endocrine treatment

      ea0049ep785
    • Potential role of vitamin D in restoring sensitivity to mTOR inhibitors in hepatocellular carcinoma (HCC): 1,25(OH)vitamin D (VitD) reverts everolimus (EVE) resistance in a hcc cell line

      ea0049ep786
    • Comparisson of subtraction and two-phase parathyroid scintigraphy conserning histological type of hyperfunctioning parathyroid tissue

      ea0049ep787
    • Endocrine health problems detected in 764 patients evaluated in a late effects clinic

      ea0049ep788
    • Magmas modulates chemoresistance in endocrine-related cancers

      ea0049ep789
    • Altered expression of the components of the splicing machinery is associated to increased malignancy and expression of aberrant splicing variants in prostate cancer

      ea0049ep790
    • Polyglandular autoimmune syndrome type III b

      ea0049ep791
    • Chronic stress and somatotroph axis in breast cancer more than a simple association

      ea0049ep792
  • Female Reproduction
  • • Cynicism and common endocrine diseases in pregnancy

      ea0049ep793
    • Thyroid ultrasonography findings in patients with polycystic ovary syndrome

      ea0049ep794
    • Comparison of free testosterone results by a radioimmunoassay and a chemiluminescent assay

      ea0049ep795
  • Growth hormone IGF axis - basic
  • • Impact of new standardization on IGF-I assay IMMULITE 2000

      ea0049ep796
  • Male Reproduction
  • • Rare case of manifestation of erectile dysfunction soon after thyroidectomy because of thyroid cancer in 56-year-old man with diabetes mellitus type 2 and diabetic neuropathy

      ea0049ep797
  • Neuroendocrinology
  • • Dissecting the androgen excess phenotype of women with idiopathic intracranial hypertension

      ea0049ep798
    • Epileptic seizures in patients with large and giant prolactinomas

      ea0049ep799
    • Prednisolone reinforces the food reward system by bilateral amygdala activation - an fMRI study

      ea0049ep800
  • Nuclear receptors and Signal transduction
  • • 18[beta]-glycyrrhetinic acid reduces VLDL secretion as a modulator for HNF4[alpha]

      ea0049ep801
    • 5[alpha]-THB as a novel anti-inflammatory drug: The roles of the glucocorticoid and mineralocorticoid receptors

      ea0049ep802
    • Development of novel human stable reporter cell line for the assessment of PPAR[gamma] transcriptional activity

      ea0049ep803
    • Functional characterization of inherited S127F substitution in V2 vasopressin receptor revealed a loss-of-function mutation leading to nephrogenic diabetes insipidus

      ea0049ep804
    • Effects of human interleukins on transcriptional activity of vitamin D receptor in transgenic gene reporter cell lines IZ-VDRE and IZ-CYP24

      ea0049ep805
    • 3-Iodothyronamine induces transient receptor potential melastatin 8 (TRPM8) channel activation in human corneal endothelial cells and human corneal keratocytes

      ea0049ep806
    • Cytotoxic activity of plant extracts from Brazilian biome in prostate cancer cell lines

      ea0049ep807
  • Obesity
  • • Evolution of patients with amyotrophic lateral sclerosis followed in a nutrition and endocrinology specific unit during 3 years

      ea0049ep808
    • Obesity, gonadotropic axis and breast cancer - is ghrelin the connexion?

      ea0049ep809
    • Differences in calcium and thyroid homeostasis and thyroid volume after bariatric surgery

      ea0049ep810
  • Paediatric endocrinology
  • • Sebaceous hyperplasia and androgen levels-still controversial

      ea0049ep811
    • Microduplication of 15q26.3 not including IGF1R as a novel genetic cause of infantile overgrowth

      ea0049ep812
    • A very rare case of 48, XXYY syndrome

      ea0049ep813
    • Clinical case of early manifestation of autoimmune polyglandular syndrome type 3 A in children

      ea0049ep814
    • A novel p.H80Y mutation in the AVPR2 gene causing congenital nephrogenic diabetes insipidus

      ea0049ep815
    • Type 1-like diabetes mellitus in an oncological endocrinology unit

      ea0049ep816
    • P3NP has high-normal values in GHD children and correlates negatively with IGF1

      ea0049ep817
    • Turner Syndrome (TS): overview of surveillance in a tertiary care hospital

      ea0049ep818
  • Pituitary - Basic
  • • Non-functioning pituitary adenomas: association between clinical-pathological and molecular parameters

      ea0049ep819
  • Steroid metabolism + action
  • • Reference values for the urinary steroid metabolome: the impact of sex and age on human adult steroidogenesis

      ea0049ep820
    • Does music effect the stress of daily life?

      ea0049ep821
    • Inhibition of 11[beta]-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole

      ea0049ep822
    • Cortisol levels and thyroid hormones in surgical patients with different sensitivity to pain

      ea0049ep823
    • Ritonavir induced Cushing's Syndrome in a patient under inhaled corticosteroids

      ea0049ep824
  • Thyroid (non-cancer)
  • • Thyroid hormone T3 protects skeletal muscle metabolism during fasting in mice

      ea0049ep825
    • False memory in elderly patients with thyroid disease

      ea0049ep826
    • Orbital disease primer for Endocrinologists-not always thyroid associated orbitopathy (TAO): a case vignette

      ea0049ep827
    • Management of very severe Graves' orbitopathy with low dose rituximab: report of two cases

      ea0049ep828
    • Evaluation of clinical performance of a new immunoassay in the determination of thyroid stimulating immunoglobulins (TSI)

      ea0049ep829
• Eposter Presentations: Pituitary and Neuroendocrinology
• • Adrenal cortex (to include Cushing's)
  • • The metabolic impact of ACTH-dependent versus ACTH-independent Cushing's syndrome: a retrospective study of 99 patients

      ea0049ep830
    • ACTH-independent subclinical Cushing's syndrome in patient with acromegaly and adrenal incidentaloma

      ea0049ep831
  • Clinical case reports - Pituitary/Adrenal
  • • Coexistence of TSH-secreting pituitary adenoma, primary hyperparathyroidism and vitamin D deficiency

      ea0049ep832
    • Central diabetes insipidus in children: about eight cases

      ea0049ep833
    • A hpothyroid case with pituitary hyperplasia mimicking TSHoma

      ea0049ep834
    • Pachydermoperiostitis associated with non secrettory pituitary macroadenoma in patient with toxic multinodular goitre

      ea0049ep835
    • Successful management of macroprolactinoma with aromatase inhibitor in a patient with hypogonadotropic hypogonadism

      ea0049ep836
    • Multifocal multisystem langerhans cell histiocytosis - a rare cause of panhypopituitarism and diabetes insipidus - a case report

      ea0049ep837
    • A rare association of autoimmune diabetes insipidus and hypophysitis with partial pituitary insufficiency

      ea0049ep838
    • Pituitary apoplexy while treating recurrence of Cushing's disease with Pasireotide

      ea0049ep839
    • Hemodialysis patient with metastatic renal cell carcinoma to the pituitary stalk presenting as hypopituitarism: an autopsy case

      ea0049ep840
    • Effect of the addition of lanreotide autogel to the treatment of an aggressive prolactinoma - a case report

      ea0049ep841
    • A hypopituitarism case diagnosed after sphenoid sinus mucocele operation

      ea0049ep842
    • Coexistence of acromegaly and rheumatoid arthritis: presentation of three cases

      ea0049ep843
    • Case of TSH secreating pituitary adenoma (TSHOMA) where course was modified by coexistant autoimmune hypothyroidism

      ea0049ep844
    • Cyclic Cushing's syndrome: a diagnostic challenge

      ea0049ep845
    • Breast cancer and newly discovered non-secretor pituitary mass- as risk of metastases?

      ea0049ep846
    • Meningoencephalitis as the first clinical sign of a pituitary macro adenoma: a case report

      ea0049ep847
    • A rare case with acromegaly: increased hypophyseal FDG uptake in PET/CT performed for lung cancer staging

      ea0049ep848
    • Abstract unavailable

      ea0049ep849
    • Temozolomide alone or in combination with bevacizumab and capecitabine in the treatment of atypical pituitary adenomas - own experience

      ea0049ep850
    • Pachydermaperiostosis: a rare syndrome presented with acromegaloid changes

      ea0049ep851
    • Temozolomide Treatment in Aggressive Pituitary Adenoma

      ea0049ep852
    • Ocult Cushing syndrome: (adicional) difficulties in hypercortisolism approach

      ea0049ep853
    • A case of cystic prolactinoma responsed to medical treatment

      ea0049ep854
    • A case of pituitary apoplexy in a patient with Cushing's disease due to corticotroph macroadenoma

      ea0049ep855
    • Ectopic ACTH syndrome presenting with partial loss of conciousness and nonconvulsive status epilepticus in a patient with no signs of Cushing syndrome

      ea0049ep856
    • Cushing's disease management through time- a case report

      ea0049ep857
    • A case of extrapontine myelinolysis after surgery for a pituitary tumor

      ea0049ep858
    • Hypopituitarism caused by an intrasellar meningioma: case report

      ea0049ep859
    • A case of tuberous sclerosis complex associated with non-functioning pituitary incidentaloma and moderate hyperprolactinaemia

      ea0049ep860
    • Patient with empty sella and clinical features of acromegaly

      ea0049ep861
    • Esthesioneuroblastoma causing ectopic ACTH Syndrome

      ea0049ep862
    • Lymphocytic hypophysitis which underwent surgery despite the absence of compression of nearby structures. A case report

      ea0049ep863
    • Title: IgG4 related hypophysitis

      ea0049ep864
    • Pituitary apoplexy as the first manifestation of silent somatotropinoma

      ea0049ep865
    • Unprogrammed pregnancy in women with active Acromegaly: a case report

      ea0049ep866
    • Acromegaly and pregnancy: case report

      ea0049ep867
    • Clinical case report: MEN-1 syndrome with coincident AIP gen mutation and MEN-1 gen deletion

      ea0049ep868
    • Coexistence of thyrotropinoma and chronic autoimmune thyroiditis, a diagnostic challenge

      ea0049ep869
    • Central diabetes insipidus and cerebral salt wasting syndrome: a challenging coexistence

      ea0049ep870
    • Adipsic diabetes insipidus - a diagnostic and therapeutic challenge

      ea0049ep871
    • Endosalpingiosis - re-thinking risk tumours in acromegaly

      ea0049ep872
  • Developmental endocrinology
  • • Can dehydroepiandrosterone-sulphate be a new diagnostic parameter in male patients with idiopathic hypogonadotropic hypogonadism?

      ea0049ep873
  • Endocrine tumours and neoplasia
  • • Insulinoma in MEN type 1 mistaken as temporal lobe epilepsy

      ea0049ep874
    • Pregnancy in multiple endocrine neoplasia type 1: a case report

      ea0049ep875
    • The giant who could not stop growing

      ea0049ep876
    • Intrasellar malignant haemangiopericytoma: a rare case

      ea0049ep877
  • Growth hormone IGF axis - basic
  • • Initial response to octreotide LAR in Mexican patients with acromegaly

      ea0049ep878
    • Pasireotide: an effective treatment for resistant acromegaly

      ea0049ep879
    • The disorder of secretion of somatotropic hormone in women with the polycystic ovaries syndrome (PCOS) by comparison to patients with the non-functional pituitary adenomas (NFPA)

      ea0049ep880
    • The levels of decorin in patients with Cushing's disease and acromegaly

      ea0049ep881
    • Could statin modify molecular phenotype of pituitary growth hormone-secreting tumors?

      ea0049ep882
    • A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH)

      ea0049ep883
    • Safety of growth hormone replacement therapy (GHRT) in adult patients with GH deficiency: data from kims

      ea0049ep884
    • Effect of GH treatment on coagulation and fibrinolysis parameters in prepubertal children with growth hormone deficiency

      ea0049ep885
    • Nodular thyroid disease in acromegaly: cohort of 69 patients at a single institution

      ea0049ep886
    • Somatropin treatment Supported by NHS: characterization of submitted patients - 2006 to 2016

      ea0049ep887
  • Male Reproduction
  • • Delayed puberty revealing an uncommon genetic disease: about one case

      ea0049ep888
  • Neuroendocrinology
  • • Empagliflozin increases urinary volume output in healthy volunteers with artificial SIADH - a placebo-controlled double blind crossover study

      ea0049ep889
    • Metformin increases pressure pain threshold in lean PCOS women

      ea0049ep890
    • Clinical features and natural history of clinically non-functioning pituitary incidentalomas

      ea0049ep891
    • Pituitary stalk lesions - experience of single center

      ea0049ep892
    • First pediatric case of successfully treated Cushing's disease in Armenia

      ea0049ep893
    • SCTR/AT1aR heteromer related osmoregulation in hypothalamus

      ea0049ep894
    • The hyponatremia in neurosurgical patients

      ea0049ep895
    • Bilateral inferior petrosal sinus sampling and the outcome of transsphenoidal surgery in patients with Cushing's disease: experience of a Tertiary Portuguese Hospital

      ea0049ep896
    • The prevalence of colorectal cancer and colon polyps in acromegaly: thirty years' experience of a tertiary referral center

      ea0049ep897
    • Acromegaly and malignant neoplasms

      ea0049ep898
    • Endogenous Cushing's syndrome ( clinical and biochemical features in a large cohort of patients

      ea0049ep899
    • Hyponatremia predating the diagnosis of malignancy in oncological/hematological patients with SIADH

      ea0049ep900
    • Hyperprolactinemia as a manifestation of hormonally inactive pituitary adenoma

      ea0049ep901
    • Abstract unavailable

      ea0049ep902
    • Abstract unavailable

      ea0049ep903
    • Study of CHD7 gene in KAL 1-negative patients previously diagnosed with congenital hypogonadotropic hypogonadism that develop new pituitary deficiencies

      ea0049ep904
    • MR-characteristics as predictors of pituitary adenomas hormonal and proliferal activity

      ea0049ep905
    • Cholinergic modulation of the hypothalamic-pituitary-adrenal activity and somatotroph function in smokers and non-smokers

      ea0049ep906
    • Diagnosis, treatment and follow-up of non-functioning pituitary adenomas

      ea0049ep907
    • Decreased prolactin levels in plasma and cerebrospinal fluid in naive to treatment patients with multiple sclerosis

      ea0049ep908
    • Cholinergic modulation of the hypothalamic-pituitary-adrenal activity and somatotroph function in DM-1

      ea0049ep909
    • Increased GH response to GHRH plus pyridostigmine unrelated to augmented glomerular filtration rate in DM-1

      ea0049ep910
    • Increased morbidity associated with the treatment of craniopharyngioma

      ea0049ep911
    • The PATRO adults study of Omnitrope for the treatment of adult patients with growth hormone deficiency: latest results

      ea0049ep912
    • Clinical case description of family with hereditary pituitary adenoma

      ea0049ep913
    • Molecular and genetic basis of the disease in families with pituitary adenomas

      ea0049ep914
    • Pituitary adenoma with gigantism and TSH-induced hyperthyroidism: a case report

      ea0049ep915
    • Secretin protects from apoptosis by activation of ERK1/2 and CREB

      ea0049ep916
    • Predictors of remission after transsphenoidal adenomectomy in patients with Cushing's disease

      ea0049ep917
    • Copeptin after arginine infusion for the differential diagnosis of the polyuria-polydipsia syndrome [ldquo]The CARGO-Study[rdquo]

      ea0049ep918
    • Diabetes mellitus in Cushing' syndrome: a systematic review

      ea0049ep919
    • Thyroiditis and hypophysitis caused by nivolumab

      ea0049ep920
    • Kallmann syndrome: about eleven clinical cases

      ea0049ep921
  • Paediatric endocrinology
  • • Endocrine manifestations of multisystem Langerhans cell histiocytosis

      ea0049ep922
    • Growth hormone deficiency - the experience of one pediatric endocrinology unit of a Portuguese hospital in the last 5 years

      ea0049ep923
  • Pituitary - Basic
  • • SSTR2 inhibits GH-secreting pituitary tumoral cells migration and invasion by increasing cofilin phosphorylation

      ea0049ep924
    • Anti-proliferative effect of sodium metaarsenite (KML001) on ACTH-secreting pituitary adenoma cells

      ea0049ep925
    • Angiogenesis-related proteins in pituitary adenomas

      ea0049ep926
    • Ketoconazole induces inhibition of cell viability and apoptosis in an ACTH-secreting tumour cell line model

      ea0049ep927
    • GPR101 orphan receptor: a novel cause of growth hormone deregulation

      ea0049ep928
    • Potential role of biguanides and statins in the treatment of pituitary adenomas

      ea0049ep929
    • Abstract unavailable

      ea0049ep930
    • Whole exome sequencing of two non-secreting pituitary adenoma tumors from the same patient

      ea0049ep931
    • Ubiquitin specific peptidase 8 (USP8) in human corticotroph pituitary tumors- possible targets and mode of action

      ea0049ep932
    • Acquired temozolomide resistance in ACTH-secreting pituitary tumour cells

      ea0049ep933
    • PP4C restrains dopamine D2 receptor expression in rat pituitary MMQ cells

      ea0049ep934
    • HER2, EGFR and PDGF family members as potential prognostic markers and their therapeutic implications

      ea0049ep935
    • Carbohydrate metabolism disturbances at different types of acromegaly treatment

      ea0049ep936
  • Pituitary - Clinical
  • • Four decades without diagnosis: Sheehan's syndrome, a retrospective analysis

      ea0049ep937
    • Prevalence of discordant acromegaly after surgical treatment and its clinical implications in a third LEVEL hospital in Latinamerica

      ea0049ep938
    • A case of IgG4-related hypophysitis with long-term cyclic evolution

      ea0049ep939
    • Duhok/IRAQ acromegaly; one year of experience

      ea0049ep940
    • Presurgical medical treatment in Cushing's disease

      ea0049ep941
    • Characteristics and 1-year follow-up of patients with profound hyponatremia due to primary polydipsia - a multicentre prospective observational study

      ea0049ep942
    • Success rates of pituitary surgery in acromegaly - a tertiary centre experience in Romania

      ea0049ep943
    • Acromegaly and cardiovascular risk

      ea0049ep944
    • Pituitary insufficiency - etiopathogeny and diagnostic aspects

      ea0049ep945
    • Abstract unavailable

      ea0049ep946
    • Long-term outcomes of medical therapy in patients with acromegaly: a retrospective analysis

      ea0049ep947
    • Resistant prolactinomas: Retrospective study of ten cases

      ea0049ep948
    • Ocular findings in adult subjects with congenital, lifetime, isolated, untreated growth hormone deficiency

      ea0049ep949
    • Evaluation of estrogen effects on the anterior pituitary hormones by using combined pituitary stimulation test (CPFT) in the Korean postmenopausal women

      ea0049ep950
    • Acute presentation of cushing disease: severe hyperglycemia and refractory hypokalemia

      ea0049ep951
    • Uncomplicated pregnancy in a patient with McCune Albright syndrome (MAS) and active acromegaly

      ea0049ep952
    • Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism

      ea0049ep953
    • Changes in pituitary tumour biology and behaviour in FIPA patient with GH secreting aggressive pituitary macro adenoma

      ea0049ep954
    • Gambling and cabergoline

      ea0049ep955
    • Rare causes of hypopituitarism in adults in a tertiary care institution

      ea0049ep956
    • Recombinant Human Growth Hormone Treatment in liver transplant patient. Case report

      ea0049ep957
    • Immune checkpoint inhibitors: an emerging cause of hypophysitis

      ea0049ep958
    • A case of hypopituitarism caused by hemorrhagic fever with renal syndrome

      ea0049ep959
    • Prevalence and Incidence of pituitary tumors: a nation-wide Population-based study using Korean National Health Insurance claims data

      ea0049ep960
    • Prevalence of acromegaly in eight counties of North-East Romania

      ea0049ep961
    • A male patient with acromegaly and metastatic renal cell carcinoma: lung, gluteal and scapular metastasis

      ea0049ep962
    • Infundibular lesion presenting with central diabetes insipidus and hypogonadism

      ea0049ep963
    • Pregnancy in Cushing's disease after treatment with surgery and cyber-knife radiosurgery

      ea0049ep964
    • The clinic-hormonal description of patients with giant pituitary adenomas

      ea0049ep965
    • Gender differences in real-life GH dosing patterns in adults with GH deficiency (AGHD): experience from a Registry in France

      ea0049ep966
    • Is there a role of immunohistochemical expression of pituitary hormones and proliferative marker ki-67 on long-term outcome in our acromegalic patients?

      ea0049ep967
    • Investigation of the pituitary functions long-term after the acute CNS infections

      ea0049ep968
    • A case with headache and pitosis: pituitary macroadenoma or ophtalmoplegic migraine?

      ea0049ep969
    • Somatostatin analogues-induced diabetes mellitus in acromegalic patients reverts after drug withdrawal: a long-term study

      ea0049ep970
    • Pituitary metastases of lung cancer presenting with hypopituatrism

      ea0049ep971
    • ACTH deficiency in patient with bilateral adrenal adenomas

      ea0049ep972
    • Clinical, histological, molecular features and outcomes of craniopharyngiomas: Single centre experience in Toledo, Spain

      ea0049ep973
    • Cushing's disease: is there a Continuum from corticotroph hyperplasia to adenoma?

      ea0049ep974
    • The use of increasing doses of cabergoline in the management of cabergoline-resistant prolactinomas

      ea0049ep975
    • Long-term efficacy of octreotide LAR in acromegaly patients, a prospective single centre study with 7 years follow up

      ea0049ep976
    • Is there a gender difference in clinically nonfunctional pituitary adenomas?

      ea0049ep977
    • The value of early postoperative OGTT as a predictor of surgical outcome in patients with acromegaly after total transsphenoidal adenomectomy

      ea0049ep978
    • Giant macroprolactinoma in women still exist

      ea0049ep979
    • Associated neoplasia in Romanian acromegalic patients

      ea0049ep980
    • Clinical and histopathologic characteristics of thyroid cancer in the patients with acromegaly

      ea0049ep981
    • The triglyceride (TG)/HDL Cholesterol (TG/HDL-C) ratio as marker of adipose tissue dysfunction at patients with acromegaly

      ea0049ep982
    • Anti-proliferative effects of high doses cabergoline in patients with prolactinoma

      ea0049ep983
    • Invasive macroprolactinomas and its response to treatment in male patients

      ea0049ep984
    • Venous glucose levels, peak GH and peak cortisol during Insulin Tolerance Test using 0.15 UNITS/Kg and 0.1 UNITS/Kg body weight

      ea0049ep985
    • Long-term impact of primary medical and surgical therapy on bone density in men versus women with prolactinomas

      ea0049ep986
    • Stenosis of the external auditory canal in an acromegalic patient: a novel complication

      ea0049ep987
    • Is Pegvisomant correct choice for acromegaly patient with dilated cardiyomypathy?

      ea0049ep988
    • Preoperative HDDST in the prognosis of CD remission after transshenoidal endoscopic surgery

      ea0049ep989
    • Somatostatin analogs in the treatment of acromegaly: single centre experience

      ea0049ep990
    • Biochemical normalization in acromegaly after 79 months' treatment with Pasireotide: case report

      ea0049ep991
    • Abstract unavailable

      ea0049ep992
    • Abstract unavailable

      ea0049ep993
    • A eight successful pregnancies in six Algerian women with acromegaly: a monocenter study of Pierre and Marie Curie center.

      ea0049ep994
    • Abstract unavailable

      ea0049ep995
    • Sheehan syndrome presenting 21 years later as severe heart failure

      ea0049ep996
    • Localization of the catheters during Bilateral sampling of the inferior petrosal sinuses can impact diagnostic power?

      ea0049ep997
    • Ipilimumab-induced hypophysitis

      ea0049ep998
    • Somatostatin Analogue Treatment of a Persistant TSH-Secreting Adenoma: a report of case

      ea0049ep999
    • Spindle cell oncocytoma of adenohypophysis: report of a rare pituitary tumor

      ea0049ep1000
    • A case of pituitary apoplexy. a acute medical emergency and restitutio ad integrum

      ea0049ep1001
    • Resistant microprolactinoma with partial empty sella

      ea0049ep1002
    • Acromegaly: clinical experience and determinants of remission

      ea0049ep1003
    • A rare case of macroprolactinoma presenting with SIADH

      ea0049ep1004
    • Clinical characterization and comparison of patients with hipophysary tumors and primary empty sella

      ea0049ep1005
    • Prolactinomas in men: retrospective analysis

      ea0049ep1006
    • Residual tumour diameter may influence reduced survival in females with nonfunctioning pituitary macroadenomas

      ea0049ep1007
    • Autoimmune hypophysitis with isolated corticotroph cell destruction due to Pembrolizumab treatment in a female patient with metastatic melanoma

      ea0049ep1008
    • Aggressive pituitary tumors: a tertiary center experience

      ea0049ep1009
    • Hypertension, acromegaly and pegvisomant treatment: Experience from ACROSTUDY

      ea0049ep1010
    • Assessment of macroprolactin through post-PEG monomeric prolactin measurement and comparison with gel fitration chromatography in hyperprolactinemic samples

      ea0049ep1011
    • Sheehan syndrome: Sequential hormone failure and late diagnosis

      ea0049ep1012
    • Multimodal treatment in pituitary carcinoma arising from a ACTH-expressing pituitary macroadenoma with an unexpected long-term survival

      ea0049ep1013
    • Renal prognosis of diabetic patients with and without central diabetes insipidus

      ea0049ep1014
    • Osilodrostat maintains normalized urinary free cortisol levels in a majority of patients with Cushing's disease: Long-term results from an extension to the LINC-2 study

      ea0049ep1015
    • Acromegaly: assessing the clinical outcome through a 10-year experience at a tertiary care hospital in Pakistan

      ea0049ep1016
    • Evaluation of upper gastrointestinal system in acromegaly

      ea0049ep1017
    • Disposition index in active acromegaly: A pilot study

      ea0049ep1018
    • In well-controlled patients with acromegaly, glucose homeostasis correlates with the level of disease control rather than with the type of treatment

      ea0049ep1019
    • European observational study of long-acting pasireotide for uncontrolled acromegaly: ACRONIS study design and rationale

      ea0049ep1020
    • Thyrotropin secreting microadenoma - case report of a patient with goiter

      ea0049ep1021
    • Non-functioning pituitary adenoma; improved endocrine outcomes with increasing surgical experience: The Manchester Cohort

      ea0049ep1022
    • Polyuria and diabetes insipidus after surgery for pituitary tumors

      ea0049ep1023
    • Etiology and some clinical characteristics of hypopituitarism over the years of follow up

      ea0049ep1024
    • A novel DICER1 gene mutation in a 10-month-old boy presenting with ACTH-secreting pituitary blastoma and lung cystic dysplasia

      ea0049ep1025
    • Pituitary insufficiency following traumatic thoracic injury in adolescent male patient-case study

      ea0049ep1026
    • Potassium homeostasis in patients with acromegaly in comparison with hypertensive patients

      ea0049ep1027
    • Russian hypothalamic and pituitary tumors registry (OGGO) data analysis: acromegaly

      ea0049ep1028
    • Adherence to hormone replacement therapy in patients with hyp-opituitarism using the Morisky 4-item scale: results of a pilot, prospective, cross-sectional study

      ea0049ep1029
    • Hormone and tumor responses to primary or pre-operative therapy with somatostatin analogs in acromegaly and the relation with T2-weighted MRI signal

      ea0049ep1030
    • Abstract unavailable

      ea0049ep1031
    • Does cyproterone acetate therapy contribute to the observed elevation in serum prolactin levels in trans women?

      ea0049ep1032
    • A rapidly resolving prolactinoma with cabergoline treatment

      ea0049ep1033
    • Pregnancy outcome in women with prolactinomas exposed to dopamine agonists at early stages of gestation

      ea0049ep1034
    • Clinical and hormonal characteristics of patients with different types hypophysitis: a single-center experience

      ea0049ep1035
    • Comparative study of different methods for monomeric prolactin determination in patients with hyperprolactinemia

      ea0049ep1036
    • Pituitary Stalk Hemangioblastoma: a case report and review of the literature

      ea0049ep1037
    • Impact of glucose metabolism disorders on IGF-1 levels in patients with acromegaly

      ea0049ep1038
    • Monthly pasireotide provides clinical benefit over 12 months in patients with Cushing's disease

      ea0049ep1039
    • Radiological study of clinically non-functioning pituitary macroadenomas: a single institutional experience

      ea0049ep1040
    • Idiopathic isolated acquired ACTH deficiency- a case series from the Irish National Pituitary Network

      ea0049ep1041
    • Autonomic impairment in idiopathic diabetes insipidus

      ea0049ep1042
    • Salivary and serum cortisol levels by liquid chromatography tandem mass spectrometry after standard dose ACTH test in the diagnosis of central hypopituitarism

      ea0049ep1043
    • Risk and diagnosis of hypocortisolism after transsphenoidal surgery for sellar tumors

      ea0049ep1044
    • Nivolumab and pembrolizumab induced hypophysitis

      ea0049ep1045
    • Heterogeneity of the patient pathway for adult growth hormone deficiency: Perspectives from a CEE Endocrinologists expert panel

      ea0049ep1046
    • Considerable delays to achieve adequate control in treating patients with acromegaly

      ea0049ep1047
    • Hyponatremia - the other face of diabetes insipidus complications

      ea0049ep1048
    • Aggressive pituitary tumours: a multicenter study

      ea0049ep1049
    • Effects of somatostatin analogs on glucose metabolism in acromegalic patients: a meta-analysis of prospective interventional studies

      ea0049ep1050
    • Prolactinomas diagnosed after menopause: presentation and outcomes from a large specialist centre

      ea0049ep1051
    • Ipilimumab induced hypophysitis - an insight from a case series in the United Kingdom

      ea0049ep1052
    • Mammary duct ectasia due to prolactin-secreting pituitary adenoma

      ea0049ep1053
    • Quantitative analysis of the pituitary gland at magnetic resonance imaging in obese patients

      ea0049ep1054
    • Hypogonadotropic hypogonadism in a patient with long-term primary hypothyroidism

      ea0049ep1055
    • Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study

      ea0049ep1056
    • DHEA-S as a marker of the secondary adrenal insufficiency following craniospinal irradiation

      ea0049ep1057
    • Clinical and laboratorial reassessment of patients with isolated growth hormone deficiency during the transition phase

      ea0049ep1058
    • What should central diabetes insipidus and panhypopituitarism point out in a patient with lung adenocarcinoma in remission?

      ea0049ep1059
    • Is there any relationship between nonfunctional pituitary adenoma and arterial stiffness?

      ea0049ep1060
    • A rare cause of hypophysitis: tuberculosis

      ea0049ep1061
    • T2-weighted MRI signal and response to somatostatin analogs in acromegaly

      ea0049ep1062
    • [ldquo]Toxic[rdquo] Goiter Reveals Cushing's Disease

      ea0049ep1063
    • Low incidence of hyperprolactinemia following traumatic brain injury

      ea0049ep1064
    • The pseudo-tumoral adenohypophysitis: A rare disorder of the postpartum

      ea0049ep1065
    • Clinically nonfunctioning pituitary adenoma: a case report

      ea0049ep1066
    • Nonfunctioning pituitary incidentaloma - delayed onset of acromegaly and concomitant primary adrenocortical insufficiency

      ea0049ep1067
    • Sheehan's syndrome in clinical practice

      ea0049ep1068
    • Mental disorders in the hospitalized patients with Cushing's disease

      ea0049ep1069
    • Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity

      ea0049ep1070
    • Surgery versus expectant observation in clinically non-functioning pituitary adenomas - a 20-year single centre experience

      ea0049ep1071
    • Risk factors for progression of the surgical remnant of non-functioning pituitary adenomas in patients treated with dopamine agonists

      ea0049ep1072
    • Aggressive macroprolactinoma - exception to the rule

      ea0049ep1073
    • Body composition and bone mineral density in male patients with isolated hypogonadotropic hypogonadism

      ea0049ep1074
    • The E in POEMS syndrome: what to expect?

      ea0049ep1075
    • Pituitary adenoma and elevated ACTH: not always corticotrophinoma

      ea0049ep1076
    • Pituitary apoplexy - presentation, management and outcome in 35 cases

      ea0049ep1077
    • Inferior petrosal sinus sampling: experience of a terciary hospital

      ea0049ep1078
    • Cushing syndrome and pregnancy: a systematic review including three new cases

      ea0049ep1079
    • 20-year retrospective study of clinically non-functioning pituitary adenomas - a single center experience

      ea0049ep1080
    • Hypopituitarism and central diabetes insipidus in an HIV patient - a late complication of cerebral toxoplasmosis and/or antiretrovirals?

      ea0049ep1081
  • Steroid metabolism + action
  • • Social stress stimulates glucocorticoid regeneration in lymphoid organs

      ea0049ep1082
• Eposter Presentations: Reproductive Endocrinology
• • Bone & Osteoporosis
  • • Effects of male hypogonadism treatment on the bone mineral density

      ea0049ep1083
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis of randomized controlled studies

      ea0049ep1084
  • Clinical case reports - Pituitary/Adrenal
  • • CHARGE Syndrome: a rare case of hypogonadotropic hypogonadism

      ea0049ep1085
    • Combination of turner syndrome and congenital adrenal hyperplasia: a rare case report

      ea0049ep1086
    • A rare case of short-term postpartum primary adrenal insufficiency

      ea0049ep1087
    • Hypogonadotropic hypogonadism, functional and transitory

      ea0049ep1088
    • Congenital adrenal hyperplasia: case series, describing results of initial dexamethasone therapy

      ea0049ep1089
  • Clinical case reports - Thyroid/Others
  • • A rare cause of a 46, XY disorder of sex development diagnosed in an adult patient

      ea0049ep1090
    • Association of short stature, microcephaly, secondary amenorrhea and consanguinity: clinical case report

      ea0049ep1091
  • Developmental endocrinology
  • • Age and developmental stage dependent relationship between plasma concentrations of leptin, luteinizing hormone, follicle stimulating hormone, prolactin, testosterone and inhibin B in boys between the age of 1 and 20 years

      ea0049ep1092
  • Endocrine tumours and neoplasia
  • • Molecular mechanisms underlying progesterone-enhanced breast cancer cell proliferation

      ea0049ep1093
    • Study of CYP17 and PSA G158A polymorphisms in prostate cancer

      ea0049ep1094
  • Female Reproduction
  • • Administration of first line anti-tuberculosis drugs induces ovarian and uterine oxidative stress and disruption of endocrine balance in rats

      ea0049ep1095
    • Development of hepatic steatosis and inflammation by chronic insulin and hCG exposure in female rats: possible implications in PCOS patients with NAFLD

      ea0049ep1096
    • Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome

      ea0049ep1097
    • Association of basal and post-synacthen stimulated 17-hydroxyprogesterone levels with insulin resistance in polycystic ovary syndrome

      ea0049ep1098
    • Serum sclerostin and dickkopf-1 levels in polycystic ovary syndrome patients

      ea0049ep1099
    • Phthalates induce ovarian failure through disturbance in folliculogenesis and steroidogenesis

      ea0049ep1100
    • Efficacy comparison of oral rosuvastatin versus oral progesterone and bevacizumab on regression of surgically endometriotic implants in rats

      ea0049ep1101
    • The relation between sex hormones and sexual function in women with Turner syndrome

      ea0049ep1102
    • BMP8 sustains expansion and survival of cumulus cells in vitro

      ea0049ep1103
    • Serum concentrations of betatrophin and its association with indirect indices of insulin resistance and beta cell function in women with polycystic ovary syndrome

      ea0049ep1104
    • Short term intervention with liraglutide and metformin increased fertility potential in a subset of obese PCOS proceeding IVF

      ea0049ep1105
    • The functional state of hypophysis - gonad axis in patients with polycystic ovary syndrome (PCOS)

      ea0049ep1106
    • Efficacy of FSH alone, FSH + LH, hMG or FSH + hCG on ART outcomes in the 'personalized' medicine era: a meta-analysis

      ea0049ep1107
    • May thiol/disulfide homeostasis predict adult PCOS?

      ea0049ep1108
    • Effects of cigarette smoke extracts on proliferation, migration, and hCG-[beta] protein expression of JEG-3 human placental cancer cells

      ea0049ep1109
    • Hyperandrogenism and overweight/obesity, independently and interactively, increase the risk of metabolic syndrome and type 2 diabetes in women - a Prospective, Population-based Cohort Study

      ea0049ep1110
    • Natural history of the Swyer Syndrome

      ea0049ep1111
    • Biological activity mediated by sfingosine-1-phospate receptors in human primary granulosa cells and immortalized granulosa cell line in vitro

      ea0049ep1112
    • Polycystic ovary syndrome and euthyroid hashimoto's thyroiditis: possible influence of thyroid autoantibodies

      ea0049ep1113
    • Novel insulin resistance index using C-peptide is reliable predictor of insulin resistance in women with PCOS

      ea0049ep1114
    • Omentin-1, a potential link between chronic low grade inflammation, metabolic and reproductive features of polycystic ovary syndrome

      ea0049ep1115
    • Hirsutism in reproductive aged Korean women

      ea0049ep1116
    • Pharmacokinetics and bioavailability of non-polar phytocomponents of Aloe vera gel and their role as an endocrine modulator in letrozole induced PCOS rat model

      ea0049ep1117
    • Influence of peroxisome proliferator-activated receptor (PPAR)-[gamma] exon 2 (Pro12Ala) and exon 6 (His447His) and Gly972Arg insulin receptor substrate (IRS)-1 polymorphisms on insulin resistance (IR) and beta cell function in Southern Mediterranean women with polycystic ovary syndrome (PCOS)

      ea0049ep1118
    • Hormonal disturbances and adipokines levels in girls with oligomenorrhea

      ea0049ep1119
    • Global methylation pattern and endocrine-metabolic profile during early infancy and puberty in sons born to women with polycystic ovary syndrome (PCOS)

      ea0049ep1120
    • Natural history of autoimmune primary ovarian insufficiency progresses through several stages from normal ovary function to clinically overt ovary dysfunction

      ea0049ep1121
    • Relationship between anabolic hormones and benign lesions in different organs in premenopousal women

      ea0049ep1122
    • Heterogeneous hCG and hMG commercial preparations result in biased intracellular signaling but induce similar progesterone response in vitro

      ea0049ep1123
    • Etiopathogenetical aspects of endocrine infertility

      ea0049ep1124
    • Prenatal androgen exposure alters gene expression and promoter methylation of two ovarian follicle maturation factors

      ea0049ep1125
    • Graduated response to pulsatile GnRH therapy in hypothalamic amenorrhea

      ea0049ep1126
    • Relationship between steroid hormones and metabolic profile in women with polycystic ovary syndrome

      ea0049ep1127
    • Secondary amenorrhea after bone marrow transplantation and adjuvant chemotherapy misdiagnosed as disorder of sex development: a case report

      ea0049ep1128
    • NCAH prevalance with novel CYP21A2 and CYP11B1 mutations in hirsut turkish women

      ea0049ep1129
    • Effects of photoperiod on estrous cycle in the Mongolian gerbil (Meriones unguiculatus)

      ea0049ep1130
    • The regulation of LHCGR-dependent signaling is linked to circadian gene expression

      ea0049ep1131
    • High dose metformin effect on weightloss, androgen levels and thyroid function in obese hypothyroid patients with PCOS

      ea0049ep1132
    • Influence of thyroid stimulating hormone (TSH) level in in-vitro fertilization (IVF) success

      ea0049ep1133
    • The efficiency of metformin in polycystic ovarian syndrome is not necessarily attributable to the improvement of insulin resistance

      ea0049ep1134
    • Serum Vitamin D status in women with the polycystic ovary syndrome

      ea0049ep1135
    • Abstract unavailable

      ea0049ep1136
    • Oxidative status imbalance in patients with polycystic ovary syndrome

      ea0049ep1137
    • Utility of oral glucose tolerance test (OGTT) in patients with polycystic ovary syndrome (PCOS)

      ea0049ep1138
    • Diagnostic performance of non-invasive markers for the presence of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome

      ea0049ep1139
    • Complementary effect of Vitamin D supplementation and lifestyle modification on anthropometric and metabolic parameters in young polycystic ovary syndrome women with Vitamin D deficiency: a 3-month prospective interventional study

      ea0049ep1140
    • Epigenetics of female hypogonadotropic hypogonadism: analysis of mRNA expression of engaged in IHH genes

      ea0049ep1141
    • How far is possible to make a diagnosis of infertility

      ea0049ep1142
    • Physiological changes of adipokines and selected steroids during the menstrual cycle

      ea0049ep1143
    • Serum activities of dipeptidyl peptidase-4 and adenosine deaminase and parameters of oxidative stress in polycystic ovary syndrome: association with obesity

      ea0049ep1144
    • Oocyte donation in women with Turner's syndrome: successful outcome can be achieved with a specialist multidisciplinary approach

      ea0049ep1145
    • The features of young women reproductive health with type 1 diabetes

      ea0049ep1146
    • The determinants of thyroid autoimmunity in patients with polycystic ovary syndrome

      ea0049ep1147
    • Metformin treatment decreased free androgen index among PCOS women

      ea0049ep1148
    • Abstract unavailable

      ea0049ep1149
    • Biochemical and clinical characteristics of polysystic ovarian syndrome (PCOS) in women with and without type 1 diabetes (TID)

      ea0049ep1150
    • A case of polycystic ovary syndrome (PCOS)

      ea0049ep1151
    • Does radioactive ıodine therapy affect fertility?

      ea0049ep1152
    • Androgen profiling by liquid chromatography-mass spectrometry (LC-MS) in reproductive-age women with and without diabetes

      ea0049ep1153
    • Anti-mullerian hormone a marker for metformin therapy efficacy in PCO: a pilot study on Egyptian population

      ea0049ep1154
    • Influence of BMI in response to ovarian stimulation and live birth in IVF

      ea0049ep1155
    • Anti-Mullerian hormone level is independently affected only by the ovarian factor among clinical and endocrinological factors in polycystic ovary syndrome

      ea0049ep1156
  • Male Reproduction
  • • Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume. Study during up to 9 years on hypogonadic patients. (December 2016)

      ea0049ep1157
    • After 9 years observation, testosterone undecanoat 1000 mg at 3 months did not increased Prostatic Specific Antigen level (December 2016)

      ea0049ep1158
    • Induction of male puberty in patients with hypogonadism hypogonadotrope with subcutaneous gonadotropin

      ea0049ep1159
    • Semen quality in young, healthy men is not related to serum concentration of vitamin D (AndroLS)

      ea0049ep1160
    • Semen quality in patients with newly diagnosed lymphoma's

      ea0049ep1161
    • Abstract unavailable

      ea0049ep1162
    • Gonadal profile in men with early-onset androgenetic alopecia: does a male PCOS-equivalent syndrome exist?

      ea0049ep1163
    • Improved conception of the normative values of testosterone in men with type 2 diabetes

      ea0049ep1164
    • Endothelial dysfunction, inflammation and insulin resistance in patients with Klinefelter Syndrome

      ea0049ep1165
    • Testosterone is poorly related to erectile dysfunction in young/middle aged human immunodeficiency virus-infected men

      ea0049ep1166
    • Early arterial stiffness and chronic inflammation in male equivalents of polycystic ovary syndrome

      ea0049ep1167
    • Abstract unavailable

      ea0049ep1168
    • Can salivary testosterone be used in the monitoring of men using transdermal testosterone replacement therapy?

      ea0049ep1169
    • Changes of dihydrotestosterone within the life in men

      ea0049ep1170
    • Male pseudohermaphroditism with 45,X/46,X,idic(Y) karyotype: a case presenting with dysgenetic testis on one side and almost normally sized testis on the other side

      ea0049ep1171
    • Effects of anabolic androgenic steroids on the reproductive system of athletes

      ea0049ep1172
    • Gonadal status in males with acute coronary syndrome and the extent of coronary artery disease: a comparative cross-sectional analysis

      ea0049ep1173
    • An unusual karyotype in a young adult with a clinical phenotype suggesting a Klinefelter syndrome

      ea0049ep1174
    • A case with taurodontism and Klinefelter syndrome

      ea0049ep1175
    • Methylation of the CPG islands from MTHFR promoter in male infertility

      ea0049ep1176
    • How relevant are the complications associated with testosterone treatment in men with hypogonadism?

      ea0049ep1177
    • Evolution of healthcare demand in a public gender identiy clinical center in Valencia (spain)

      ea0049ep1178
    • Leptin modulates Sertoli cells mitochondrial function and biogenesis with implications for the nutritional support of spermatogenesis

      ea0049ep1179
    • Study of CDX-2 VDR gene polymorphisms in male infertility

      ea0049ep1180
    • CHARGE syndrome - late diagnosis in adulthood

      ea0049ep1181
    • Azoospermia revealing the uncommon Jacob's syndrome

      ea0049ep1182
  • Neuroendocrinology
  • • Prenatal intervention by P271 reduces LH pulsatility and testosterone levels in PCOS condition

      ea0049ep1183
    • Prenatal testosterone exposure increases anxiety-like behavior in female rats

      ea0049ep1184
  • Obesity
  • • Placental maternal and fetal vascular circulation in healthy non obese and metabolically healthy obese pregnant women

      ea0049ep1185
    • The dynamics of anthropometric data in fertile age women by various types of the treatment

      ea0049ep1186
    • The disorder of secretion of somatotropic hormone in women with obesity in the polycystic ovaries syndrome (PCOS) by comparison to patients with the non-functional pituitary adenomas (NFPA)

      ea0049ep1187
  • Paediatric endocrinology
  • • 17alpha-hydroxyprogesterone in non-CAH children and adolescents at different ages

      ea0049ep1188
  • Steroid metabolism + action
  • • Effects of estrogen and progesterone on the protein expression of EMT- and pluripotency-associated markers in human embryonic stem cells

      ea0049ep1189
    • Homo-dimerisation of cytochrome P450c17 resolves the conundrum of the dual activities of cytochrome P450c17

      ea0049ep1190
    • Non-alcoholic fatty liver disease and its relation with sex steroids in men

      ea0049ep1191
• Eposter Presentations: Thyroid
• • Clinical case reports - Thyroid/Others
  • • An adverse outcome in a thyrotoxic lady with propylthiouracil induced necrotising leukocytoclastic vasculitis

      ea0049ep1192
    • Synchronous papillary thyroid carcinoma and primary hyperparathyroidism: a rare association

      ea0049ep1193
    • A case with langerhans cell histiocytosis having papillary microcarcinoma of thyroid: two birds in one nest

      ea0049ep1194
    • Amiodarone and refractory thyrotoxicosis in a patient with complex arrhythmia

      ea0049ep1195
    • Relapsed Graves' thyrotoxicosis following total thyroidectomy 20 years earlier

      ea0049ep1196
    • Where is the thyroxin disappearing?

      ea0049ep1197
    • Hyalinizing trabecular tumor of the thyroid gland

      ea0049ep1198
    • Riedel thyroiditis presenting with pleuro-pericardial involvement

      ea0049ep1199
    • A Novel Thyroid Hormone Receptor Beta Gene Mutation: p.L450F (c.C1633T) in a family with Resistance to Thyroid Hormone

      ea0049ep1200
    • Tuberculosis of the thyroid gland: a case report

      ea0049ep1201
    • Follicular variant of papillary thyroid carcinoma with lung, bone, and soft tissue metastases

      ea0049ep1202
    • Severe acute hepatitis associated with thyrotoxicosis

      ea0049ep1203
    • Isolated ocular Miasthenia Gravis and Graves' disease - a challenging ophtalmopathy

      ea0049ep1204
    • Pleiotropic function of vitamin D and goiter

      ea0049ep1205
    • Amyloid goiter secondary to Crohn's disease

      ea0049ep1206
    • Two case reports of amiodarone induced thyroid dysfunction: thyrotoxic and myxedematous crisis

      ea0049ep1207
    • Hashimoto's thyroiditis in a patient with ectopic thyroid tissue

      ea0049ep1208
    • Autoimmune thyroid disease occurring as a possible late complication after a non-occupational HIV Postexposure Prophylaxis

      ea0049ep1209
    • Recurrent Thyroiditis in an Amiodarone treated patient: An Illustrative Case Demonstrating the Spectrum of Abnormalities

      ea0049ep1210
    • Thyroid storm subsequent to amiodarone-induced thyrotoxicosis

      ea0049ep1211
    • Atrial flutter with 1:1 atrioventricular conduction: An uncommon cardiac manifestation of hyperthyroidism

      ea0049ep1212
    • Pharyngeal Irritation, Incidental Neck Masses; A difficult journey

      ea0049ep1213
    • Papillary thyroid microcarcinoma in struma ovarii tissue: a case report

      ea0049ep1214
    • Simultaneous occurrence of RET-negative Medullary Thyroid Carcinoma (MTC) and extrathyroidal B large cell Non-Hodgkin Lymphoma (NHL)

      ea0049ep1215
    • miRNAs microarray differential profile in papillary thyroid carcinoma

      ea0049ep1216
    • Simultaneous papillary and medullary thyroid carcinoma in siblings with RET 611 mutation. More than a coincidence?

      ea0049ep1217
    • Thyroid nodule size at ultrasound as a predictor of malignancy

      ea0049ep1218
    • Struma ovarii - A report of thirteen cases

      ea0049ep1219
    • Diagnosis of medullary thyroid carcinoma at early stage

      ea0049ep1220
    • Clinicopathological characteristics and outcomes of differentiated thyroid carcinoma in children and adolescents

      ea0049ep1221
  • Nuclear receptors and Signal transduction
  • • The human TR[alpha] variants affect the specification of haematopoietic stem cells during zebrafish haematopoiesis

      ea0049ep1222
  • Paediatric endocrinology
  • • An interesting etiology in childhood choreoathetosis; autoimmune hyperthyroiditis

      ea0049ep1223
    • Thyroid pathology and breasts diseases in adolescent girls

      ea0049ep1224
    • Age and development stage dependent association between thyroid hormones and growth hormone and linear growth velocity in boys between the age of 1 and 20 years

      ea0049ep1225
    • Pediatric case of Autoimmune Polyglandular Syndrome type IIIC: autoimmune thyroid disease and severe autoimmune thrombocytopenia

      ea0049ep1226
    • Pediatric thyroid nodule: cytologic and histopathologic correlation

      ea0049ep1227
  • Thyroid (non-cancer)
  • • Thyroid autoimmunity in beta thalassemia minor

      ea0049ep1228
    • Thyroid disorders and type 1 diabetes

      ea0049ep1229
    • Keep calm and put on the emergency list: total thyroidectomy for refractory thyrotoxicosis

      ea0049ep1230
    • Screening with TSH and anti-TPO antibodies of patients with vitiligo

      ea0049ep1231
    • Clinical aspects of cardiothyreosis in patients with Graves' disease

      ea0049ep1232
    • Risk factors associated with the severity of Graves' ophthalmopathy

      ea0049ep1233
    • Determination of plasma cortisol levels in women with dysthyroidism

      ea0049ep1234
    • Therapeutic plasma exchange in the treatment of hyperthyroidism

      ea0049ep1235
    • Adult outcome of congenital hypothyroidism

      ea0049ep1236
    • Asymptomatic riedel thyroiditis presented in a patient with thyroid storm and polyglandular autoimmune disease

      ea0049ep1237
    • Congenital hypothyroidism in children with down syndrome

      ea0049ep1238
    • Retrospective audit: To investigate the long-term outcome of fixed dose 300 MBq of radioiodine (131-I) treatment for Autonomous Toxic Thyroid Nodule

      ea0049ep1239
    • Assessment of thyroid functions, thyroid autoimmunity and insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease

      ea0049ep1240
    • Two pseudomalabsorbtion cases successfully treated with parenteral levothyroxine

      ea0049ep1241
    • Follow-up observations on nodular goiter in Japanese - Progression and related factors

      ea0049ep1242
    • Aggravation of thyroid dysfunction in a case of thyroid hormone resistance after near total thyroidectomy for multinodular goiter

      ea0049ep1243
    • Thyroid function and weight loss after Roux-en-Y gastric bypass: observational study

      ea0049ep1244
    • Correlation between serum nitrite (NO2) levels, TQ7 and GHQ12 questionnaire scores in treatment-naive hypothyroid patients

      ea0049ep1245
    • Vitamin D levels in Graves' disease (GD) are lower than in general population but do not correlate with laboratory and clinical parameters in GD or SNPs associated with GD

      ea0049ep1246
    • Action of several bioavailable antioxidants in orbital fibroblasts from patients with Graves' Orbitopathy (GO): a new frontier in GO treatment?

      ea0049ep1247
    • Intrathyroidal and peripheral venous blood lymphocyte subset patterns in patients with Graves disease

      ea0049ep1248
    • No impact of subclinical hypothyroidism on cognitive functions among the elderly

      ea0049ep1249
    • Prolonged iodine excess due to hysterosalpingography in a pregnant woman

      ea0049ep1250
    • The challenge of diagnosing thyroid storm: a comparison of the Japanese Thyroid Association Criteria to de Burch Wartofsky Point Scale

      ea0049ep1251
    • The role of FNDC5 gene expression in irisin level changes accompanying thyroid pathologies

      ea0049ep1252
    • Long term effects of the less than total thyroidectomy: The experience of a tertiary care center

      ea0049ep1253
    • Severe hyperthyroidism imposes large amounts of antithyroid compounds

      ea0049ep1254
    • Postpartum thyrotoxicosis - a diagnosis, sometimes, postponed

      ea0049ep1255
    • Clinical characteristics of painless thyroiditis

      ea0049ep1256
    • The effectiveness of parathyroidectomy in children with primary hyperparathyroidism

      ea0049ep1257
    • Fluctuating thyroid hormones in Graves disease: a case series of brittle Graves

      ea0049ep1258
    • The role of an ultra-sensitive fourth-generation TSH assay in the management of subclinical hyperthyroidism

      ea0049ep1259
    • Non-thyroidal illness syndrome in chronic renal failure and oxidative stress: preliminary data on triiodothyronine relationships with extracellular superoxide-dismutase

      ea0049ep1260
    • Therapeutic options in severe thyrotoxicosis with malabsorption

      ea0049ep1261
    • Congenital disorders in children of the mothers with thyroid malfunctioning at pregnancy

      ea0049ep1262
    • Psychometric evaluation of the newly developed hypoparathyroidism symptom diary

      ea0049ep1263
    • Early diagnosis of primary biliary cirrhosis during follow-up for Graves' disease

      ea0049ep1264
    • Survey on the management of hypothyroidism during pregnancy by general practitioners, endocrinologists and obstetricians in Australia and New Zealand

      ea0049ep1265
    • Analysis of cardiovascular changes in Graves disease and their dynamic during the treatment

      ea0049ep1266
    • Prevalence of the thyroiditis in childbearing age women

      ea0049ep1267
    • Prevalence and etiology of the hypothyroidy in childbearing age women

      ea0049ep1268
    • Effectiveness of radioiodine treatment for autonomous toxic node

      ea0049ep1269
    • Endemic goiter in Xinjiang, Northwestern China

      ea0049ep1270
    • How does overt and subclinical hypothyroidism due to thyroiditis of Hashimoto affect lipid parameters

      ea0049ep1271
    • Primary hypothyreosis in cobalt intoxication

      ea0049ep1272
    • Evaluation of circulating irisin levels in patients with never treated overt hyperthyrodisim

      ea0049ep1273
    • Is there a correlation between serum selenium level and the severity of Graves' orbitopathy?

      ea0049ep1274
    • Nicotinamide phosphoribosyltransferase expression in thyroid glands of patients with Graves' disease

      ea0049ep1275
    • Associations between thyroid and kidney functions

      ea0049ep1276
    • Hypothyroidism - once a week treatment option in young- and middle-aged adults

      ea0049ep1277
    • Effect of subclinical hypothyroidism and autoimmunity on adverse pregnancy and neonatal outcome in our population

      ea0049ep1278
    • Metastatic differentiated thyroid carcinoma: cumulative doses of adjunct 131i-iodide therapy

      ea0049ep1279
    • Autoimmune thyroid disease may affect prognosis of breast cancer

      ea0049ep1280
    • Subacute Thyroiditis with an atypical clinical course and thyroid ^99mTc uptake

      ea0049ep1281
    • Weak numeracy is common problem in patients with thyroid diseases

      ea0049ep1282
    • A case of levothyroxine tablet malabsorption associated with gastric neuroendocrine tumour corrected with gel capsule formulation

      ea0049ep1283
    • Percutaneous ablation of benign thyroid nodules: specific simulators for practicing enolization and laser procedures

      ea0049ep1284
    • Improved diagnostics with increased treatment of hypothyroidism during pregnancy - a 10 year study of Finnish pregnant women

      ea0049ep1285
    • Radiofrequency ablation for benign thyroid nodules: 450 patients - three years follow-up

      ea0049ep1286
    • Coexistence of Graves' disease and unilateral benign struma ovarii: A case report

      ea0049ep1287
    • Clinical characteristics and outcomes of patients with myxedema coma: a 15-years experience of a tertiary care center in Thailand

      ea0049ep1288
    • Evaluation of interrelationships between thyroid function, autoimmunity, insulin resistance and lipid profile in Graves' disease

      ea0049ep1289
    • Successful radioiodine treatment of Graves disease for a patient with a history of «iodide allergy»

      ea0049ep1290
    • Trans-axillary endoscopic thyroidectomy - technique

      ea0049ep1291
    • Trans-axillary endoscopic thyroidectomy - scarless surgery of the neck: our experience

      ea0049ep1292
    • TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability

      ea0049ep1293
    • May erythrovirus (parvovirus) B19 trigger autoimmune thyroid diseases?

      ea0049ep1294
    • Treatment of toxic multinodular goiter with 131 radioactive iodine - effects in volume reduction, thyroid function and autoimmunity

      ea0049ep1295
    • Four out of five patients with acute kidney injury have thyroid dysfunction

      ea0049ep1296
    • The assessment of influence vitamin D deficiency on the Hashimoto's thyroiditis activity

      ea0049ep1297
    • The role of 99mTc-sestamibi in amiodarone-induced thyrotoxicosis - Case report

      ea0049ep1298
    • Effect of vitamin D supplementation on patients with Graves disease

      ea0049ep1299
    • Primary hyperparathyroidism coexisting with Graves' disease in a patient with vitamin D deficiency

      ea0049ep1300
    • Primary underdosed hypothyroidism - parodontal implications in adults

      ea0049ep1301
    • Assessment of the degree of depression in patients with chronic autoimmune thyroiditis depending on the serum autoantibodies and thyroid hormone levels

      ea0049ep1302
    • Frequency and prognostic factors of non-diagnostic cytology in ultrasound guided thyroid fine needle aspiration biopsy: a 2-year single centre experience

      ea0049ep1303
    • Juvenile hypothyroidism-particularities in the development of the dento-maxilary system

      ea0049ep1304
    • Thyrotoxic periodic paralysis

      ea0049ep1305
    • Audit of utility of radio-isotope scan in the investigation of thyrotoxicosis or subclinical hyperthyroidism and timing of anti-thyroid medication

      ea0049ep1306
    • Thyroid autoimmunity and frequency of malignant or suspicious for malignancy thyroid nodule cytology

      ea0049ep1307
    • Clinical experience with glucocorticoid therapy in patients with endocrine ophthalmopathy

      ea0049ep1308
    • Thyroid storm presenting in the context of recent influenza vaccination and untreated Graves disease

      ea0049ep1309
    • Relapsing Graves' hyperthyroidism in a male patient with central hypothyroidism after surgery of craniopharyngioma: case report

      ea0049ep1310
    • TSH normalization and negative anti-TSH receptor antibodies - Predictive value for remission in Graves' disease

      ea0049ep1311
    • Treatment choice and patient satisfaction in thyrotoxicosis

      ea0049ep1312
    • Management of relapsing Graves: a clinical survey among endocrinologists in Israel

      ea0049ep1313
    • Case report: identification and characterization of interference by IgM anti-streptavidin antibody in a patient with spurious thyroid function tests

      ea0049ep1314
    • Severe Grave's dermopathy and acropachy discording with moderate ophtalmopathy: (a case report)

      ea0049ep1315
    • The importance of the study of several immunoregulatory cytokines in the manifest hypothyroidism

      ea0049ep1316
    • The position of immunoglobuline G4 positive in Hashimoto's thyroiditis

      ea0049ep1317
    • TRAB positive thyroid dysfunction associated with Alemtuzumab treatment for MS: A case series

      ea0049ep1318
    • Serum levels of insulin-like growth factor 1 in patients with hyperthyroidism or euthyroidism

      ea0049ep1319
    • Evaluation of oxidative stres by means of thiol-disulphide homeostasis in patients with euthyroid Hashimoto's thyroiditis

      ea0049ep1320
    • Hashimoto Encephalopathy with polymorphic neuropsychiatric signs: a case report

      ea0049ep1321
    • Cardiothyreosis: prevalence and risk factors

      ea0049ep1322
    • Takotsubo cardiomyopathy associated with thyrotoxicosis

      ea0049ep1323
    • Therapeutic and evolutionary characteristics of subclinical hypothyroidism

      ea0049ep1324
    • The manner of performing the thyroid ultrasound examination and the reliability of assessment of the thyroid size in school-aged children

      ea0049ep1325
    • Which cytologic or architectural characteristics are associated with malignancy in AUS/FLUS cytologies according to subgroups?

      ea0049ep1326
    • Relationship between thyroid volume and baseline vitamin D levels in new-onset graves disease

      ea0049ep1327
    • A novel mutation in thyroid hormone receptor-beta gene causing resitance to thyroid hormone in a tunisian female

      ea0049ep1328
    • Succesfull treatment of hyperthyroidism with plasmapheresis

      ea0049ep1329
    • Measurement of anti-thyroglobulin antibodies, a matter of equipment?

      ea0049ep1330
    • Reference range determination of TSH during the first trimester of pregnancy and the impact of its future implantation in the South area of Seville

      ea0049ep1331
    • Iodine content of iodized salt in Spain

      ea0049ep1332
    • Low DHEAS levels predict rheumatism in primary hypothyroidism: preliminary data from tertiary hospital

      ea0049ep1333
    • A thyroid storm in a context of diabetic ketoacidosis: case report

      ea0049ep1334
    • Hyalinizing trabecular adenoma of the thyroid

      ea0049ep1335
    • Amiodaron induced hyperthyreosis and recurrent ventricular tachycardia

      ea0049ep1336
    • Autoimmune thyroiditis in patients with latent autoimmune diabetes of adults (LADA)

      ea0049ep1337
    • Thyroid and metabolic disorders in patient with kidney injury undergoing renal biopsy

      ea0049ep1338
    • Reversible thyrotoxic pulmonary hypertension with heart failure: 2 cases

      ea0049ep1339
    • Peripheral neuropathy in hypothyroidism - about a clinical case

      ea0049ep1340
    • Is Levothyroxine requirement the same for tablet and soft gel formulation in postsurgical hypothyroidism?

      ea0049ep1341
    • Immune reaction to food antigens in Graves'disease (GD) patients: role of gliadin and other food antigens

      ea0049ep1342
    • Neutrophil/lymphocyte (N/L) ratio should not be used as an indicator of inflammation in hyperthyroid patients

      ea0049ep1343
    • Quality of life in patients with hyperthyreosis and hypothyreosis in slovak republic

      ea0049ep1344
    • Broken heart by thyroid? A rare case of Graves' disease associated to Takotsubo cardiomiopathy

      ea0049ep1345
    • The association of gene polymorphisms with the clinical outcome of Graves' disease

      ea0049ep1346
    • The impact of levothyroxine sodium treatment on dynamic thiol/disulphide homeostasis in overt hypothyroidism

      ea0049ep1347
    • The role of vitamin D receptor gene FokI (rs2228570) polymorphism in the pathogenesis of thyroid associated orbitopathy

      ea0049ep1348
    • Lymphoid hyperplasia in Graves' disease: about 2 cases

      ea0049ep1349
    • Effects of hypothyroidism on nutritional status: which impact?

      ea0049ep1350
    • Outcome of radioiodine therapy in patients with hyperthyroidism

      ea0049ep1351
    • An unusual case of subacute thyroiditis after alemtuzumab treatment

      ea0049ep1352
    • Pattern of amiodarone-induced thyrotoxicoxis before and after universal salt iodization

      ea0049ep1353
    • They think it's all ovar(ii)

      ea0049ep1354
    • Perinatal outcome in graves-basedow disease during pregnancy

      ea0049ep1355
    • TSH receptor stimulating immunoglobulins - performance of an automated immunoassay

      ea0049ep1356
    • Genetic variation in NFE2L2 and SEPS1S associated with increased risk of Hashimoto's thyroiditis

      ea0049ep1357
    • Safety and efficacy of cholestyramine in the adjuvant management of Graves thyrotoxicosis

      ea0049ep1358
    • A slow but continuous growth: Case study of a thyroid nodule

      ea0049ep1359
    • Mirela Tirnovan1, Anamaria Bursuc1, Alina Daniela Belceanu1, Adina Manolachie1, Ioana Armasu1, Iulia Crumpei1, Georgiana Constantinescu1, Luminita Apostu2, Carmen Vulpoi1

      ea0049ep1360
    • Oxidative profiles in patients with autoimmune thyroid diseases

      ea0049ep1361
    • Levothyroxine absorption test in the management of a patient with persistent hypothyroidism

      ea0049ep1362
    • Serum irisin level in different thyroid dysfunction states and its relation to markers of muscle dysfunction

      ea0049ep1363
    • Iodine deficiency is still prevalent in pregnant women from Romania after universal salt iodization

      ea0049ep1364
    • The potential of smartphone applications in management and compliance to recommended lifestyle in Hashimoto's patients

      ea0049ep1365
    • Dynamic risk stratification for predicting recurrence in patients with differentiated thyroid cancer treated without radioactive iodine remnant ablation therapy

      ea0049ep1366
    • Association between lymph node metastasis and patients' age in papillary thyroid microcarcinoma

      ea0049ep1367
    • Breast cancer and family history for breast cancer in patients with differentiated thyroid carcinoma

      ea0049ep1368
    • Differential diagnosis between Anaplastic Thyroid Cancer and Primitive Lymphoma of the Thyroid gland: A 66-cases study

      ea0049ep1369
    • The role of preoperative serum thyroglobulin values in the diagnosis of differentiated thyroid cancer

      ea0049ep1370
    • Is there an impact of the concurrent presence of chronic autoimmune thyroiditis in differentiated thyroid cancer patients?

      ea0049ep1371
    • 20,000 euros for diagnosis of one thyroid cancer case: It is not too much?

      ea0049ep1372
    • Unilateral Graves' disease with papillary carcinoma of the hyperfunctioning lobe

      ea0049ep1373
    • Trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma - an Israeli multicenter study

      ea0049ep1374
    • Association of preoperative neutrophil lymphocyte ratio and platelet lymphocyte ratio with clinical features of differentiated thyroid cancer

      ea0049ep1375
    • Differentiated thyroid cancer in patients taking lithium for bipolar affective disorder: a case series

      ea0049ep1376
    • Predictive value of CHAID Algorithm in the diagnosis of malignancy in thyroid nodules with Bethesda III (AUS/FLUS) cytology

      ea0049ep1377
    • Thyroid autoimmunity and risk of incidental thyroid microcarcinoma in non-toxic nodular thyroid diseases

      ea0049ep1378
    • Effects of combination of metformin and pioglitazone on AMPK/mTOR signal pathway, p53 and apoptosis in human anaplastic thyroid cancer cells

      ea0049ep1379
    • Vitamin D status and MPV changes in differentiated thyroid cancer

      ea0049ep1380
    • BRAFV600E status and Stimulated Thyroglobulin at ablation time increase prognostic value of American Thyroid Association (ATA) classification systems for persistent disease in Differentiated Thyroid Carcinoma (DTC)

      ea0049ep1381
    • High sensitivity of BRAF detection method does not alter response to therapy of papillary thyroid cancer of known BRAF status

      ea0049ep1382
    • Thyroid nodules ultrasound classification and the importance of the endocrinologist clinical feeling

      ea0049ep1383
    • Five-year follow-up of thyroid cold nodules with somatic oncogene mutations in Hungarian patients

      ea0049ep1384
    • Usefulness of preoperative ultrasonography and computed tomography for evaluation of recurrent laryngeal nerve invasion by Papillary Thyroid microcarcinoma

      ea0049ep1385
    • Solitary metastasis of papillary thyroid cancer in the sellar region and cavernous sinus

      ea0049ep1386
    • Calcitonin: clinical and laboratory evaluation in a tertiary hospital

      ea0049ep1387
    • Neuroendocrine progression of medullary thyroid cancer - case report

      ea0049ep1388
    • Cytohistologic correlation of thyroid nodules

      ea0049ep1389
    • Importance of central compartment neck metastasis in the differentiated thyroid microcarcinomas

      ea0049ep1390
    • The impact of age and gender on the presentation and prognosis of medullary thyroid cancer - an Israeli multicenter study

      ea0049ep1391
    • Is post-treatment whole body scan useful in differentiated thyroid cancer after thyroid ablation?

      ea0049ep1392
    • Evolution in the management of thyroid cancer: an observational study in two Belgian referral centres

      ea0049ep1393
    • Retrospective analysis of unusual thyroid tumours with clear cell features: morphology and differential diagnosis

      ea0049ep1394
    • Stimulated calcitonin levels as a predictor of medullary thyroid cancer

      ea0049ep1395
    • The relationship between extrathyroidal extension and BRAFV600E mutation in papillary thyroid cancer

      ea0049ep1396
    • Insulin resistance and BRAFV600E mutation in the patients with differentiated thyroid carcinoma

      ea0049ep1397
    • Beware a rapidly enlarging Thyroid mass- a case of Thyroid Lymphoma

      ea0049ep1398
    • Complementary thyroidectomy in papillary thyroid cancer

      ea0049ep1399
    • A case report: co-occurence of medullary thyroid carcinoma and papillary thyroid carcinoma

      ea0049ep1400
    • Thyroid papillary carcinoma in the patients with resistance to thyroid hormone

      ea0049ep1401
    • A rare case: papillary thyroid carcinoma in the ectopic thyroid

      ea0049ep1402
    • Co-occurrence of papillary and follicular thyroid carcinoma in a patient

      ea0049ep1403
    • A rare cause of respiratory failure: Anaplastic carcinoma

      ea0049ep1404
    • Our experience of strain elastography in the evaluation of thyroid nodules

      ea0049ep1405
    • Association of TIMP-3 expression and BRAF V600E mutation status in papillary thyroid cancer

      ea0049ep1406
    • Histologically-proven Hashimoto's thyroiditis significantly decreases the risk of structural recurrence in patients with low risk intra-thyroidal papillary thyroid cancer

      ea0049ep1407
    • Evaluation of disease outcome in patients affected with differentiated thyroid carcinoma treated with total thyroidectomy or lobectomy

      ea0049ep1408
    • Does the delayed risk stratification system help to evaluate the risk of unfavorable clinical outcome in pT1aN0/Nx stage patients with differentiated thyroid cancer treated without radioactive iodine?

      ea0049ep1409
    • The impact of post-radioiodine therapy SPECT/CT on risk stratification in differentiated thyroid cancer; a bi-institutional study

      ea0049ep1410
    • Clinical features of medullary thyroid carcinoma (MTC) in simultaneous occurrence with differentiated thyroid cancer (DTC)

      ea0049ep1411
    • Concomitant thyroid inflammatory myofibroblastic and follicular tumors

      ea0049ep1412
    • Is thyroid imaging reporting and data system useful in prediction of malignancy in thyroid nodules with persistent nondiagnostic cytology?

      ea0049ep1413
    • Significant difference between the prevalence of C cell hyperplasia (CCH) in benign thyroid nodules without histological thyroiditis (HT) and in papillary/follicular thyroid cancers (PTC/FTC) at histology

      ea0049ep1414
    • Primary thyroid lymphoma: a differential diagnosis to be considered

      ea0049ep1415
    • Relation between TSH levels and the aggressiveness of differentiated thyroid carcinomas

      ea0049ep1416
    • Ultrasonographic features of thyroid nodules with suspicious or malignant cytology

      ea0049ep1417
    • Development of papillary thyroid carcinoma in a patient with multiple solid cell nests of the thyroid

      ea0049ep1418
    • Statistical analyses on thyroid cancer in Romania

      ea0049ep1419
    • Prognostic value of preoperative serum calcitonin concentration on primary surgery outcomes in medullary thyroid cancer

      ea0049ep1420
    • Standardized mortality of thyroid cancer in Korea between 1985 and 2015: analysis of Korean national data

      ea0049ep1421
    • Incidental thyroid uptake detected by 68Ga-DOTANOC positron Emission Tomography: is it clinical significant?

      ea0049ep1422
    • An association between breast cancer and the development of thyroid cancer

      ea0049ep1423
    • Lung metastases from differentiated thyroid carcinoma: long term outcome and its prognostic factors related to progression free survival

      ea0049ep1424
    • Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?

      ea0049ep1425
    • A new strategy to estimate levothyroxine requirement after total thyroidectomy and radioiodine remnant ablation for 'intermediate' and 'high' risk differentiated thyroid cancer

      ea0049ep1426
    • Follicular thyroid carcinoma in a patient with graves' disease

      ea0049ep1427
    • Papillary thyroid carcinoma in children: report of 15 cases

      ea0049ep1428
    • Evaluation of differentiated thyroid cancer patients according to different scoring systems: a single center experience

      ea0049ep1429
    • A rare association of thyroid micro carcinoma and thyroid tuberculosis

      ea0049ep1430
    • GA/GG Heterozygosity of ARG280HIS polymorphism in XRCC1 GENE: Genetic susceptibility genotype in differentiated thyroid cancer?

      ea0049ep1431
    • Expression analyses of HABP2 in neoplastic and normal thyroid tissues: could this gene play a role in the pathogenesis of familial non medullary thyroid cancer?

      ea0049ep1432
    • Abstract unavailable

      ea0049ep1433
    • Mutation analysis of papillary thyroid cancers using a newly developed targeted multi-gene panel in Hungarian population

      ea0049ep1434
    • K1 cell line in vitro: the impact of diagnostic absorbed doses from 131I

      ea0049ep1435
    • Massive thyroid gland metastasis from nonsmall cell lung cancer

      ea0049ep1436
    • Papillary thyroid cancer and chronic lymphocytic thyroiditis presenting with diffuse microcalcifications without focal mass on ultrasound

      ea0049ep1437
    • Columnar cell variant of papillary thyroid carcinoma

      ea0049ep1438
    • A higher frequency of papillary thyroid carcinoma in myotonic dystrophy

      ea0049ep1439
    • Management of treatment-related toxicity caused by multi kinase inhibitors administered due to advanced thyroid carcinoma

      ea0049ep1440
    • Cooperation between an endocrine nurse, psychologist and physician and their mediating role in the care of depression in patients treated with multi kinase inhibitors due thyroid cancer

      ea0049ep1441
    • Malignancy risk stratification in thyroid nodules according to the Bethesda system for reporting thyroid cytopathology

      ea0049ep1442
    • The sensitivity and positive predictive value (PPV) of 131I-post-therapy whole body scan is higher than serum Tg values in detecting metastases in early stage of differentiated thyroid cancer patients

      ea0049ep1443
    • Evaluation of clinicopathological factors in papillary thyroid cancer with cervical lymph node metastasis

      ea0049ep1444
    • Theranostic management of medullary thyroid cancer (MTC) with (111In/177Lu) CP04: how close are we to a clinical solution?

      ea0049ep1445
    • Medullary thyroid carcinoma - diagnosis and outcome of patients treated in a tertiary center

      ea0049ep1446
    • Papillary carcinoma of thyroglossal duct cyst with cervical lymph node metastasis

      ea0049ep1447
    • Impact of RAC1/1b signalling on Sodium Iodide symporter regulation

      ea0049ep1448
    • The usefulness of the study of sodium iodide symporter expression in thyroid primary tumors

      ea0049ep1449
    • Concomitant occurrence of papillary thyroid cancer (PTC) in a branchial cleft cyst (BCC) and an occult multifocal PTC in the thyroid gland

      ea0049ep1450
    • Comparative analysis of clinicopathological characteristics between Korean and Italian thyroid cancer patients

      ea0049ep1451
    • Malignant struma ovarii and synchronous tumour of thyroid gland in the same patient: a single pathway for two different tumours?

      ea0049ep1452
    • Does Preoperative Serum Neopterin Level Predict Differentiated Thyroid Carcinoma?

      ea0049ep1453
    • Unexpectedly low thyroglobulin levels in differentiated thyroid carcinoma - case report

      ea0049ep1454
    • Papillary thyroid microcarcinoma: is it worth ablating the patients with radioiodine?

      ea0049ep1455
    • Anaplastic thyroid carcinoma and multinodular toxic goiter

      ea0049ep1456
    • Evaluate the effectiveness of the Bethesda system for reporting thyroid cytopathology in the prediction of thyroid cancer (TBSRTC) on fine needle aspiration (FNA) in Moscow region, Russia

      ea0049ep1457
    • Outcomes and imaging results in patients with medullary thyroid cancer

      ea0049ep1458
    • Lymph node metastasis of differentiated thyroid cancer: role of thyroglobulin in the washout fluid of fine-needle aspiration biopsies

      ea0049ep1459
    • The epidemiology of thyroid cancer within a center of excellence in Athens: Real life data

      ea0049ep1460
    • Is thyroglobulin at ablation a good predictor of the thyroid remnant size in differentiated thyroid cancer?

      ea0049ep1461
    • Prevalence of thyroid cancer in malaga and province

      ea0049ep1462
    • Lymph node metastases location (central vs lateral neck) in well-differentiated thyroid carcinoma: Is it important?

      ea0049ep1463
    • Two cases with metastatic thyroid cancer

      ea0049ep1464
    • Isolated bone metastases: a rare form of presentation of papillary thyroid carcinoma

      ea0049ep1465
    • Association between preoperative serum MMP-9 and histopathological features of thyroid tumors

      ea0049ep1466
    • Follicular thyroid carcinoma and follicular variant papillary thyroid carcinoma: Clinical and histological features depending on the initial size

      ea0049ep1467
    • Ten years of TSH suppression therapy in differentiated thyroid cancer analysed by HR-pQCT

      ea0049ep1468
    • Metastatic papillary thyroid carcinoma with intraglandular dissemination in remission of Graves' disease

      ea0049ep1469
    • Thyroid nodule size and the risk of malignancy

      ea0049ep1470
    • Lateral cervical lymph node metastasis from papillary thyroid cancer of undetected primary: a case report

      ea0049ep1471
    • Birt-Hogg-Dube and papillary thyroid carcinoma: a case report

      ea0049ep1472
    • Diagnosis of papillary thyroid carcinoma: Is it time to reconsider?

      ea0049ep1473
    • Patient with thyroid carcinoma showing thymus-like differentiation: a case study

      ea0049ep1474
    • Minimally and widely invasive follicular thyroid carcinomas: are there significant differences in clinical behaviour and prognosis?

      ea0049ep1475
    • Cystic masses of neck: a case report

      ea0049ep1476
    • Staging of thyroid cancer at the time of its diagnosis in a single clinical centre

      ea0049ep1477
    • Cystic nodule and carcinoma of thyroid gland, diagnosis and treatment of cistic nodule

      ea0049ep1478
    • Incidence of thyroid cancer in the gray bethesda categories

      ea0049ep1479
    • Sentinel lymph node biopsy in medullary thyroid microcarcinoma after methylene blue dye mapping - a pilot study

      ea0049ep1480
    • Lymph node categorization as a prognostic factor in a historical series of medullary thyroid cancer cases within a regional hospital

      ea0049ep1481
    • A case of bilateralmetastaticrenal tumorof thyroid carcinoma

      ea0049ep1482
    • Is prophylactic central cervical dissection in papillary carcinoma of the thyroid justified?

      ea0049ep1483
    • Thyroid cancer frequency over three decades

      ea0049ep1484
    • Thyroid nodules: a huge dilemma!

      ea0049ep1485
    • Timing to repeat thyroid fine-needle aspiration after a follicular lesion of undetermined significance result - does it matter?

      ea0049ep1486
    • Development of hypoparathyroidism due to targeted therapies

      ea0049ep1487